{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:48:14Z","timestamp":1784238494196,"version":"3.55.0"},"publisher-location":"Cham","reference-count":662,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030312053","type":"print"},{"value":"9783030312060","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-31206-0_14","type":"book-chapter","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T08:03:08Z","timestamp":1577952188000},"page":"275-353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Targeting Purinergic Signaling and Cell Therapy in Cardiovascular and Neurodegenerative Diseases"],"prefix":"10.1007","author":[{"given":"Roberta","family":"Andrejew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talita","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gatha","family":"Oliveira-Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deidiane","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Godoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Granato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"issue":"3","key":"14_CR1","first-page":"509","volume":"24","author":"G Burnstock","year":"1972","unstructured":"Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24(3):509\u2013581","journal-title":"Pharmacol Rev"},{"issue":"4","key":"14_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0306-4522(76)90054-3","volume":"1","author":"G Burnstock","year":"1976","unstructured":"Burnstock G (1976) Do some nerve cells release more than one transmitter? Neuroscience 1(4):239\u2013248","journal-title":"Neuroscience"},{"issue":"1","key":"14_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1113\/expphysiol.2008.043620","volume":"94","author":"G Burnstock","year":"2009","unstructured":"Burnstock G (2009) Purinergic cotransmission. Exp Physiol 94(1):20\u201324","journal-title":"Exp Physiol"},{"issue":"1","key":"14_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1590\/S0100-879X2008005000037","volume":"42","author":"G Burnstock","year":"2008","unstructured":"Burnstock G (2008) Purinergic signalling: past, present and future. Braz J Med Biol Res 42(1):3\u20138","journal-title":"Braz J Med Biol Res"},{"key":"14_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/2398212818817494","volume":"2","author":"G Burnstock","year":"2018","unstructured":"Burnstock G (2018) Purine and purinergic receptors. Brain Neurosci Adv 2:239821281881749","journal-title":"Brain Neurosci Adv"},{"issue":"5","key":"14_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/0306-3623(85)90001-1","volume":"16","author":"G Burnstock","year":"1985","unstructured":"Burnstock G, Kennedy C (1985) Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 16(5):433\u2013440","journal-title":"Gen Pharmacol"},{"issue":"11","key":"14_CR7","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1073\/pnas.90.11.5113","volume":"90","author":"KD Lustig","year":"1993","unstructured":"Lustig KD, Shiau AK, Brake AJ, Julius D (1993) Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Natl Acad Sci U S A 90(11):5113\u20135117","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"14_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0014-5793(93)81397-I","volume":"324","author":"TE Webb","year":"1993","unstructured":"Webb TE, Simon J, Krishek BJ, Bateson AN, Smart TG, King BF et al (1993) Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett 324(2):219\u2013225","journal-title":"FEBS Lett"},{"issue":"6497","key":"14_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/371519a0","volume":"371","author":"AJ Brake","year":"1994","unstructured":"Brake AJ, Wagenbach MJ, Julius D (1994) New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371(6497):519\u2013523","journal-title":"Nature"},{"issue":"6497","key":"14_CR10","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/371516a0","volume":"371","author":"S Valera","year":"1994","unstructured":"Valera S, Hussy N, Evans RJ, Adami N, North RA, Surprenant A et al (1994) A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. Nature 371(6497):516\u2013519","journal-title":"Nature"},{"issue":"7","key":"14_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrd2605","volume":"7","author":"G Burnstock","year":"2008","unstructured":"Burnstock G (2008) Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov 7(7):575\u2013590","journal-title":"Nat Rev Drug Discov"},{"issue":"40","key":"14_CR12","doi-asserted-by":"publisher","first-page":"41650","DOI":"10.1074\/jbc.M408203200","volume":"279","author":"KC Agboh","year":"2004","unstructured":"Agboh KC, Webb TE, Evans RJ, Ennion SJ (2004) Functional characterization of a P2X receptor from Schistosoma mansoni. J Biol Chem 279(40):41650\u201341657","journal-title":"J Biol Chem"},{"issue":"7150","key":"14_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nature05926","volume":"448","author":"SJ Fountain","year":"2007","unstructured":"Fountain SJ, Parkinson K, Young MT, Cao L, Thompson CRL, North RA (2007) An intracellular P2X receptor required for osmoregulation in Dictyostelium discoideum. Nature 448(7150):200\u2013203","journal-title":"Nature"},{"issue":"2","key":"14_CR14","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1104\/pp.103.024091","volume":"133","author":"V Demidchik","year":"2003","unstructured":"Demidchik V, Nichols C, Oliynyk M, Dark A, Glover BJ, Davies JM (2003) Is ATP a signaling agent in plants? Plant Physiol 133(2):456\u2013461","journal-title":"Plant Physiol"},{"issue":"3","key":"14_CR15","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1104\/pp.106.085670","volume":"142","author":"S-Y Kim","year":"2006","unstructured":"Kim S-Y, Sivaguru M, Stacey G (2006) Extracellular ATP in plants. Visualization, localization, and analysis of physiological significance in growth and signaling. Plant Physiol 142(3):984\u2013992","journal-title":"Plant Physiol"},{"issue":"8\u20139","key":"14_CR16","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1023\/A:1012388618693","volume":"26","author":"P Bodin","year":"2001","unstructured":"Bodin P, Burnstock G (2001) Purinergic signalling: ATP release. Neurochem Res 26(8\u20139):959\u2013969","journal-title":"Neurochem Res"},{"issue":"2","key":"14_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1152\/physrev.00043.2006","volume":"87","author":"Geoffrey Burnstock","year":"2007","unstructured":"Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87(2):659\u2013797","journal-title":"Physiological Reviews"},{"issue":"3","key":"14_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","volume":"8","author":"H Zimmermann","year":"2012","unstructured":"Zimmermann H, Zebisch M, Str\u00e4ter N (2012) Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal 8(3):437\u2013502","journal-title":"Purinergic Signal"},{"issue":"1700","key":"14_CR19","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2015.0422","volume":"371","author":"G Burnstock","year":"2016","unstructured":"Burnstock G (2016) Short- and long-term (trophic) purinergic signalling. Philos Trans R Soc Lond Ser B Biol Sci 371(1700):20150422","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"9","key":"14_CR20","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S0028-3908(97)00125-1","volume":"36","author":"G Burnstock","year":"1997","unstructured":"Burnstock G (1997) The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 36(9):1127\u20131139","journal-title":"Neuropharmacology"},{"issue":"3","key":"14_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2302\/kjm.2013-0003-RE","volume":"62","author":"G Burnstock","year":"2013","unstructured":"Burnstock G (2013) Purinergic signalling: pathophysiology and therapeutic potential. Keio J Med 62(3):63\u201373","journal-title":"Keio J Med"},{"issue":"5","key":"14_CR22","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.cell.2017.01.042","volume":"168","author":"A Glukhova","year":"2017","unstructured":"Glukhova A, Thal DM, Nguyen AT, Vecchio EA, J\u00f6rg M, Scammells PJ et al (2017) Structure of the adenosine A1 receptor reveals the basis for subtype selectivity. Cell 168(5):867\u2013877.e13","journal-title":"Cell"},{"issue":"8","key":"14_CR23","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1073\/pnas.1621423114","volume":"114","author":"B Sun","year":"2017","unstructured":"Sun B, Bachhawat P, Chu ML-H, Wood M, Ceska T, Sands ZA et al (2017) Crystal structure of the adenosine A2A receptor bound to an antagonist reveals a potential allosteric pocket. Proc Natl Acad Sci U S A 114(8):2066\u20132071","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6027","key":"14_CR24","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1126\/science.1202793","volume":"332","author":"F Xu","year":"2011","unstructured":"Xu F, Wu H, Katritch V, Han GW, Jacobson KA, Gao Z-G et al (2011) Structure of an agonist-bound human A2A adenosine receptor. Science 332(6027):322\u2013327","journal-title":"Science"},{"issue":"1\u20132","key":"14_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cell.2017.12.004","volume":"172","author":"MT Eddy","year":"2018","unstructured":"Eddy MT, Lee M-Y, Gao Z-G, White KL, Didenko T, Horst R et al (2018) Allosteric coupling of drug binding and intracellular signaling in the A2A adenosine receptor. Cell 172(1\u20132):68\u201380.e12","journal-title":"Cell"},{"issue":"5","key":"14_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00424-006-0078-1","volume":"452","author":"TM Egan","year":"2006","unstructured":"Egan TM, Samways DSK, Li Z (2006) Biophysics of P2X receptors. Pflugers Arch 452(5):501\u2013512","journal-title":"Pflugers Arch"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fncel.2014.00006","volume":"8","author":"DSK Samways","year":"2014","unstructured":"Samways DSK, Li Z, Egan TM (2014) Principles and properties of ion flow in P2X receptors. Front Cell Neurosci 8:6","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"14_CR28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11302-012-9314-7","volume":"8","author":"K Kaczmarek-H\u00e1jek","year":"2012","unstructured":"Kaczmarek-H\u00e1jek K, L\u00f6rinczi E, Hausmann R, Nicke A (2012) Molecular and functional properties of P2X receptors\u00a0\u2013 recent progress and persisting challenges. Purinergic Signal 8(3):375\u2013417","journal-title":"Purinergic Signal"},{"issue":"7397","key":"14_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11010","volume":"485","author":"M Hattori","year":"2012","unstructured":"Hattori M, Gouaux E (2012) Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature 485(7397):207\u2013212","journal-title":"Nature"},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"e22153","DOI":"10.7554\/eLife.22153","volume":"5","author":"A Karasawa","year":"2016","unstructured":"Karasawa A, Kawate T (2016) Structural basis for subtype-specific inhibition of the P2X7 receptor. elife 5:e22153","journal-title":"elife"},{"issue":"4","key":"14_CR31","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.celrep.2015.12.087","volume":"14","author":"G Kasuya","year":"2016","unstructured":"Kasuya G, Fujiwara Y, Takemoto M, Dohmae N, Nakada-Nakura Y, Ishitani R et al (2016) Structural insights into divalent cation modulations of ATP-gated P2X receptor channels. Cell Rep 14(4):932\u2013944","journal-title":"Cell Rep"},{"issue":"7255","key":"14_CR32","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nature08198","volume":"460","author":"T Kawate","year":"2009","unstructured":"Kawate T, Michel JC, Birdsong WT, Gouaux E (2009) Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature 460(7255):592\u2013598","journal-title":"Nature"},{"issue":"7623","key":"14_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/nature19367","volume":"538","author":"SE Mansoor","year":"2016","unstructured":"Mansoor SE, L\u00fc W, Oosterheert W, Shekhar M, Tajkhorshid E, Gouaux E (2016) X-ray structures define human P2X(3) receptor gating cycle and antagonist action. Nature 538(7623):66\u201371","journal-title":"Nature"},{"issue":"12","key":"14_CR34","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1634\/stemcells.2005-0588","volume":"24","author":"JS Heo","year":"2006","unstructured":"Heo JS, Han HJ (2006) ATP stimulates mouse embryonic stem cell proliferation via protein kinase C, phosphatidylinositol 3-kinase\/Akt, and mitogen-activated protein kinase signaling pathways. Stem Cells 24(12):2637\u20132648","journal-title":"Stem Cells"},{"issue":"14","key":"14_CR35","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1002\/jnr.21765","volume":"86","author":"JT Neary","year":"2008","unstructured":"Neary JT, Shi Y-F, Kang Y, Tran MD (2008) Opposing effects of P2X(7) and P2Y purine\/pyrimidine-preferring receptors on proliferation of astrocytes induced by fibroblast growth factor-2: implications for CNS development, injury, and repair. J Neurosci Res 86(14):3096\u20133105","journal-title":"J Neurosci Res"},{"issue":"8","key":"14_CR36","doi-asserted-by":"publisher","first-page":"e751","DOI":"10.1038\/cddis.2013.274","volume":"4","author":"H-K Tsao","year":"2013","unstructured":"Tsao H-K, Chiu P-H, Sun SH (2013) PKC-dependent ERK phosphorylation is essential for P2X7 receptor-mediated neuronal differentiation of neural progenitor cells. Cell Death Dis 4(8):e751","journal-title":"Cell Death Dis"},{"issue":"2","key":"14_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/glia.23056","volume":"65","author":"Y Tang","year":"2017","unstructured":"Tang Y, Illes P (2017) Regulation of adult neural progenitor cell functions by purinergic signaling. Glia 65(2):213\u2013230","journal-title":"Glia"},{"issue":"1","key":"14_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0028-3908(01)00157-5","volume":"42","author":"M D\u00edaz-Hern\u00e1ndez","year":"2002","unstructured":"D\u00edaz-Hern\u00e1ndez M, Pintor J, Castro E, Miras-Portugal MT (2002) Co-localisation of functional nicotinic and ionotropic nucleotide receptors in isolated cholinergic synaptic terminals. Neuropharmacology 42(1):20\u201333","journal-title":"Neuropharmacology"},{"issue":"1","key":"14_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1046\/j.1471-4159.2001.t01-1-00228.x","volume":"77","author":"R G\u00f3mez-Villafuertes","year":"2001","unstructured":"G\u00f3mez-Villafuertes R, Gualix J, Miras-Portugal MT (2001) Single GABAergic synaptic terminals from rat midbrain exhibit functional P2X and dinucleotide receptors, able to induce GABA secretion. J Neurochem 77(1):84\u201393","journal-title":"J Neurochem"},{"issue":"1","key":"14_CR40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1046\/j.1471-4159.2003.01975.x","volume":"87","author":"J Gualix","year":"2003","unstructured":"Gualix J, G\u00f3mez-Villafuertes R, D\u00edaz-Hern\u00e1ndez M, Miras-Portugal MT (2003) Presence of functional ATP and dinucleotide receptors in glutamatergic synaptic terminals from rat midbrain. J Neurochem 87(1):160\u2013171","journal-title":"J Neurochem"},{"key":"14_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neuropharm.2015.10.030","volume":"104","author":"I K\u00fcgelgen von","year":"2016","unstructured":"von K\u00fcgelgen I, Hoffmann K (2016) Pharmacology and structure of P2Y receptors. Neuropharmacology 104:50\u201361","journal-title":"Neuropharmacology"},{"key":"14_CR42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainresbull.2019.03.010","volume":"151","author":"I K\u00fcgelgen von","year":"2019","unstructured":"von K\u00fcgelgen I (2019) Pharmacology of P2Y receptors. Brain Res Bull 151:12\u201324","journal-title":"Brain Res Bull"},{"issue":"7498","key":"14_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature13083","volume":"509","author":"K Zhang","year":"2014","unstructured":"Zhang K, Zhang J, Gao Z-G, Zhang D, Zhu L, Han GW et al (2014) Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Nature 509(7498):115\u2013118","journal-title":"Nature"},{"issue":"7498","key":"14_CR44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature13288","volume":"509","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhang K, Gao Z-G, Paoletta S, Zhang D, Han GW et al (2014) Agonist-bound structure of the human P2Y12 receptor. Nature 509(7498):119\u2013122","journal-title":"Nature"},{"issue":"7547","key":"14_CR45","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature14287","volume":"520","author":"D Zhang","year":"2015","unstructured":"Zhang D, Gao Z-G, Zhang K, Kiselev E, Crane S, Wang J et\u00a0al (2015) Two disparate ligand-binding sites in the human P2Y1 receptor. Nature 520(7547):317\u2013321","journal-title":"Nature"},{"issue":"21","key":"14_CR46","doi-asserted-by":"publisher","first-page":"14639","DOI":"10.1074\/jbc.274.21.14639","volume":"274","author":"C Hoffmann","year":"1999","unstructured":"Hoffmann C, Moro S, Nicholas RA, Harden TK, Jacobson KA (1999) The role of amino acids in extracellular loops of the human P2Y1 receptor in surface expression and activation processes. J Biol Chem 274(21):14639\u201314647","journal-title":"J Biol Chem"},{"issue":"11","key":"14_CR47","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1111\/j.1538-7836.2008.03136.x","volume":"6","author":"I Algaier","year":"2008","unstructured":"Algaier I, Jakubowski JA, Asai F, von K\u00fcgelgen I (2008) Interaction of the active metabolite of prasugrel, R-138727, with cysteine 97 and cysteine 175 of the human P2Y12 receptor. J Thromb Haemost 6(11):1908\u20131914","journal-title":"J Thromb Haemost"},{"issue":"1","key":"14_CR48","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1538-7836.2008.03202.x","volume":"7","author":"Z Ding","year":"2009","unstructured":"Ding Z, Bynagari YS, Mada SR, Jakubowski JA, Kunapuli SP (2009) Studies on the role of the extracellular cysteines and oligomeric structures of the P2Y12 receptor when interacting with antagonists. J Thromb Haemost 7(1):232\u2013234","journal-title":"J Thromb Haemost"},{"issue":"9","key":"14_CR49","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1021\/jm801442p","volume":"52","author":"P Hillmann","year":"2009","unstructured":"Hillmann P, Ko G-Y, Spinrath A, Raulf A, von K\u00fcgelgen I, Wolff SC et al (2009) Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling. J Med Chem 52(9):2762\u20132775","journal-title":"J Med Chem"},{"issue":"1","key":"14_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11302-015-9483-2","volume":"12","author":"H Zimmermann","year":"2016","unstructured":"Zimmermann H (2016) Extracellular ATP and other nucleotides\u2014ubiquitous triggers of intercellular messenger release. Purinergic Signal 12(1):25\u201357","journal-title":"Purinergic Signal"},{"issue":"5","key":"14_CR51","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1515\/cmble-2015-0050","volume":"20","author":"K Pucha\u0142owicz","year":"2015","unstructured":"Pucha\u0142owicz K, Baranowska-Bosiacka I, Dziedziejko V, Chlubek D (2015) Purinergic signaling and the functioning of the nervous system cells. Cell Mol Biol Lett 20(5):867\u2013918","journal-title":"Cell Mol Biol Lett"},{"issue":"8","key":"14_CR52","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s00114-002-0344-9","volume":"89","author":"J Ringe","year":"2002","unstructured":"Ringe J, Kaps C, Burmester G-R, Sittinger M (2002) Stem cells for regenerative medicine: advances in the engineering of tissues and organs. Naturwissenschaften 89(8):338\u2013351","journal-title":"Naturwissenschaften"},{"issue":"5","key":"14_CR53","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s12015-013-9443-6","volume":"9","author":"PL Mart\u00ednez-Morales","year":"2013","unstructured":"Mart\u00ednez-Morales PL, Revilla A, Oca\u00f1a I, Gonz\u00e1lez C, Sainz P, McGuire D et al (2013) Progress in stem cell therapy for major human neurological disorders. Stem Cell Rev 9(5):685\u2013699","journal-title":"Stem Cell Rev"},{"issue":"47","key":"14_CR54","doi-asserted-by":"publisher","first-page":"14452","DOI":"10.1073\/pnas.1508520112","volume":"112","author":"AS Mao","year":"2015","unstructured":"Mao AS, Mooney DJ (2015) Regenerative medicine: current therapies and future directions. Proc Natl Acad Sci U S A 112(47):14452\u201314459","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5457","key":"14_CR55","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1126\/science.287.5457.1427","volume":"287","author":"FM Watt","year":"2000","unstructured":"Watt FM, Hogan BL (2000) Out of Eden: stem cells and their niches. Science 287(5457):1427\u20131430","journal-title":"Science"},{"key":"14_CR56","unstructured":"Department of Health and Human Services (2001) Stem cells: scientific progress and future research directions | stemcells.nih.gov"},{"key":"14_CR57","unstructured":"Department of Health and Human Services (2006) Regenerative medicine | stemcells.nih.gov"},{"issue":"1","key":"14_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.nec.2006.10.013","volume":"18","author":"A Qui\u00f1ones-Hinojosa","year":"2007","unstructured":"Qui\u00f1ones-Hinojosa A, Sanai N, Gonzalez-Perez O, Garcia-Verdugo JM (2007) The human brain subventricular zone: stem cells in this niche and its organization. Neurosurg Clin N Am 18(1):15\u201320","journal-title":"Neurosurg Clin N Am"},{"issue":"2","key":"14_CR59","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/path.2474","volume":"217","author":"MR Walker","year":"2009","unstructured":"Walker MR, Patel KK, Stappenbeck TS (2009) The stem cell niche. J Pathol 217(2):169\u2013180","journal-title":"J Pathol"},{"issue":"4","key":"14_CR60","doi-asserted-by":"publisher","first-page":"396","DOI":"10.4161\/cam.3.4.8604","volume":"3","author":"R Xi","year":"2009","unstructured":"Xi R (2009) Anchoring stem cells in the niche by cell adhesion molecules. Cell Adhes Migr 3(4):396\u2013401","journal-title":"Cell Adhes Migr"},{"issue":"9","key":"14_CR61","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/stem.481","volume":"28","author":"MC Florian","year":"2010","unstructured":"Florian MC, Geiger H (2010) Concise review: polarity in stem cells, disease, and aging. Stem Cells 28(9):1623\u20131629","journal-title":"Stem Cells"},{"issue":"4","key":"14_CR62","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2174\/157488811797904362","volume":"6","author":"BZ Barkho","year":"2011","unstructured":"Barkho BZ, Zhao X (2011) Adult neural stem cells: response to stroke injury and potential for therapeutic applications. Curr Stem Cell Res Ther 6(4):327\u2013338","journal-title":"Curr Stem Cell Res Ther"},{"issue":"9","key":"14_CR63","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1039\/c2ib20080e","volume":"4","author":"Kshitiz","year":"2012","unstructured":"Kshitiz, Levchenko A, D-HKKJPPKWHAJE, Park J, Kim P, Helen W, Engler AJ et al (2012) Control of stem cell fate and function by engineering physical microenvironments. Integr Biol 4(9):1008\u20131018","journal-title":"Integr Biol"},{"issue":"1","key":"14_CR64","doi-asserted-by":"publisher","DOI":"10.1088\/1748-6041\/11\/1\/014109","volume":"11","author":"X Lin","year":"2016","unstructured":"Lin X, Shi Y, Cao Y, Liu W (2016) Recent progress in stem cell differentiation directed by material and mechanical cues. Biomed Mater 11(1):014109","journal-title":"Biomed Mater"},{"issue":"1","key":"14_CR65","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5966\/sctm.2013-0118","volume":"3","author":"DM Titmarsh","year":"2014","unstructured":"Titmarsh DM, Chen H, Glass NR, Cooper-White JJ (2014) Concise review: microfluidic technology platforms: poised to accelerate development and translation of stem cell-derived therapies. Stem Cells Transl Med 3(1):81\u201390","journal-title":"Stem Cells Transl Med"},{"issue":"5\u20136","key":"14_CR66","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1089\/ten.tea.2013.0337","volume":"20","author":"XM Ang","year":"2014","unstructured":"Ang XM, Lee MHC, Blocki A, Chen C, Ong LLS, Asada HH et al (2014) Macromolecular crowding amplifies adipogenesis of human bone marrow-derived mesenchymal stem cells by enhancing the pro-adipogenic microenvironment. Tissue Eng Part A 20(5\u20136):966\u2013981","journal-title":"Tissue Eng Part A"},{"issue":"3","key":"14_CR67","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.arr.2013.04.002","volume":"12","author":"SH Yuan","year":"2013","unstructured":"Yuan SH, Shaner M (2013) Bioengineered stem cells in neural development and neurodegeneration research. Ageing Res Rev 12(3):739\u2013748","journal-title":"Ageing Res Rev"},{"issue":"5","key":"14_CR68","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/jcbfm.2013.3","volume":"33","author":"V Donega","year":"2013","unstructured":"Donega V, van Velthoven CTJ, Nijboer CH, Kavelaars A, Heijnen CJ (2013) The endogenous regenerative capacity of the damaged newborn brain: boosting neurogenesis with mesenchymal stem cell treatment. J Cereb Blood Flow Metab 33(5):625\u2013634","journal-title":"J Cereb Blood Flow Metab"},{"key":"14_CR69","first-page":"5","volume":"7","author":"CJ Taylor","year":"2013","unstructured":"Taylor CJ, Jhaveri DJ, Bartlett PF (2013) The therapeutic potential of endogenous hippocampal stem cells for the treatment of neurological disorders. Front Cell Neurosci 7:5","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"14_CR70","first-page":"421","volume":"10","author":"H Chopra","year":"2013","unstructured":"Chopra H, Hans MK, Shetty S (2013) Stem cells-the hidden treasure: a strategic review. Dent Res J (Isfahan) 10(4):421\u2013427","journal-title":"Dent Res J (Isfahan)"},{"key":"14_CR71","first-page":"1600","volume":"19","author":"F Castro-Mu\u00f1ozledo","year":"2013","unstructured":"Castro-Mu\u00f1ozledo F (2013) Review: corneal epithelial stem cells, their niche and wound healing. Mol Vis 19:1600\u20131613","journal-title":"Mol Vis"},{"issue":"16","key":"14_CR72","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1242\/dev.093096","volume":"140","author":"EB Sequerra","year":"2013","unstructured":"Sequerra EB, Costa MR, Menezes JRL, Hedin-Pereira C (2013) Adult neural stem cells: plastic or restricted neuronal fates? Development 140(16):3303\u20133309","journal-title":"Development"},{"key":"14_CR73","first-page":"1","volume-title":"Cellular Quiescence","author":"Wai-Kin So","year":"2017","unstructured":"So WK, Cheung TH (2018) Molecular regulation of cellular quiescence: a perspective from adult stem cells and its niches. In: Methods Mol Biol 1686:1\u201325. https:\/\/doi.org\/10.1007\/978-1-4939-7371-2_1"},{"issue":"12","key":"14_CR74","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1242\/dev.092270","volume":"140","author":"CM Ramsden","year":"2013","unstructured":"Ramsden CM, Powner MB, Carr A-JF, Smart MJK, da Cruz L, Coffey PJ (2013) Stem cells in retinal regeneration: past, present and future. Development 140(12):2576\u20132585","journal-title":"Development"},{"issue":"6137","key":"14_CR75","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1126\/science.1234852","volume":"340","author":"T Sato","year":"2013","unstructured":"Sato T, Clevers H (2013) Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science 340(6137):1190\u20131194","journal-title":"Science"},{"issue":"1","key":"14_CR76","first-page":"3","volume":"76","author":"N Lanthier","year":"2013","unstructured":"Lanthier N, Rubbia-Brandt L, Spahr L (2013) Liver progenitor cells and therapeutic potential of stem cells in human chronic liver diseases. Acta Gastroenterol Belg 76(1):3\u20139","journal-title":"Acta Gastroenterol Belg"},{"issue":"2","key":"14_CR77","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/jcp.21521","volume":"217","author":"M Valtieri","year":"2008","unstructured":"Valtieri M, Sorrentino A (2008) The mesenchymal stromal cell contribution to homeostasis. J Cell Physiol 217(2):296\u2013300","journal-title":"J Cell Physiol"},{"issue":"14","key":"14_CR78","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/cne.24669","volume":"527","author":"S Rastegar","year":"2019","unstructured":"Rastegar S, Parimisetty A, Cassam Sulliman N, Narra SS, Weber S, Rastegar M et al (2019) Expression of adiponectin receptors in the brain of adult zebrafish and mouse: links with neurogenic niches and brain repair. J Comp Neurol 527(14):2317\u20132333. https:\/\/doi.org\/10.1002\/cne.24669","journal-title":"J Comp Neurol"},{"issue":"2","key":"14_CR79","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/jnc.12084","volume":"124","author":"GC Bellenchi","year":"2013","unstructured":"Bellenchi GC, Volpicelli F, Piscopo V, Perrone-Capano C, di Porzio U (2013) Adult neural stem cells: an endogenous tool to repair brain injury? J Neurochem 124(2):159\u2013167","journal-title":"J Neurochem"},{"key":"14_CR80","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fncel.2012.00070","volume":"6","author":"KJ Christie","year":"2013","unstructured":"Christie KJ, Turnley AM (2013) Regulation of endogenous neural stem\/progenitor cells for neural repair\u2014factors that promote neurogenesis and gliogenesis in the normal and damaged brain. Front Cell Neurosci 6:70","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"14_CR81","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.stem.2011.04.007","volume":"8","author":"E Pastrana","year":"2011","unstructured":"Pastrana E, Silva-Vargas V, Doetsch F (2011) Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell 8(5):486\u2013498","journal-title":"Cell Stem Cell"},{"issue":"1","key":"14_CR82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1253\/circj.CJ-13-1440","volume":"78","author":"S Tara","year":"2014","unstructured":"Tara S, Rocco KA, Hibino N, Sugiura T, Kurobe H, Breuer CK et al (2014) Vessel bioengineering. Circ J 78(1):12\u201319","journal-title":"Circ J"},{"key":"14_CR83","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/632972","volume":"2013","author":"N Haque","year":"2013","unstructured":"Haque N, Rahman MT, Abu Kasim NH, Alabsi AM (2013) Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy. ScientificWorldJournal 2013:632972","journal-title":"ScientificWorldJournal"},{"issue":"9","key":"14_CR84","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8(9):726\u2013736","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"14_CR85","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/PSN.0000000000000156","volume":"36","author":"H Warren","year":"2016","unstructured":"Warren H (2016) Embryonic stem cell research. Plast Surg Nurs 36(4):157\u2013161","journal-title":"Plast Surg Nurs"},{"key":"14_CR86","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-319-74470-4_3","volume":"1056","author":"RW Brooks","year":"2018","unstructured":"Brooks RW, Robbins PD (2018) Treating age-related diseases with somatic stem cells. Adv Exp Med Biol 1056:29\u201345","journal-title":"Adv Exp Med Biol"},{"key":"14_CR87","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.mad.2017.08.013","volume":"168","author":"SW Choi","year":"2017","unstructured":"Choi SW, Lee JY, Kang K-S (2017) miRNAs in stem cell aging and age-related disease. Mech Ageing Dev 168:20\u201329","journal-title":"Mech Ageing Dev"},{"key":"14_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5813147","volume":"2019","author":"E Cianflone","year":"2019","unstructured":"Cianflone E, Torella M, Chimenti C, De Angelis A, Beltrami AP, Urbanek K et al (2019) Adult cardiac stem cell aging: a reversible stochastic phenomenon? Oxidative Med Cell Longev 2019:1\u201319","journal-title":"Oxidative Med Cell Longev"},{"issue":"5","key":"14_CR89","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00005-017-0460-z","volume":"65","author":"S Giacoppo","year":"2017","unstructured":"Giacoppo S, Bramanti P, Mazzon E (2017) The transplantation of mesenchymal stem cells derived from unconventional sources: an innovative approach to multiple sclerosis therapy. Arch Immunol Ther Exp 65(5):363\u2013379","journal-title":"Arch Immunol Ther Exp"},{"issue":"2","key":"14_CR90","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","volume":"6","author":"AJ Friedenstein","year":"1968","unstructured":"Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP (1968) Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6(2):230\u2013247","journal-title":"Transplantation"},{"issue":"1","key":"14_CR91","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.htct.2018.05.001","volume":"41","author":"T Debnath","year":"2019","unstructured":"Debnath T, Chelluri LK (2019) Standardization and quality assessment for clinical grade mesenchymal stem cells from human adipose tissue. Hematol Transfus Cell Ther 41(1):7","journal-title":"Hematol Transfus Cell Ther"},{"issue":"7","key":"14_CR92","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3181\/0712-RM-356","volume":"233","author":"CK Rebelatto","year":"2008","unstructured":"Rebelatto CK, Aguiar AM, Moret\u00e3o MP, Senegaglia AC, Hansen P, Barchiki F et al (2008) Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood) 233(7):901\u2013913","journal-title":"Exp Biol Med (Maywood)"},{"key":"14_CR93","doi-asserted-by":"crossref","unstructured":"Iwatani S, Yoshida M, Yamana K, Kurokawa D, Kuroda J, Thwin KKM et al (2019) Isolation and characterization of human umbilical cord-derived mesenchymal stem cells from preterm and term infants. J Vis Exp (143):e58806","DOI":"10.3791\/58806"},{"issue":"1","key":"14_CR94","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00441-017-2699-4","volume":"372","author":"D Bharti","year":"2018","unstructured":"Bharti D, Shivakumar SB, Park J-K, Ullah I, Subbarao RB, Park J-S et al (2018) Comparative analysis of human Wharton\u2019s jelly mesenchymal stem cells derived from different parts of the same umbilical cord. Cell Tissue Res 372(1):51\u201365","journal-title":"Cell Tissue Res"},{"issue":"1","key":"14_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-018-1105-9","volume":"10","author":"L Chen","year":"2019","unstructured":"Chen L, Qu J, Xiang C (2019) The multi-functional roles of menstrual blood-derived stem cells in regenerative medicine. Stem Cell Res Ther 10(1):1","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"14_CR96","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1111\/jcmm.13437","volume":"22","author":"Y Liu","year":"2018","unstructured":"Liu Y, Niu R, Yang F, Yan Y, Liang S, Sun Y et al (2018) Biological characteristics of human menstrual blood-derived endometrial stem cells. J Cell Mol Med 22(3):1627\u20131639","journal-title":"J Cell Mol Med"},{"key":"14_CR97","first-page":"1","volume":"2018","author":"C Wu","year":"2018","unstructured":"Wu C, Chen L, Huang Y, Huang Y, Parolini O, Zhong Q et al (2018) Comparison of the proliferation and differentiation potential of human urine-, placenta decidua basalis-, and bone marrow-derived stem cells. Stem Cells Int 2018:1\u201311","journal-title":"Stem Cells Int"},{"issue":"8","key":"14_CR98","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1182\/blood.V98.8.2396","volume":"98","author":"C Campagnoli","year":"2001","unstructured":"Campagnoli C, Roberts IAG, Kumar S, Bennett PR, Bellantuono I, Fisk NM (2001) Identification of mesenchymal stem\/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98(8):2396\u20132403","journal-title":"Blood"},{"issue":"5","key":"14_CR99","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3727\/000000005783983070","volume":"14","author":"CG Fan","year":"2005","unstructured":"Fan CG, Tang FW, Zhang QJ, Lu SH, Liu HY, Zhao ZM et al (2005) Characterization and neural differentiation of fetal lung mesenchymal stem cells. Cell Transplant 14(5):311\u2013321","journal-title":"Cell Transplant"},{"issue":"11","key":"14_CR100","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1681\/ASN.2006030275","volume":"17","author":"S Gupta","year":"2006","unstructured":"Gupta S, Verfaillie C, Chmielewski D, Kren S, Eidman K, Connaire J et\u00a0al (2006) Isolation and characterization of kidney-derived stem cells. J Am Soc Nephrol 17(11):3028\u20133040","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"14_CR101","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/000313489906500106","volume":"65","author":"JT Williams","year":"1999","unstructured":"Williams JT, Southerland SS, Souza J, Calcutt AF, Cartledge RG (1999) Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg 65(1):22\u201326","journal-title":"Am Surg"},{"key":"14_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/7486279","volume":"2019","author":"V Miceli","year":"2019","unstructured":"Miceli V, Pampalone M, Vella S, Carreca AP, Amico G, Conaldi PG (2019) Comparison of immunosuppressive and angiogenic properties of human amnion-derived mesenchymal stem cells between 2D and 3D culture systems. Stem Cells Int 2019:1\u201316","journal-title":"Stem Cells Int"},{"key":"14_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2041731417702531","volume":"8","author":"EP Chalisserry","year":"2017","unstructured":"Chalisserry EP, Nam SY, Park SH, Anil S (2017) Therapeutic potential of dental stem cells. J Tissue Eng 8:1\u201317","journal-title":"J Tissue Eng"},{"issue":"5","key":"14_CR104","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3390\/ijms20051132","volume":"20","author":"Y Yamada","year":"2019","unstructured":"Yamada Y, Nakamura-Yamada S, Kusano K, Baba S (2019) Clinical potential and current progress of dental pulp stem cells for various systemic diseases in regenerative medicine: a concise review. Int J Mol Sci 20(5):1132","journal-title":"Int J Mol Sci"},{"key":"14_CR105","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315","journal-title":"Cytotherapy"},{"issue":"5","key":"14_CR106","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/14653240500319234","volume":"7","author":"EM Horwitz","year":"2005","unstructured":"Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC et al (2005) Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 7(5):393\u2013395","journal-title":"Cytotherapy"},{"issue":"3","key":"14_CR107","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/stem.269","volume":"28","author":"HK Salem","year":"2010","unstructured":"Salem HK, Thiemermann C (2010) Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28(3):585\u2013596","journal-title":"Stem Cells"},{"issue":"1","key":"14_CR108","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/ar2116","volume":"9","author":"CM Kolf","year":"2007","unstructured":"Kolf CM, Cho E, Tuan RS (2007) Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9(1):204","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"14_CR109","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1073\/pnas.1812951116","volume":"116","author":"GC Yeo","year":"2019","unstructured":"Yeo GC, Weiss AS (2019) Soluble matrix protein is a potent modulator of mesenchymal stem cell performance. Proc Natl Acad Sci 116(6):2042\u20132051","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"14_CR110","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1634\/stemcells.2007-1122","volume":"26","author":"L Silva Meirelles da","year":"2008","unstructured":"da Silva Meirelles L, Caplan AI, Nardi NB (2008) In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26(9):2287\u20132299","journal-title":"Stem Cells"},{"issue":"2","key":"14_CR111","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/path.2469","volume":"217","author":"AI Caplan","year":"2009","unstructured":"Caplan AI (2009) Why are MSCs therapeutic? New data: new insight. J Pathol 217(2):318\u2013324","journal-title":"J Pathol"},{"issue":"5","key":"14_CR112","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1359\/jbmr.1998.13.5.828","volume":"13","author":"MJ Doherty","year":"1998","unstructured":"Doherty MJ, Ashton BA, Walsh S, Beresford JN, Grant ME, Canfield AE (1998) Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res 13(5):828\u2013838","journal-title":"J Bone Miner Res"},{"key":"14_CR113","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.stem.2008.08.008","volume":"3","author":"AI Caplan","year":"2008","unstructured":"Caplan AI (2008) All MSCs are pericytes? Cell Stem Cell 3:229","journal-title":"Cell Stem Cell"},{"issue":"3","key":"14_CR114","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","volume":"3","author":"M Crisan","year":"2008","unstructured":"Crisan M, Yap S, Casteilla L, Chen C-W, Corselli M, Park TS et al (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3(3):301\u2013313","journal-title":"Cell Stem Cell"},{"issue":"15","key":"14_CR115","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1161\/01.CIR.0000144457.55518.E5","volume":"110","author":"C Farrington-Rock","year":"2004","unstructured":"Farrington-Rock C, Crofts NJ, Doherty MJ, Ashton BA, Griffin-Jones C, Canfield AE (2004) Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 110(15):2226\u20132232","journal-title":"Circulation"},{"issue":"3","key":"14_CR116","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/ncb1542","volume":"9","author":"A Dellavalle","year":"2007","unstructured":"Dellavalle A, Sampaolesi M, Tonlorenzi R, Tagliafico E, Sacchetti B, Perani L et al (2007) Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9(3):255\u2013267","journal-title":"Nat Cell Biol"},{"issue":"6","key":"14_CR117","doi-asserted-by":"publisher","first-page":"510","DOI":"10.5966\/sctm.2012-0002","volume":"1","author":"AW James","year":"2012","unstructured":"James AW, Zara JN, Zhang X, Askarinam A, Goyal R, Chiang M et al (2012) Perivascular stem cells: a prospectively purified mesenchymal stem cell population for bone tissue engineering. Stem Cells Transl Med 1(6):510\u2013519","journal-title":"Stem Cells Transl Med"},{"issue":"11\u201312","key":"14_CR118","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1089\/ten.tea.2012.0367","volume":"19","author":"A Askarinam","year":"2013","unstructured":"Askarinam A, James AW, Zara JN, Goyal R, Corselli M, Pan A et al (2013) Human perivascular stem cells show enhanced osteogenesis and vasculogenesis with Nel-like molecule I protein. Tissue Eng Part A 19(11\u201312):1386\u20131397","journal-title":"Tissue Eng Part A"},{"issue":"5\u20136","key":"14_CR119","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.cytogfr.2009.10.014","volume":"20","author":"C-W Chen","year":"2009","unstructured":"Chen C-W, Montelatici E, Crisan M, Corselli M, Huard J, Lazzari L et al (2009) Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both? Cytokine Growth Factor Rev 20(5\u20136):429\u2013434","journal-title":"Cytokine Growth Factor Rev"},{"issue":"12","key":"14_CR120","doi-asserted-by":"publisher","first-page":"9005","DOI":"10.1167\/iovs.11-8008","volume":"52","author":"Z Tu","year":"2011","unstructured":"Tu Z, Li Y, Smith DS, Sheibani N, Huang S, Kern T et al (2011) Retinal pericytes inhibit activated T cell proliferation. Invest Ophthalmol Vis Sci 52(12):9005\u20139010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"14_CR121","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0014-4800(70)90084-5","volume":"13","author":"DJ Crocker","year":"1970","unstructured":"Crocker DJ, Murad TM, Geer JC (1970) Role of the pericyte in wound healing. An ultrastructural study. Exp Mol Pathol 13(1):51\u201365","journal-title":"Exp Mol Pathol"},{"issue":"11","key":"14_CR122","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/nn.2946","volume":"14","author":"EA Winkler","year":"2011","unstructured":"Winkler EA, Bell RD, Zlokovic BV (2011) Central nervous system pericytes in health and disease. Nat Neurosci 14(11):1398\u20131405","journal-title":"Nat Neurosci"},{"issue":"1","key":"14_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0847-6","volume":"122","author":"T Dalkara","year":"2011","unstructured":"Dalkara T, Gursoy-Ozdemir Y, Yemisci M (2011) Brain microvascular pericytes in health and disease. Acta Neuropathol 122(1):1\u20139","journal-title":"Acta Neuropathol"},{"issue":"7112","key":"14_CR124","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nature05193","volume":"443","author":"CM Peppiatt","year":"2006","unstructured":"Peppiatt CM, Howarth C, Mobbs P, Attwell D (2006) Bidirectional control of CNS capillary diameter by pericytes. Nature 443(7112):700\u2013704","journal-title":"Nature"},{"issue":"7323","key":"14_CR125","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nature09513","volume":"468","author":"R Daneman","year":"2010","unstructured":"Daneman R, Zhou L, Kebede AA, Barres BA (2010) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468(7323):562\u2013566","journal-title":"Nature"},{"issue":"7323","key":"14_CR126","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik A, Genov\u00e9 G, M\u00e4e M, Nisancioglu MH, Wallgard E, Niaudet C et al (2010) Pericytes regulate the blood-brain barrier. Nature 468(7323):557\u2013561","journal-title":"Nature"},{"issue":"5","key":"14_CR127","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcb.20886","volume":"98","author":"AI Caplan","year":"2006","unstructured":"Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98(5):1076\u20131084","journal-title":"J Cell Biochem"},{"issue":"4","key":"14_CR128","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1212\/WNL.59.4.514","volume":"59","author":"Y Li","year":"2002","unstructured":"Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX et al (2002) Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59(4):514\u2013523","journal-title":"Neurology"},{"issue":"3","key":"14_CR129","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1089\/154732804323099190","volume":"13","author":"W Zhang","year":"2004","unstructured":"Zhang W, Ge W, Li C, You S, Liao L, Han Q et al (2004) Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev 13(3):263\u2013271","journal-title":"Stem Cells Dev"},{"issue":"1","key":"14_CR130","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ymthe.2004.09.020","volume":"11","author":"K Kurozumi","year":"2005","unstructured":"Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Ishii K, Kobune M et al (2005) Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 11(1):96\u2013104","journal-title":"Mol Ther"},{"issue":"4","key":"14_CR131","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.coph.2006.02.008","volume":"6","author":"M Krampera","year":"2006","unstructured":"Krampera M, Pasini A, Pizzolo G, Cosmi L, Romagnani S, Annunziato F (2006) Regenerative and immunomodulatory potential of mesenchymal stem cells. Curr Opin Pharmacol 6(4):435\u2013441","journal-title":"Curr Opin Pharmacol"},{"issue":"50","key":"14_CR132","doi-asserted-by":"publisher","first-page":"18171","DOI":"10.1073\/pnas.0508945102","volume":"102","author":"JR Munoz","year":"2005","unstructured":"Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ (2005) Human stem\/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci U S A 102(50):18171\u201318176","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"14_CR133","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1161\/CIRCULATIONAHA.109.863084","volume":"120","author":"LM Barbosa da Fonseca","year":"2009","unstructured":"Barbosa da Fonseca LM, Battistella V, de Freitas GR, Gutfilen B, dos Santos Goldenberg RC, Maiolino A et al (2009) Early tissue distribution of bone marrow mononuclear cells after intra-arterial delivery in a patient with chronic stroke. Circulation 120(6):539\u2013541","journal-title":"Circulation"},{"issue":"2","key":"14_CR134","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3727\/096368909X479677","volume":"19","author":"ACM Assis","year":"2010","unstructured":"Assis ACM, Carvalho JL, Jacoby BA, Ferreira RLB, Castanheira P, Diniz SOF et al (2010) Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart. Cell Transplant 19(2):219\u2013230","journal-title":"Cell Transplant"},{"key":"14_CR135","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/342968","volume":"2012","author":"SK Kang","year":"2012","unstructured":"Kang SK, Shin IS, Ko MS, Jo JY, Ra JC (2012) Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy. Stem Cells Int 2012:342968","journal-title":"Stem Cells Int"},{"key":"14_CR136","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cellimm.2015.01.002","volume":"293","author":"T Gharibi","year":"2015","unstructured":"Gharibi T, Ahmadi M, Seyfizadeh N, Jadidi-Niaragh F, Yousefi M (2015) Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis. Cell Immunol 293:113","journal-title":"Cell Immunol"},{"issue":"11","key":"14_CR137","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1080\/10428190802455875","volume":"49","author":"Z Zhi-Gang","year":"2008","unstructured":"Zhi-Gang Z, Wei-Ming L, Zhi-Chao C, Yong Y, Ping Z (2008) Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patient with hematological malignant diseases. Leuk Lymphoma 49(11):2187\u20132195","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"14_CR138","first-page":"608","volume":"7","author":"Z Ye","year":"2008","unstructured":"Ye Z, Wang Y, Xie H-Y, Zheng S-S (2008) Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells. Hepatobiliary Pancreat Dis Int 7(6):608\u2013614","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"7","key":"14_CR139","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1182\/blood-2004-09-3696","volume":"105","author":"S Glennie","year":"2005","unstructured":"Glennie S, Soeiro I, Dyson PJ, Lam EW-F, Dazzi F (2005) Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105(7):2821\u20132827","journal-title":"Blood"},{"issue":"8","key":"14_CR140","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","volume":"76","author":"I Rasmusson","year":"2003","unstructured":"Rasmusson I, Ringd\u00e9n O, Sundberg B, Le Blanc K (2003) Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76(8):1208\u20131213","journal-title":"Transplantation"},{"issue":"5","key":"14_CR141","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/ndt\/gfr015","volume":"26","author":"S Gatti","year":"2011","unstructured":"Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetta C et al (2011) Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 26(5):1474\u20131483","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"14_CR142","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2217\/rme.11.35","volume":"6","author":"RC Lai","year":"2011","unstructured":"Lai RC, Chen TS, Lim SK (2011) Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med 6(4):481\u2013492","journal-title":"Regen Med"},{"issue":"11","key":"14_CR143","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/jcbfm.2013.152","volume":"33","author":"H Xin","year":"2013","unstructured":"Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, Chopp M (2013) Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab 33(11):1711\u20131715","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"14_CR144","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/scd.2012.0395","volume":"22","author":"T Li","year":"2013","unstructured":"Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L et al (2013) Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev 22(6):845\u2013854","journal-title":"Stem Cells Dev"},{"issue":"5","key":"14_CR145","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nm.2769","volume":"18","author":"DJ Prockop","year":"2012","unstructured":"Prockop DJ (2012) Mitochondria to the rescue. Nat Med 18(5):653\u2013654","journal-title":"Nat Med"},{"issue":"5","key":"14_CR146","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nm.2736","volume":"18","author":"MN Islam","year":"2012","unstructured":"Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K et al (2012) Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 18(5):759\u2013765","journal-title":"Nat Med"},{"issue":"3","key":"14_CR147","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032778","volume":"7","author":"YM Cho","year":"2012","unstructured":"Cho YM, Kim JH, Kim M, Park SJ, Koh SH, Ahn HS et al (2012) Mesenchymal stem cells transfer mitochondria to the cells with virtually no mitochondrial function but not with pathogenic mtDNA mutations. Moran M, editor. PLoS One 7(3):e32778","journal-title":"PLoS One"},{"key":"14_CR148","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.mito.2015.02.006","volume":"22","author":"H-Y Lin","year":"2015","unstructured":"Lin H-Y, Liou C-W, Chen S-D, Hsu T-Y, Chuang J-H, Wang P-W et al (2015) Mitochondrial transfer from Wharton\u2019s jelly-derived mesenchymal stem cells to mitochondria-defective cells recaptures impaired mitochondrial function. Mitochondrion 22:31\u201344","journal-title":"Mitochondrion"},{"key":"14_CR149","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.semcdb.2016.02.011","volume":"52","author":"Y-C Hsu","year":"2016","unstructured":"Hsu Y-C, Wu Y-T, Yu T-H, Wei Y-H (2016) Mitochondria in mesenchymal stem cell biology and cell therapy: from cellular differentiation to mitochondrial transfer. Semin Cell Dev Biol 52:119\u2013131","journal-title":"Semin Cell Dev Biol"},{"key":"14_CR150","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3389\/fphys.2018.01572","volume":"9","author":"C Newell","year":"2018","unstructured":"Newell C, Sabouny R, Hittel DS, Shutt TE, Khan A, Klein MS et al (2018) Mesenchymal stem cells shift mitochondrial dynamics and enhance oxidative phosphorylation in recipient cells. Front Physiol 9:1572","journal-title":"Front Physiol"},{"issue":"3","key":"14_CR151","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004722","volume":"4","author":"A Yuan","year":"2009","unstructured":"Yuan A, Farber EL, Rapoport AL, Tejada D, Deniskin R, Akhmedov NB et al (2009) Transfer of microRNAs by embryonic stem cell microvesicles. Lewin A, editor. PLoS One 4(3):e4722","journal-title":"PLoS One"},{"issue":"7","key":"14_CR152","doi-asserted-by":"publisher","first-page":"e11803","DOI":"10.1371\/journal.pone.0011803","volume":"5","author":"F Collino","year":"2010","unstructured":"Collino F, Deregibus MC, Bruno S, Sterpone L, Aghemo G, Viltono L et al (2010) Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One 5(7):e11803","journal-title":"PLoS One"},{"issue":"8","key":"14_CR153","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1093\/ndt\/gfs168","volume":"27","author":"L Biancone","year":"2012","unstructured":"Biancone L, Bruno S, Deregibus MC, Tetta C, Camussi G (2012) Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant 27(8):3037\u20133042","journal-title":"Nephrol Dial Transplant"},{"key":"14_CR154","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3389\/fphys.2012.00359","volume":"3","author":"SR Baglio","year":"2012","unstructured":"Baglio SR, Pegtel DM, Baldini N (2012) Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol 3:359","journal-title":"Front Physiol"},{"issue":"1","key":"14_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-013-1084-8","volume":"113","author":"JC Akers","year":"2013","unstructured":"Akers JC, Gonda D, Kim R, Carter BS, Chen CC (2013) Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neuro-Oncol 113(1):1\u201311","journal-title":"J Neuro-Oncol"},{"issue":"11","key":"14_CR156","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/3305","volume":"4","author":"PS Eriksson","year":"1998","unstructured":"Eriksson PS, Perfilieva E, Bj\u00f6rk-Eriksson T, Alborn A-M, Nordborg C, Peterson DA et al (1998) Neurogenesis in the adult human hippocampus. Nat Med 4(11):1313\u20131317","journal-title":"Nat Med"},{"issue":"12","key":"14_CR157","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1007\/s000180200012","volume":"59","author":"JC Conover","year":"2002","unstructured":"Conover JC, Allen RL (2002) The subventricular zone: new molecular and cellular developments. Cell Mol Life Sci 59(12):2128\u20132135","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"14_CR158","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/(SICI)1097-0029(19980401)41:1<2::AID-JEMT2>3.0.CO;2-Z","volume":"41","author":"JE Bruni","year":"1998","unstructured":"Bruni JE (1998) Ependymal development, proliferation, and functions: a review. Microsc Res Tech 41(1):2\u201313","journal-title":"Microsc Res Tech"},{"issue":"11","key":"14_CR159","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1523\/JNEUROSCI.19-11-04462.1999","volume":"19","author":"BJ Chiasson","year":"1999","unstructured":"Chiasson BJ, Tropepe V, Morshead CM, van der Kooy D (1999) Adult mammalian forebrain ependymal and subependymal cells demonstrate proliferative potential, but only subependymal cells have neural stem cell characteristics. J Neurosci 19(11):4462\u20134471","journal-title":"J Neurosci"},{"issue":"6","key":"14_CR160","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0092-8674(00)80783-7","volume":"97","author":"F Doetsch","year":"1999","unstructured":"Doetsch F, Caill\u00e9 I, Lim DA, Garc\u00eda-Verdugo JM, Alvarez-Buylla A (1999) Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97(6):703\u2013716","journal-title":"Cell"},{"issue":"11","key":"14_CR161","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/nn1144","volume":"6","author":"F Doetsch","year":"2003","unstructured":"Doetsch F (2003) The glial identity of neural stem cells. Nat Neurosci 6(11):1127\u20131134","journal-title":"Nat Neurosci"},{"issue":"9","key":"14_CR162","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1046\/j.1460-9568.2002.02238.x","volume":"16","author":"B Winner","year":"2002","unstructured":"Winner B, Cooper-Kuhn CM, Aigner R, Winkler J, Kuhn HG (2002) Long-term survival and cell death of newly generated neurons in the adult rat olfactory bulb. Eur J Neurosci 16(9):1681\u20131689","journal-title":"Eur J Neurosci"},{"issue":"6","key":"14_CR163","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1523\/JNEUROSCI.16-06-02027.1996","volume":"16","author":"HG Kuhn","year":"1996","unstructured":"Kuhn HG, Dickinson-Anson H, Gage FH (1996) Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 16(6):2027\u20132033","journal-title":"J Neurosci"},{"issue":"18","key":"14_CR164","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.1523\/JNEUROSCI.21-18-07153.2001","volume":"21","author":"B Seri","year":"2001","unstructured":"Seri B, Garc\u00eda-Verdugo JM, McEwen BS, Alvarez-Buylla A (2001) Astrocytes give rise to new neurons in the adult mammalian hippocampus. J Neurosci 21(18):7153\u20137160","journal-title":"J Neurosci"},{"issue":"5457","key":"14_CR165","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1126\/science.287.5457.1433","volume":"287","author":"FH Gage","year":"2000","unstructured":"Gage FH (2000) Mammalian neural stem cells. Science 287(5457):1433\u20131438","journal-title":"Science"},{"issue":"3","key":"14_CR166","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1073\/pnas.0710000105","volume":"105","author":"V Coskun","year":"2008","unstructured":"Coskun V, Wu H, Blanchi B, Tsao S, Kim K, Zhao J et\u00a0al (2008) CD133+ neural stem cells in the ependyma of mammalian postnatal forebrain. Proc Natl Acad Sci U S A 105(3):1026\u20131031","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"14_CR167","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1523\/JNEUROSCI.0224-08.2008","volume":"28","author":"J Luo","year":"2008","unstructured":"Luo J, Shook BA, Daniels SB, Conover JC (2008) Subventricular zone-mediated ependyma repair in the adult mammalian brain. J Neurosci 28(14):3804\u20133813","journal-title":"J Neurosci"},{"issue":"5","key":"14_CR168","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.tins.2005.03.005","volume":"28","author":"P-M Lledo","year":"2005","unstructured":"Lledo P-M, Saghatelyan A (2005) Integrating new neurons into the adult olfactory bulb: joining the network, life-death decisions, and the effects of sensory experience. Trends Neurosci 28(5):248\u2013254","journal-title":"Trends Neurosci"},{"issue":"3","key":"14_CR169","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nrn1867","volume":"7","author":"P-M Lledo","year":"2006","unstructured":"Lledo P-M, Alonso M, Grubb MS (2006) Adult neurogenesis and functional plasticity in neuronal circuits. Nat Rev Neurosci 7(3):179\u2013193","journal-title":"Nat Rev Neurosci"},{"issue":"46","key":"14_CR170","doi-asserted-by":"publisher","first-page":"10729","DOI":"10.1523\/JNEUROSCI.2250-05.2005","volume":"25","author":"SSP Magavi","year":"2005","unstructured":"Magavi SSP, Mitchell BD, Szentirmai O, Carter BS, Macklis JD (2005) Adult-born and preexisting olfactory granule neurons undergo distinct experience-dependent modifications of their olfactory responses in vivo. J Neurosci 25(46):10729\u201310739","journal-title":"J Neurosci"},{"issue":"5634","key":"14_CR171","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"L Santarelli","year":"2003","unstructured":"Santarelli L (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301(5634):805\u2013809","journal-title":"Science"},{"issue":"6","key":"14_CR172","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/j.1460-9568.2011.07614.x","volume":"33","author":"BA Samuels","year":"2011","unstructured":"Samuels BA, Hen R (2011) Neurogenesis and affective disorders. Eur J Neurosci 33(6):1152\u20131159","journal-title":"Eur J Neurosci"},{"issue":"1","key":"14_CR173","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41598-018-38140-y","volume":"9","author":"AC Ferreira","year":"2019","unstructured":"Ferreira AC, Novais A, Sousa N, Sousa JC, Marques F (2019) Voluntary running rescues the defective hippocampal neurogenesis and behaviour observed in lipocalin 2-null mice. Sci Rep 9(1):1649","journal-title":"Sci Rep"},{"issue":"3","key":"14_CR174","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00441-017-2735-4","volume":"373","author":"T Toda","year":"2018","unstructured":"Toda T, Gage FH (2018) Review: adult neurogenesis contributes to hippocampal plasticity. Cell Tissue Res 373(3):693\u2013709","journal-title":"Cell Tissue Res"},{"key":"14_CR175","first-page":"1","volume":"2018","author":"H Zhou","year":"2018","unstructured":"Zhou H, Wang B, Sun H, Xu X, Wang Y (2018) Epigenetic regulations in neural stem cells and neurological diseases. Stem Cells Int 2018:1\u201310","journal-title":"Stem Cells Int"},{"issue":"5391","key":"14_CR176","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145\u20131147","journal-title":"Science"},{"key":"14_CR177","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663","journal-title":"Cell"},{"issue":"5","key":"14_CR178","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861\u2013872","journal-title":"Cell"},{"issue":"6","key":"14_CR179","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s12015-017-9766-9","volume":"13","author":"A Chhabra","year":"2017","unstructured":"Chhabra A (2017) Derivation of human induced pluripotent stem cell (iPSC) lines and mechanism of pluripotency: historical perspective and recent advances. Stem Cell Rev Rep 13(6):757\u2013773","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"14_CR180","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40164-018-0122-9","volume":"7","author":"H Xu","year":"2018","unstructured":"Xu H, Jiao Y, Qin S, Zhao W, Chu Q, Wu K (2018) Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine. Exp Hematol Oncol 7(1):30","journal-title":"Exp Hematol Oncol"},{"key":"14_CR181","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/4568979","volume":"2019","author":"K Ben M\u2019Barek","year":"2019","unstructured":"Ben M\u2019Barek K, Monville C (2019) Cell therapy for retinal dystrophies: from cell suspension formulation to complex retinal tissue bioengineering. Stem Cells Int 2019:1\u201314","journal-title":"Stem Cells Int"},{"key":"14_CR182","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fcell.2015.00002","volume":"3","author":"VK Singh","year":"2015","unstructured":"Singh VK, Kalsan M, Kumar N, Saini A, Chandra R (2015) Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery. Front Cell Dev Biol 3:2","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"14_CR183","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/toxsci\/kft239","volume":"137","author":"S Kameoka","year":"2014","unstructured":"Kameoka S, Babiarz J, Kolaja K, Chiao E (2014) A high-throughput screen for teratogens using human pluripotent stem cells. Toxicol Sci 137(1):76\u201390","journal-title":"Toxicol Sci"},{"issue":"10","key":"14_CR184","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.18632\/aging.101309","volume":"9","author":"F Colasuonno","year":"2017","unstructured":"Colasuonno F, Borghi R, Niceforo A, Muzzi M, Bertini E, Di Giulio A et al (2017) Senescence-associated ultrastructural features of long-term cultures of induced pluripotent stem cells (iPSCs). Aging (Albany NY) 9(10):2209\u20132222","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"14_CR185","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s12015-009-9062-4","volume":"5","author":"A Zarzeczny","year":"2009","unstructured":"Zarzeczny A, Caulfield T (2009) Emerging ethical, legal and social issues associated with stem cell research & and the current role of the moral status of the embryo. Stem Cell Rev 5(2):96\u2013101","journal-title":"Stem Cell Rev"},{"issue":"6859","key":"14_CR186","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/35102154","volume":"414","author":"PJ Donovan","year":"2001","unstructured":"Donovan PJ, Gearhart J (2001) The end of the beginning for pluripotent stem cells. Nature 414(6859):92\u201397","journal-title":"Nature"},{"issue":"6","key":"14_CR187","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1089\/cell.2012.0039","volume":"14","author":"H Rezanejad","year":"2012","unstructured":"Rezanejad H, Matin MM (2012) Induced pluripotent stem cells: progress and future perspectives in the stem cell world. Cell Reprogram 14(6):459\u2013470","journal-title":"Cell Reprogram"},{"issue":"4","key":"14_CR188","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10897-013-9572-8","volume":"22","author":"B Kirkpatrick","year":"2013","unstructured":"Kirkpatrick B, Hercher L, Facio F, Fonda J, Hahn S, Sapp J et\u00a0al (2013) Stem cell research and therapy: the position of the National Society of Genetic Counselors. J Genet Couns 22(4):407\u2013410","journal-title":"J Genet Couns"},{"issue":"4","key":"14_CR189","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2174\/1389450119666180831095830","volume":"20","author":"R Sharma","year":"2019","unstructured":"Sharma R (2019) Stem cells and tissue engineering in medical practice: ethical and regulatory policies. Curr Drug Targets 20(4):388\u2013398","journal-title":"Curr Drug Targets"},{"issue":"7471","key":"14_CR190","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature12586","volume":"502","author":"M Abad","year":"2013","unstructured":"Abad M, Mosteiro L, Pantoja C, Ca\u00f1amero M, Rayon T, Ors I et al (2013) Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature 502(7471):340\u2013345","journal-title":"Nature"},{"issue":"1","key":"14_CR191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/scd.2013.0266","volume":"23","author":"D Lukovic","year":"2014","unstructured":"Lukovic D, Stojkovic M, Moreno-Manzano V, Bhattacharya SS, Erceg S (2014) Perspectives and future directions of human pluripotent stem cell-based therapies: lessons from Geron\u2019s clinical trial for spinal cord injury. Stem Cells Dev 23(1):1\u20134","journal-title":"Stem Cells Dev"},{"issue":"5","key":"14_CR192","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/btpr.1794","volume":"29","author":"LR Geuss","year":"2013","unstructured":"Geuss LR, Suggs LJ (2013) Making cardiomyocytes: how mechanical stimulation can influence differentiation of pluripotent stem cells. Biotechnol Prog 29(5):1089\u20131096","journal-title":"Biotechnol Prog"},{"issue":"11","key":"14_CR193","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jcma.2013.07.007","volume":"76","author":"C-H Chiang","year":"2013","unstructured":"Chiang C-H, Huo T-I, Sun C-C, Hsieh J-H, Chien Y, Lu K-H et al (2013) Induced pluripotent stem cells and hepatic differentiation. J Chin Med Assoc 76(11):599\u2013605","journal-title":"J Chin Med Assoc"},{"issue":"1","key":"14_CR194","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12967-016-1097-0","volume":"14","author":"MP Walczak","year":"2016","unstructured":"Walczak MP, Drozd AM, Stoczynska-Fidelus E, Rieske P, Grzela DP (2016) Directed differentiation of human iPSC into insulin producing cells is improved by induced expression of PDX1 and NKX6.1 factors in IPC progenitors. J Transl Med 14(1):341","journal-title":"J Transl Med"},{"issue":"6","key":"14_CR195","doi-asserted-by":"publisher","first-page":"8443","DOI":"10.1002\/jcp.27769","volume":"234","author":"BK Velmurugan","year":"2019","unstructured":"Velmurugan BK, Bharathi Priya L, Poornima P, Lee L, Baskaran R (2019) Biomaterial aided differentiation and maturation of induced pluripotent stem cells. J Cell Physiol 234(6):8443\u20138454","journal-title":"J Cell Physiol"},{"key":"14_CR196","doi-asserted-by":"publisher","first-page":"340","DOI":"10.15283\/ijsc18123","volume":"12","author":"M-S Lim","year":"2019","unstructured":"Lim M-S, Ko SH, Kim MS, Lee B, Jung H-S, Kim K et al (2019) Hybrid nanofiber scaffold-based direct conversion of neural precursor cells\/dopamine neurons. Int J Stem Cells 12:340","journal-title":"Int J Stem Cells"},{"issue":"1","key":"14_CR197","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13287-018-0824-2","volume":"9","author":"RP Tan","year":"2018","unstructured":"Tan RP, Chan AHP, Lennartsson K, Miravet MM, Lee BSL, Rnjak-Kovacina J et\u00a0al (2018) Integration of induced pluripotent stem cell-derived endothelial cells with polycaprolactone\/gelatin-based electrospun scaffolds for enhanced therapeutic angiogenesis. Stem Cell Res Ther 9(1):70","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"14_CR198","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3727\/096368913X674639","volume":"24","author":"H-F Chen","year":"2015","unstructured":"Chen H-F, Yu C-Y, Chen M-J, Chou S-H, Chiang M-S, Chou W-H et al (2015) Characteristic expression of major histocompatibility complex and immune privilege genes in human pluripotent stem cells and their derivatives. Cell Transplant 24(5):845\u2013864","journal-title":"Cell Transplant"},{"issue":"7227","key":"14_CR199","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nature07677","volume":"457","author":"AD Ebert","year":"2009","unstructured":"Ebert AD, Yu J, Rose FF, Mattis VB, Lorson CL, Thomson JA et al (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457(7227):277\u2013280","journal-title":"Nature"},{"issue":"7","key":"14_CR200","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3727\/096368911X600957","volume":"21","author":"S Paulsen B da","year":"2012","unstructured":"Paulsen B da S, de Moraes Maciel R, Galina A, Souza da Silveira M, dos Santos Souza C, Drummond H et al (2012) Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient. Cell Transplant 21(7):1547\u20131559","journal-title":"Cell Transplant"},{"issue":"3","key":"14_CR201","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/CIRCRESAHA.111.256149","volume":"112","author":"H Okano","year":"2013","unstructured":"Okano H, Nakamura M, Yoshida K, Okada Y, Tsuji O, Nori S et al (2013) Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res 112(3):523\u2013533","journal-title":"Circ Res"},{"issue":"2","key":"14_CR202","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.stem.2008.01.004","volume":"2","author":"T Brambrink","year":"2008","unstructured":"Brambrink T, Foreman R, Welstead GG, Lengner CJ, Wernig M, Suh H et al (2008) Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2(2):151\u2013159","journal-title":"Cell Stem Cell"},{"issue":"3","key":"14_CR203","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.stem.2008.02.001","volume":"2","author":"M Stadtfeld","year":"2008","unstructured":"Stadtfeld M, Maherali N, Breault DT, Hochedlinger K (2008) Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2(3):230\u2013240","journal-title":"Cell Stem Cell"},{"issue":"1","key":"14_CR204","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/s41467-019-09636-6","volume":"10","author":"X Hu","year":"2019","unstructured":"Hu X, Liu ZZ, Chen X, Schulz VP, Kumar A, Hartman AA et al (2019) MKL1-actin pathway restricts chromatin accessibility and prevents mature pluripotency activation. Nat Commun 10(1):1695","journal-title":"Nat Commun"},{"issue":"3","key":"14_CR205","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2016.12.016","volume":"168","author":"C Chronis","year":"2017","unstructured":"Chronis C, Fiziev P, Papp B, Butz S, Bonora G, Sabri S et al (2017) Cooperative binding of transcription factors orchestrates reprogramming. Cell 168(3):442\u2013459.e20","journal-title":"Cell"},{"issue":"4","key":"14_CR206","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw0025","volume":"5","author":"MS Simic","year":"2019","unstructured":"Simic MS, Moehle EA, Schinzel RT, Lorbeer FK, Halloran JJ, Heydari K et al (2019) Transient activation of the UPR ER is an essential step in the acquisition of pluripotency during reprogramming. Sci Adv 5(4):eaaw0025","journal-title":"Sci Adv"},{"issue":"5889","key":"14_CR207","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1126\/science.1154884","volume":"321","author":"T Aoi","year":"2008","unstructured":"Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K et al (2008) Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321(5889):699\u2013702","journal-title":"Science"},{"key":"14_CR208","doi-asserted-by":"crossref","unstructured":"Francesconi M, Di Stefano B, Berenguer C, de Andr\u00e9s-Aguayo L, Plana-Carmona M, Mendez-Lago M et al. (2019) Single cell RNA-seq identifies the origins of heterogeneity in efficient cell transdifferentiation and reprogramming. elife 8","DOI":"10.7554\/eLife.41627"},{"issue":"11","key":"14_CR209","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/nbt.1503","volume":"26","author":"T Aasen","year":"2008","unstructured":"Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F et al (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26(11):1276\u20131284","journal-title":"Nat Biotechnol"},{"issue":"8","key":"14_CR210","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/stem.1138","volume":"30","author":"MJ Barrero","year":"2012","unstructured":"Barrero MJ, Berdasco M, Paramonov I, Bilic J, Vitaloni M, Esteller M et al (2012) DNA hypermethylation in somatic cells correlates with higher reprogramming efficiency. Stem Cells 30(8):1696\u20131702","journal-title":"Stem Cells"},{"key":"14_CR211","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/1566524019666190325113945","volume":"19","author":"J Zhou","year":"2019","unstructured":"Zhou J, Sun J (2019) A revolution in reprogramming: small molecules. Curr Mol Med 19:77","journal-title":"Curr Mol Med"},{"issue":"5","key":"14_CR212","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.gpb.2013.08.002","volume":"11","author":"J Wang","year":"2013","unstructured":"Wang J, Gu Q, Hao J, Bai D, Liu L, Zhao X et al (2013) Generation of induced pluripotent stem cells with high efficiency from human umbilical cord blood mononuclear cells. Genomics Proteomics Bioinformatics 11(5):304\u2013311","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"14_CR213","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bcmd.2019.01.003","volume":"76","author":"I Sfougataki","year":"2019","unstructured":"Sfougataki I, Grafakos I, Varela I, Mitrakos A, Karagiannidou A, Tzannoudaki M et al (2019) Reprogramming of bone marrow derived mesenchymal stromal cells to human induced pluripotent stem cells from pediatric patients with hematological diseases using a commercial mRNA kit. Blood Cells Mol Dis 76:32\u201339","journal-title":"Blood Cells Mol Dis"},{"issue":"12","key":"14_CR214","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1001\/jama.2019.2341","volume":"321","author":"TM Yau","year":"2019","unstructured":"Yau TM, Pagani FD, Mancini DM, Chang HL, Lala A, Woo YJ et al (2019) Intramyocardial injection of mesenchymal precursor cells and successful temporary weaning from left ventricular assist device support in patients with advanced heart failure. JAMA 321(12):1176","journal-title":"JAMA"},{"issue":"3","key":"14_CR215","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3233\/JAD-160406","volume":"54","author":"JM Kang","year":"2016","unstructured":"Kang JM, Yeon BK, Cho S-J, Suh Y-H (2016) Stem cell therapy for Alzheimer\u2019s disease: a review of recent clinical trials. J Alzheimers Dis 54(3):879\u2013889","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"14_CR216","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/labinvest.2017.100","volume":"97","author":"A Higuchi","year":"2017","unstructured":"Higuchi A, Ku N-J, Tseng Y-C, Pan C-H, Li H-F, Kumar SS et al (2017) Stem cell therapies for myocardial infarction in clinical trials: bioengineering and biomaterial aspects. Lab Investig 97(10):1167\u20131179","journal-title":"Lab Investig"},{"issue":"3","key":"14_CR217","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2174\/1573403X13666170502103833","volume":"13","author":"R Katarzyna","year":"2017","unstructured":"Katarzyna R (2017) Adult stem cell therapy for cardiac repair in patients after acute myocardial infarction leading to ischemic heart failure: an overview of evidence from the recent clinical trials. Curr Cardiol Rev 13(3):223\u2013231","journal-title":"Curr Cardiol Rev"},{"issue":"1","key":"14_CR218","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/bmb\/ldw059","volume":"121","author":"H Yu","year":"2017","unstructured":"Yu H, Lu K, Zhu J, Wang J (2017) Stem cell therapy for ischemic heart diseases. Br Med Bull 121(1):135\u2013154","journal-title":"Br Med Bull"},{"issue":"1","key":"14_CR219","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13287-019-1165-5","volume":"10","author":"W Zakrzewski","year":"2019","unstructured":"Zakrzewski W, Dobrzy\u0144ski M, Szymonowicz M, Rybak Z (2019) Stem cells: past, present, and future. Stem Cell Res Ther 10(1):68","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"14_CR220","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/stem.2575","volume":"35","author":"DG Phinney","year":"2017","unstructured":"Phinney DG, Pittenger MF (2017) Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells 35(4):851\u2013858","journal-title":"Stem Cells"},{"issue":"4","key":"14_CR221","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.7150\/thno.30853","volume":"9","author":"C Liu","year":"2019","unstructured":"Liu C, Su C (2019) Design strategies and application progress of therapeutic exosomes. Theranostics 9(4):1015\u20131028","journal-title":"Theranostics"},{"key":"14_CR222","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2019.03.016","volume":"285","author":"AS Moghaddam","year":"2019","unstructured":"Moghaddam AS, Afshari JT, Esmaeili S-A, Saburi E, Joneidi Z, Momtazi-Borojeni AA (2019) Cardioprotective microRNAs: lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease. Atherosclerosis 285:1\u20139","journal-title":"Atherosclerosis"},{"issue":"1","key":"14_CR223","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/ten.teb.2017.0127","volume":"24","author":"EB Peters","year":"2018","unstructured":"Peters EB (2018) Endothelial progenitor cells for the vascularization of engineered tissues. Tissue Eng Part B Rev 24(1):1\u201324","journal-title":"Tissue Eng Part B Rev"},{"issue":"5","key":"14_CR224","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.tins.2018.02.008","volume":"41","author":"JM H\u00e9bert","year":"2018","unstructured":"H\u00e9bert JM, Vijg J (2018) Cell replacement to reverse brain aging: challenges, pitfalls, and opportunities. Trends Neurosci 41(5):267\u2013279","journal-title":"Trends Neurosci"},{"issue":"3","key":"14_CR225","doi-asserted-by":"publisher","first-page":"e0213032","DOI":"10.1371\/journal.pone.0213032","volume":"14","author":"DN Urrutia","year":"2019","unstructured":"Urrutia DN, Caviedes P, Mardones R, Minguell JJ, Vega-Letter AM, Jofre CM (2019) Comparative study of the neural differentiation capacity of mesenchymal stromal cells from different tissue sources: an approach for their use in neural regeneration therapies. Papaccio G, editor. PLoS One 14(3):e0213032","journal-title":"PLoS One"},{"issue":"2","key":"14_CR226","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3760\/cma.j.issn.0366-6999.20120064","volume":"127","author":"C Han","year":"2014","unstructured":"Han C, Zhang L, Song L, Liu Y, Zou W, Piao H et al (2014) Human adipose-derived mesenchymal stem cells: a better cell source for nervous system regeneration. Chin Med J 127(2):329\u2013337","journal-title":"Chin Med J"},{"key":"14_CR227","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnmol.2019.00080","volume":"12","author":"H Li","year":"2019","unstructured":"Li H, Yahaya BH, Ng WH, Yusoff NM, Lin J (2019) Conditioned medium of human menstrual blood-derived endometrial stem cells protects against MPP+-induced cytotoxicity in vitro. Front Mol Neurosci 12:80","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"14_CR228","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s11626-018-0311-1","volume":"55","author":"S Chen","year":"2019","unstructured":"Chen S, Dong C, Zhang J, Tang B, Xi Z, Cai F et al (2019) Human menstrual blood\u2013derived stem cells protect H9c2 cells against hydrogen peroxide\u2013associated apoptosis. In Vitro Cell Dev Biol Anim 55(2):104\u2013112","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"6","key":"14_CR229","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/stem.1364","volume":"31","author":"R Manuguerra-Gagn\u00e9","year":"2013","unstructured":"Manuguerra-Gagn\u00e9 R, Boulos PR, Ammar A, Leblond FA, Krosl G, Pichette V et al (2013) Transplantation of mesenchymal stem cells promotes tissue regeneration in a glaucoma model through laser-induced paracrine factor secretion and progenitor cell recruitment. Stem Cells 31(6):1136\u20131148","journal-title":"Stem Cells"},{"issue":"1","key":"14_CR230","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1172\/JCI40543","volume":"120","author":"O Lindvall","year":"2010","unstructured":"Lindvall O, Kokaia Z (2010) Stem cells in human neurodegenerative disorders\u00a0\u2013 time for clinical translation? J Clin Invest 120(1):29\u201340","journal-title":"J Clin Invest"},{"issue":"3","key":"14_CR231","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/ana.22487","volume":"70","author":"JS Lunn","year":"2011","unstructured":"Lunn JS, Sakowski SA, Hur J, Feldman EL (2011) Stem cell technology for neurodegenerative diseases. Ann Neurol 70(3):353\u2013361","journal-title":"Ann Neurol"},{"issue":"3","key":"14_CR232","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1160\/th15-06-0467","volume":"115","author":"F Franchi","year":"2016","unstructured":"Franchi F, Rollini F, Cho JR, King R, Phoenix F, Bhatti M et al (2016) Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study. Thromb Haemost 115(3):622\u2013631","journal-title":"Thromb Haemost"},{"issue":"2","key":"14_CR233","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00213-011-2315-3","volume":"218","author":"I Wonodi","year":"2011","unstructured":"Wonodi I, Gopinath HV, Liu J, Adami H, Hong LE, Allen-Emerson R et al (2011) Dipyridamole monotherapy in schizophrenia. Psychopharmacology 218(2):341\u2013345","journal-title":"Psychopharmacology"},{"issue":"3","key":"14_CR234","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1161\/CIRCINTERVENTIONS.110.960997","volume":"4","author":"JL Ferreiro","year":"2011","unstructured":"Ferreiro JL, Ueno M, Tomasello SD, Capodanno D, Desai B, Dharmashankar K et al (2011) Pharmacodynamic evaluation of pantoprazole therapy on clopidogrel effects. Circ Cardiovasc Interv 4(3):273\u2013279","journal-title":"Circ Cardiovasc Interv"},{"key":"14_CR235","unstructured":"World Health Organization (WHO) (2018) The top 10 causes of death [Internet]. [cited 2019 May 3]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death"},{"key":"14_CR236","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/bs.apha.2016.08.001","volume":"78","author":"R Mazurek","year":"2017","unstructured":"Mazurek R, Dave JM, Chandran RR, Misra A, Sheikh AQ, Greif DM (2017) Vascular cells in blood vessel wall development and disease. Adv Pharmacol 78:323\u2013350","journal-title":"Adv Pharmacol"},{"issue":"5","key":"14_CR237","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1161\/CIRCULATIONAHA.109.881441","volume":"122","author":"NJ Leeper","year":"2010","unstructured":"Leeper NJ, Hunter AL, Cooke JP (2010) Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells. Circulation 122(5):517\u2013526","journal-title":"Circulation"},{"issue":"8","key":"14_CR238","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00018-017-2730-7","volume":"75","author":"D Klein","year":"2018","unstructured":"Klein D (2018) iPSCs-based generation of vascular cells: reprogramming approaches and applications. Cell Mol Life Sci 75(8):1411\u20131433","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"14_CR239","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/MOH.0000000000000140","volume":"22","author":"MC Yoder","year":"2015","unstructured":"Yoder MC (2015) Differentiation of pluripotent stem cells into endothelial cells. Curr Opin Hematol 22(3):252\u2013257","journal-title":"Curr Opin Hematol"},{"issue":"14","key":"14_CR240","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1113\/JP270033","volume":"593","author":"G Wang","year":"2015","unstructured":"Wang G, Jacquet L, Karamariti E, Xu Q (2015) Origin and differentiation of vascular smooth muscle cells. J Physiol 593(14):3013\u20133030","journal-title":"J Physiol"},{"issue":"3","key":"14_CR241","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1113\/jphysiol.1929.sp002608","volume":"68","author":"AN Drury","year":"1929","unstructured":"Drury AN, Szent-Gy\u00f6rgyi A (1929) The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 68(3):213\u2013237","journal-title":"J Physiol"},{"issue":"2","key":"14_CR242","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1152\/ajplegacy.1963.204.2.317","volume":"204","author":"RM Berne","year":"1963","unstructured":"Berne RM (1963) Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol 204(2):317\u2013322","journal-title":"Am J Physiol"},{"issue":"5","key":"14_CR243","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000158389","volume":"19","author":"N Toda","year":"1982","unstructured":"Toda N, Okunishi H, Taniyama K, Miyazaki M (1982) Responses to adenine nucleotides and related compounds of isolated dog cerebral, coronary and mesenteric arteries. J Vasc Res 19(5):226\u2013236","journal-title":"J Vasc Res"},{"key":"14_CR244","first-page":"65","volume-title":"Biological actions of the adenine nucleotides","author":"HN Green","year":"1950","unstructured":"Green HN, Stoner HB (1950) The effect of purine derivatives on the cardiovascular system. In: Biological actions of the adenine nucleotides. Lewis, London, pp 65\u2013103"},{"issue":"4","key":"14_CR245","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1113\/jphysiol.1934.sp003095","volume":"80","author":"JH Gillespie","year":"1934","unstructured":"Gillespie JH (1934) The biological significance of the linkages in adenosine triphosphoric acid. J Physiol 80(4):345\u2013359","journal-title":"J Physiol"},{"issue":"2","key":"14_CR246","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1113\/jphysiol.1933.sp002958","volume":"77","author":"JH Gaddum","year":"1933","unstructured":"Gaddum JH, Holtz P (1933) The localization of the action of drugs on the pulmonary vessels of dogs and cats. J Physiol 77(2):139\u2013158","journal-title":"J Physiol"},{"key":"14_CR247","first-page":"1118","volume":"27","author":"Z Minic","year":"2013","unstructured":"Minic Z, O\u2019Leary DS, Goshgarian HG, ST (2013) Immunohistochemistry confirms the functional evidence that the cardiopulmonary chemoreflex (CCR) pathways in the caudal nucleus of the solitary tract (cNTS) are directly inhibited by A1 adenosine receptors and indirectly inhibited by A2a receptors via GAB. FASEB J 27:1118","journal-title":"FASEB J"},{"issue":"5","key":"14_CR248","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/sj.bjp.0706043","volume":"144","author":"CW Schindler","year":"2005","unstructured":"Schindler CW, Karcz-Kubicha M, Thorndike EB, M\u00fcller CE, Tella SR, Ferr\u00e9 S et al (2005) Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists. Br J Pharmacol 144(5):642\u2013650","journal-title":"Br J Pharmacol"},{"key":"14_CR249","unstructured":"Dinelli CA The clinical use of adenosinetriphosphate. Minerva Med 44:1338\u20131344"},{"key":"14_CR250","first-page":"1205","volume":"95","author":"J Olivet","year":"1953","unstructured":"Olivet J, Grund G (1953) Heart therapy with adenylic acid. Munch Med Wochenschr 95:1205\u20131206","journal-title":"Munch Med Wochenschr"},{"key":"14_CR251","first-page":"604","volume":"34","author":"F Tursi","year":"1954","unstructured":"Tursi F (1954) The use of A.T.P. in circulatory insufficiency and angina pectoris. Rass Int Clin Ter 34:604\u2013606","journal-title":"Rass Int Clin Ter"},{"key":"14_CR252","first-page":"2000","volume":"47","author":"F Cadario","year":"1956","unstructured":"Cadario F, Porretti FRA (1956) Use of adenosinetriphosphate (ATP) in cardiovascular diseases; clinical contribution. Minerva Med 47:2000\u20132006","journal-title":"Minerva Med"},{"key":"14_CR253","unstructured":"Kraucher GK (1955) Treatment of circulatory disorders with adenine compounds. Wien Med Wochenschr 105:303\u2013305"},{"key":"14_CR254","unstructured":"Heidelmann G (1956) [Management of cardiovascular diseases with muscle adenylic acid]. Munch Med Wochenschr 98(47):1631\u20131633"},{"issue":"3","key":"14_CR255","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1046\/j.1469-7580.1999.19430335.x","volume":"194","author":"G Burnstock","year":"1999","unstructured":"Burnstock G (1999) Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 194(3):335\u2013342","journal-title":"J Anat"},{"issue":"6","key":"14_CR256","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/00005344-200112000-00012","volume":"38","author":"P Bodin","year":"2001","unstructured":"Bodin P, Burnstock G (2001) Evidence that release of adenosine triphosphate from endothelial cells during increased shear stress is vesicular. J Cardiovasc Pharmacol 38(6):900\u2013908","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"14_CR257","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1152\/physrev.2001.81.2.767","volume":"81","author":"G Vassort","year":"2001","unstructured":"Vassort G (2001) Adenosine 5\u2032-triphosphate: a P2-purinergic agonist in the myocardium. Physiol Rev 81(2):767\u2013806","journal-title":"Physiol Rev"},{"issue":"10","key":"14_CR258","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1039\/c1ib00044f","volume":"3","author":"J Wan","year":"2011","unstructured":"Wan J, Forsyth AM, Stone HA (2011) Red blood cell dynamics: from cell deformation to ATP release. Integr Biol 3(10):972","journal-title":"Integr Biol"},{"key":"14_CR259","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1062798713000586","volume":"22","author":"G Burnstock","year":"2014","unstructured":"Burnstock G (2014) The Erasmus Lecture 2012. The concept of cotransmission: focus on ATP as a cotransmitter and its significance in health and disease. Eur Rev 22:1\u201317","journal-title":"Eur Rev"},{"key":"14_CR260","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1124\/pr.113.008029","volume":"66","author":"V Ralevic","year":"2014","unstructured":"Ralevic V, Burnstock G (2014) Purinergic signalling and blood vessels in health and disease. Pharmacol Rev 66:102\u2013192","journal-title":"Pharmacol Rev"},{"issue":"5","key":"14_CR261","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/cvr\/17.5.301","volume":"17","author":"CA Williams","year":"1983","unstructured":"Williams CA, Forrester T (1983) Possible source of adenosine triphosphate released from rat myocytes in response to hypoxia and acidosis. Cardiovasc Res 17(5):301\u2013312","journal-title":"Cardiovasc Res"},{"issue":"2","key":"14_CR262","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1113\/jphysiol.1977.sp011862","volume":"268","author":"T Forrester","year":"1977","unstructured":"Forrester T, Williams CA (1977) Release of adenosine triphosphate from isolated adult heart cells in response to hypoxia. J Physiol 268(2):371\u2013390","journal-title":"J Physiol"},{"issue":"2","key":"14_CR263","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0022-2828(87)80561-8","volume":"19","author":"C Vial","year":"1987","unstructured":"Vial C, Owen P, Opie LH, Posel D (1987) Significance of release of adenosine triphosphate and adenosine induced by hypoxia or adrenaline in perfused rat heart. J Mol Cell Cardiol 19(2):187\u2013197","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"14_CR264","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000158005","volume":"11","author":"BM Paddle","year":"1974","unstructured":"Paddle BM, Burnstock G (1974) Release of ATP from perfused heart during coronary vasodilatation. J Vasc Res 11(3):110\u2013119","journal-title":"J Vasc Res"},{"issue":"2","key":"14_CR265","first-page":"542","volume":"240","author":"H Darius","year":"1987","unstructured":"Darius H, Stahl GL, Lefer AM (1987) Pharmacologic modulation of ATP release from isolated rat hearts in response to vasoconstrictor stimuli using a continuous flow technique. J Pharmacol Exp Ther 240(2):542\u2013547","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"14_CR266","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000159125","volume":"33","author":"AJ Vials","year":"1996","unstructured":"Vials AJ, Burnstock G (1996) ATP release from the isolated perfused guinea pig heart in response to increased flow. J Vasc Res 33(1):1\u20134","journal-title":"J Vasc Res"},{"issue":"6","key":"14_CR267","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1096\/fj.12-204677","volume":"26","author":"D Lu","year":"2012","unstructured":"Lu D, Soleymani S, Madakshire R, Insel PA (2012) ATP released from cardiac fibroblasts via connexin hemichannels activates profibrotic P2Y2 receptors. FASEB J 26(6):2580\u20132591","journal-title":"FASEB J"},{"key":"14_CR268","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0197-0186(90)90158-P","volume":"17","author":"G Burnstock","year":"1990","unstructured":"Burnstock G (1990) Noradrenaline and ATP as cotransmitters insympathetic nerves. Neurochem Int 17:357","journal-title":"Neurochem Int"},{"issue":"3","key":"14_CR269","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1161\/01.RES.68.3.797","volume":"68","author":"MM Borst","year":"1991","unstructured":"Borst MM, Schrader J (1991) Adenine nucleotide release from isolated perfused guinea pig hearts and extracellular formation of adenosine. Circ Res 68(3):797\u2013806","journal-title":"Circ Res"},{"issue":"3","key":"14_CR270","doi-asserted-by":"publisher","first-page":"C766","DOI":"10.1152\/ajpcell.1998.275.3.C766","volume":"275","author":"AI Kuzmin","year":"1998","unstructured":"Kuzmin AI, Lakomkin VL, Kapelko VI, Vassort G (1998) Interstitial ATP level and degradation in control and postmyocardial infarcted rats. Am J Physiol 275(3):C766\u2013C771","journal-title":"Am J Physiol"},{"issue":"3","key":"14_CR271","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000058038","volume":"65","author":"PJ White","year":"2002","unstructured":"White PJ, Nguyen TT (2002) Chronic caffeine treatment causes changes in cardiac adenosine receptor function in rats. Pharmacology 65(3):129\u2013135","journal-title":"Pharmacology"},{"issue":"1","key":"14_CR272","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1365-201X.2007.01690.x","volume":"190","author":"J-N Yang","year":"2007","unstructured":"Yang J-N, Tiselius C, Dar\u00e9 E, Johansson B, Valen G, Fredholm BB (2007) Sex differences in mouse heart rate and body temperature and in their regulation by adenosine A1 receptors. Acta Physiol 190(1):63\u201375","journal-title":"Acta Physiol"},{"issue":"5 Pt 2","key":"14_CR273","first-page":"H1634","volume":"264","author":"HT Lee","year":"1993","unstructured":"Lee HT, Thompson CI, Linden J, Belloni FL (1993) Differential sensitization of cardiac actions of adenosine in rats after chronic theophylline treatment. Am J Phys 264(5 Pt 2):H1634\u2013H1643","journal-title":"Am J Phys"},{"issue":"4","key":"14_CR274","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/sj.bjp.0703647","volume":"131","author":"M Avkiran","year":"2000","unstructured":"Avkiran M, Yokoyama H (2000) Adenosine A 1 receptor stimulation inhibits \u03b1 1 -adrenergic activation of the cardiac sarcolemmal Na + \/H + exchanger. Br J Pharmacol 131(4):659\u2013662","journal-title":"Br J Pharmacol"},{"issue":"2","key":"14_CR275","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/sj.bjp.0704487","volume":"135","author":"L Sterin-Borda","year":"2002","unstructured":"Sterin-Borda L, G\u00f3mez RM, Borda E (2002) Role of nitric oxide\/cyclic GMP in myocardial adenosine A1 receptor-inotropic response. Br J Pharmacol 135(2):444\u2013450","journal-title":"Br J Pharmacol"},{"key":"14_CR276","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cardiores.2004.12.004","volume":"65","author":"Z Xu","year":"2005","unstructured":"Xu Z, Park SS, Mueller RA, Bagnell RC, Patterson CBP (2005) Adenosine produces nitric oxide and prevents mitochondrial oxidant damage in rat cardiomyocytes. Cardiovasc Res 65:803\u2013812","journal-title":"Cardiovasc Res"},{"issue":"4","key":"14_CR277","doi-asserted-by":"publisher","first-page":"H1472","DOI":"10.1152\/ajpheart.2000.279.4.H1472","volume":"279","author":"TS Monahan","year":"2000","unstructured":"Monahan TS, Sawmiller DR, Fenton RA, Dobson JG (2000) Adenosine A2a -receptor activation increases contractility in isolated perfused hearts. Am J Physiol Circ Physiol 279(4):H1472\u2013H1481","journal-title":"Am J Physiol Circ Physiol"},{"issue":"31","key":"14_CR278","doi-asserted-by":"publisher","first-page":"18678","DOI":"10.1074\/jbc.271.31.18678","volume":"271","author":"BT Liang","year":"1996","unstructured":"Liang BT, Morley JF (1996) A new cyclic AMP-independent, Gs-mediated stimulatory mechanism via the adenosine A2a receptor in the intact cardiac cell. J Biol Chem 271(31):18678\u201318685","journal-title":"J Biol Chem"},{"issue":"5","key":"14_CR279","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.yjmcc.2008.03.003","volume":"44","author":"B Teng","year":"2008","unstructured":"Teng B, Ledent C, Mustafa SJ (2008) Up-regulation of A 2B adenosine receptor in A2A adenosine receptor knockout mouse coronary artery. J Mol Cell Cardiol 44(5):905\u2013914","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"14_CR280","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1476-5381.1993.tb13629.x","volume":"109","author":"MF Gurden","year":"1993","unstructured":"Gurden MF, Coates J, Ellis F, Evans B, Foster M, Hornby E et al (1993) Functional characterization of three adenosine receptor types. Br J Pharmacol 109(3):693\u2013698","journal-title":"Br J Pharmacol"},{"issue":"4","key":"14_CR281","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/sj.bjp.0701891","volume":"124","author":"BJ Meester","year":"1998","unstructured":"Meester BJ, Shankley NP, Welsh NJ, Wood J, Meijler FL, Black JW (1998) Pharmacological classification of adenosine receptors in the sinoatrial and atrioventricular nodes of the guinea-pig. Br J Pharmacol 124(4):685\u2013692","journal-title":"Br J Pharmacol"},{"issue":"4 Pt 1","key":"14_CR282","doi-asserted-by":"publisher","first-page":"C750","DOI":"10.1152\/ajpcell.1989.257.4.C750","volume":"257","author":"MB Young De","year":"1989","unstructured":"De Young MB, Scarpa A (1989) ATP receptor-induced Ca2+ transients in cardiac myocytes: sources of mobilized Ca2+. Am J Phys 257(4 Pt 1):C750\u2013C758","journal-title":"Am J Phys"},{"issue":"5 Pt 1","key":"14_CR283","doi-asserted-by":"publisher","first-page":"C933","DOI":"10.1152\/ajpcell.1992.263.5.C933","volume":"263","author":"JS Zheng","year":"1992","unstructured":"Zheng JS, Christie A, Levy MN, Scarpa A (1992) Ca2+ mobilization by extracellular ATP in rat cardiac myocytes: regulation by protein kinase C and A. Am J Phys 263(5 Pt 1):C933\u2013C940","journal-title":"Am J Phys"},{"key":"14_CR284","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1113\/jphysiol.1988.sp017157","volume":"401","author":"A Legssyer","year":"1988","unstructured":"Legssyer A, Poggioli J, Renard D, Vassort G (1988) ATP and other adenine compounds increase mechanical activity and inositol trisphosphate production in rat heart. J Physiol 401:185","journal-title":"J Physiol"},{"issue":"3","key":"14_CR285","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1161\/01.RES.70.3.477","volume":"70","author":"M Yamada","year":"1992","unstructured":"Yamada M, Hamamori Y, Akita H, Yokoyama M (1992) P2-purinoceptor activation stimulates phosphoinositide hydrolysis and inhibits accumulation of cAMP in cultured ventricular myocytes. Circ Res 70(3):477\u2013485","journal-title":"Circ Res"},{"issue":"15","key":"14_CR286","doi-asserted-by":"publisher","first-page":"8063","DOI":"10.1073\/pnas.93.15.8063","volume":"93","author":"L Vulchanova","year":"1996","unstructured":"Vulchanova L, Arvidsson U, Riedl M, Wang J, Buell G, Surprenant A et al (1996) Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry. Proc Natl Acad Sci 93(15):8063\u20138067","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"14_CR287","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1124\/mol.51.1.109","volume":"51","author":"M Garcia-Guzman","year":"1997","unstructured":"Garcia-Guzman M, Soto F, Gomez-Hernandez JM, Lund PE, St\u00fchmer W (1997) Characterization of recombinant human P2X4 receptor reveals pharmacological differences to the rat homologue. Mol Pharmacol 51(1):109\u2013118","journal-title":"Mol Pharmacol"},{"issue":"1\u20132","key":"14_CR288","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0169-328X(97)00036-3","volume":"47","author":"M Garcia-Guzman","year":"1997","unstructured":"Garcia-Guzman M, St\u00fchmer W, Soto F (1997) Molecular characterization and pharmacological properties of the human P2X3 purinoceptor. Brain Res Mol Brain Res 47(1\u20132):59\u201366","journal-title":"Brain Res Mol Brain Res"},{"key":"14_CR289","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0024-3205(97)01168-5","volume":"62","author":"Y Bogdanov","year":"1998","unstructured":"Bogdanov Y, Rubino A, Burnstock G (1998) Characterisation of subtypes of the P2X and P2Y families of receptors in the foetal human heart. Life Sci 62:697\u2013703","journal-title":"Life Sci"},{"issue":"1","key":"14_CR290","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11302-014-9436-1","volume":"11","author":"G Burnstock","year":"2015","unstructured":"Burnstock G, Pelleg A (2015) Cardiac purinergic signalling in health and disease. Purinergic Signal 11(1):1\u201346","journal-title":"Purinergic Signal"},{"issue":"2","key":"14_CR291","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.lfs.2004.11.029","volume":"77","author":"X Liao","year":"2005","unstructured":"Liao X, Wang X, Gu Y, Chen Q, Chen L-Y (2005) Involvement of death receptor signaling in mechanical stretch-induced cardiomyocyte apoptosis. Life Sci 77(2):160\u2013174","journal-title":"Life Sci"},{"issue":"1","key":"14_CR292","doi-asserted-by":"publisher","first-page":"H334","DOI":"10.1152\/ajpheart.2001.281.1.H334","volume":"281","author":"Q Mei","year":"2001","unstructured":"Mei Q, Liang BT (2001) P2 purinergic receptor activation enhances cardiac contractility in isolated rat and mouse hearts. Am J Physiol Heart Circ Physiol 281(1):H334\u2013H341","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"14","key":"14_CR293","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1096\/fj.01-0445fje","volume":"15","author":"B Hu","year":"2001","unstructured":"Hu B, Mei Q-B, Yao X-J, Smith E, Barry WH, Liang BT (2001) A novel contractile phenotype with cardiac transgenic expression of the human P2X 4 receptor. FASEB J 15(14):2739\u20132741","journal-title":"FASEB J"},{"issue":"18","key":"14_CR294","doi-asserted-by":"publisher","first-page":"15752","DOI":"10.1074\/jbc.M112097200","volume":"277","author":"B Hu","year":"2002","unstructured":"Hu B, Senkler C, Yang A, Soto F, Liang BT (2002) P2X4 receptor is a glycosylated cardiac receptor mediating a positive inotropic response to ATP. J Biol Chem 277(18):15752\u201315757","journal-title":"J Biol Chem"},{"issue":"2","key":"14_CR295","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1096\/fj.05-4749com","volume":"20","author":"J-B Shen","year":"2006","unstructured":"Shen J-B, Pappano AJ, Liang BT (2006) Extracellular ATP-stimulated current in wild-type and P2X 4 receptor transgenic mouse ventricular myocytes: implications for a cardiac physiologic role of P2X 4 receptors. FASEB J 20(2):277\u2013284","journal-title":"FASEB J"},{"key":"14_CR296","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1536\/ihj.49.221","volume":"49","author":"W Liang","year":"2008","unstructured":"Liang W, McDonald P, McManus B, van Breemen C, Wang X (2008) P2Y2 receptor-mediated Ca2+ signaling and spontaneous Ca2+ releases in human valvular myofibroblasts. Int Heart J 49:221\u2013236","journal-title":"Int Heart J"},{"issue":"3","key":"14_CR297","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10517-014-2334-2","volume":"156","author":"TA Anikina","year":"2014","unstructured":"Anikina TA, Anisimova IN, Zverev AA, Sitdikov FG, Zefirov TL (2014) Involvement of P2Y2,4 receptors in the regulation of myocardial contractility in growing rats. Bull Exp Biol Med 156(3):299\u2013302","journal-title":"Bull Exp Biol Med"},{"issue":"1","key":"14_CR298","doi-asserted-by":"publisher","first-page":"H21","DOI":"10.1152\/ajpheart.00135.2008","volume":"295","author":"J Alvarez","year":"2008","unstructured":"Alvarez J, Coulombe A, Cazorla O, Ugur M, Rauzier J-M, Magyar J et\u00a0al (2008) ATP\/UTP activate cation-permeable channels with TRPC3\/7 properties in rat cardiomyocytes. Am J Physiol Circ Physiol 295(1):H21\u2013H28","journal-title":"Am J Physiol Circ Physiol"},{"key":"14_CR299","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1476-5381.2009.00172.x","volume":"158","author":"A Talasila","year":"2009","unstructured":"Talasila A, Germack R, Dickenson JM (2009) Characterization of P2Y receptor subtypes functionally expressed on neonatal rat cardiac myofibroblasts. Br J Pharmacol 158:339\u2013353","journal-title":"Br J Pharmacol"},{"issue":"3","key":"14_CR300","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.yjmcc.2010.05.001","volume":"49","author":"OO Braun","year":"2010","unstructured":"Braun OO, Lu D, Aroonsakool N, Insel PA (2010) Uridine triphosphate (UTP) induces profibrotic responses in cardiac fibroblasts by activation of P2Y2 receptors. J Mol Cell Cardiol 49(3):362\u2013369","journal-title":"J Mol Cell Cardiol"},{"issue":"23","key":"14_CR301","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1038\/emboj.2008.237","volume":"27","author":"M Nishida","year":"2008","unstructured":"Nishida M, Sato Y, Uemura A, Narita Y, Tozaki-Saitoh H, Nakaya M et al (2008) P2Y6 receptor-Galpha12\/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis. EMBO J 27(23):3104\u20133115","journal-title":"EMBO J"},{"issue":"26","key":"14_CR302","doi-asserted-by":"publisher","first-page":"19040","DOI":"10.1074\/jbc.M113.466102","volume":"288","author":"D Lu","year":"2013","unstructured":"Lu D, Insel PA (2013) Hydrolysis of extracellular ATP by ectonucleoside triphosphate diphosphohydrolase (ENTPD) establishes the set point for fibrotic activity of cardiac fibroblasts. J Biol Chem 288(26):19040\u201319049","journal-title":"J Biol Chem"},{"key":"14_CR303","first-page":"355","volume":"41","author":"AM Wedd","year":"1931","unstructured":"Wedd AM (1931) The action of adenosine and certain related compounds on the coronary flow of the perfused heart of the rabbit. J Pharmacol Exp Ther 41:355\u2013366","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"14_CR304","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/01.RES.74.3.401","volume":"74","author":"S Yang","year":"1994","unstructured":"Yang S, Cheek DJ, Westfall DP, Buxton IL (1994) Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells. Circ Res 74(3):401\u2013407","journal-title":"Circ Res"},{"issue":"4","key":"14_CR305","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2169\/internalmedicine.38.324","volume":"38","author":"M Kato","year":"1999","unstructured":"Kato M, Shiode N, Teragawa H, Hirao H, Yamada T, Yamagata T et al (1999) Adenosine 5\u2032-triphosphate induced dilation of human coronary microvessels in vivo. Intern Med 38(4):324\u2013329","journal-title":"Intern Med"},{"key":"14_CR306","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/eurheartj\/10.suppl_F.28","volume":"10 Suppl F","author":"S Nees","year":"1989","unstructured":"Nees S (1989) Coronary flow increases induced by adenosine and adenine nucleotides are mediated by the coronary endothelium: a new principle of the regulation of coronary flow. Eur Heart J 10 Suppl F:28\u201335","journal-title":"Eur Heart J"},{"issue":"3","key":"14_CR307","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/BF00788634","volume":"92","author":"OS Opgaard","year":"1997","unstructured":"Opgaard OS, Edvinsson L (1997) Mechanical properties and effects of sympathetic co-transmitters on human coronary arteries and veins. Basic Res Cardiol 92(3):168\u2013180","journal-title":"Basic Res Cardiol"},{"key":"14_CR308","first-page":"519","volume":"212","author":"YKH Takata","year":"1980","unstructured":"Takata YKH (1980) ATP-induced hyperpolarization of smooth muscle cells of the guinea-pig coronary artery. J Pharmacol Exp Ther 212:519\u2013526","journal-title":"J Pharmacol Exp Ther"},{"issue":"2\u20133","key":"14_CR309","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0014-2999(94)90413-8","volume":"251","author":"AJ Vials","year":"1994","unstructured":"Vials AJ, Burnstock G (1994) The effect of suramin on vasodilator responses to ATP and 2-methylthio-ATP in the Sprague-Dawley rat coronary vasculature. Eur J Pharmacol 251(2\u20133):299\u2013302","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"14_CR310","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/sj.bjp.0702610","volume":"127","author":"O Korchazhkina","year":"1999","unstructured":"Korchazhkina O, Wright G, Exley C (1999) Intravascular ATP and coronary vasodilation in the isolated working rat heart. Br J Pharmacol 127(3):701\u2013708","journal-title":"Br J Pharmacol"},{"issue":"3","key":"14_CR311","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1006\/mvre.2001.2306","volume":"61","author":"F Moccia","year":"2001","unstructured":"Moccia F, Baruffi S, Spaggiari S, Coltrini D, Berra-Romani R, Signorelli S et al (2001) P2Y1 and P2Y2 receptor-operated Ca2+ signals in primary cultures of cardiac microvascular endothelial cells. Microvasc Res 61(3):240\u2013252","journal-title":"Microvasc Res"},{"issue":"7","key":"14_CR312","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1111\/j.1476-5381.1996.tb15323.x","volume":"117","author":"S Yang","year":"1996","unstructured":"Yang S, Buxton ILO, Probert CB, Talbot JN, Bradley ME (1996) Evidence for a discrete UTP receptor in cardiac endothelial cells. Br J Pharmacol 117(7):1572\u20131578","journal-title":"Br J Pharmacol"},{"issue":"1","key":"14_CR313","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1600-0773.1999.tb01056.x","volume":"85","author":"BJ Z\u00fcnkler","year":"1999","unstructured":"Z\u00fcnkler BJ, Gr\u00e4fe M, Henning B, K\u00fchne S, Ott T, Fleck E et al (1999) Effects of P2 purinoceptor agonists on membrane potential and intracellular Ca2+ of human cardiac endothelial cells. Pharmacol Toxicol 85(1):7\u201315","journal-title":"Pharmacol Toxicol"},{"issue":"3","key":"14_CR314","first-page":"755","volume":"293","author":"M Malmsj\u00f6","year":"2000","unstructured":"Malmsj\u00f6 M, Hou M, Harden TK, Pendergast W, Pantev E, Edvinsson L et al (2000) Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5\u2032-O-thiodiphosphate and uridine 5\u2032-O-3-thiotriphosphate. J Pharmacol Exp Ther 293(3):755\u2013760","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"14_CR315","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/sj.bjp.0707120","volume":"150","author":"SJ Rayment","year":"2007","unstructured":"Rayment SJ, Latif ML, Ralevic V, Alexander SPH (2007) Evidence for the expression of multiple uracil nucleotide-stimulated P2 receptors coupled to smooth muscle contraction in porcine isolated arteries. Br J Pharmacol 150(5):604\u2013612","journal-title":"Br J Pharmacol"},{"issue":"4","key":"14_CR316","doi-asserted-by":"publisher","first-page":"H1586","DOI":"10.1152\/ajpheart.00983.2004","volume":"288","author":"M Farias","year":"2005","unstructured":"Farias M, Gorman MW, Savage MV, Feigl EO (2005) Plasma ATP during exercise: possible role in regulation of coronary blood flow. Am J Physiol Heart Circ Physiol 288(4):H1586\u2013H1590","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"14_CR317","doi-asserted-by":"publisher","first-page":"H1981","DOI":"10.1152\/ajpheart.00611.2010","volume":"299","author":"MW Gorman","year":"2010","unstructured":"Gorman MW, Rooke GA, Savage MV, Jayasekara MPS, Jacobson KA, Feigl EO (2010) Adenine nucleotide control of coronary blood flow during exercise. Am J Physiol Heart Circ Physiol 299(6):H1981\u2013H1989","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"14_CR318","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/JES.0b013e3182348cdd","volume":"40","author":"MW Gorman","year":"2012","unstructured":"Gorman MW, Feigl EO (2012) Control of coronary blood flow during exercise. Exerc Sport Sci Rev 40(1):37\u201342","journal-title":"Exerc Sport Sci Rev"},{"issue":"1","key":"14_CR319","doi-asserted-by":"publisher","first-page":"H204","DOI":"10.1152\/ajpheart.00068.2002","volume":"284","author":"R Rubio","year":"2003","unstructured":"Rubio R, Ceballos G (2003) Sole activation of three luminal adenosine receptor subtypes in different parts of coronary vasculature. Am J Physiol Heart Circ Physiol 284(1):H204\u2013H214","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"14_CR320","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00005344-200301000-00010","volume":"41","author":"AK Hinschen","year":"2003","unstructured":"Hinschen AK, Rose\u2019Meyer RB, Headrick JP (2003) Adenosine receptor subtypes mediating coronary vasodilation in rat hearts. J Cardiovasc Pharmacol 41(1):73\u201380","journal-title":"J Cardiovasc Pharmacol"},{"issue":"7","key":"14_CR321","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/sj.bjp.0704170","volume":"133","author":"A Flood","year":"2001","unstructured":"Flood A, Headrick JP (2001) Functional characterization of coronary vascular adenosine receptors in the mouse. Br J Pharmacol 133(7):1063\u20131072","journal-title":"Br J Pharmacol"},{"issue":"4","key":"14_CR322","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/00005344-200304000-00008","volume":"41","author":"MAH Talukder","year":"2003","unstructured":"Talukder MAH, Morrison RR, Ledent C, Mustafa SJ (2003) Endogenous adenosine increases coronary flow by activation of both A2A and A2B receptors in mice. J Cardiovasc Pharmacol 41(4):562\u2013570","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"14_CR323","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11302-008-9114-2","volume":"4","author":"A Pelleg","year":"2008","unstructured":"Pelleg A, Belardinelli L (2008) The first second-generation adenosine drug enters the US market. Purinergic Signal 4(4):407\u2013408","journal-title":"Purinergic Signal"},{"issue":"7","key":"14_CR324","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1042\/CBI20110111","volume":"36","author":"Z Xiao","year":"2012","unstructured":"Xiao Z, Yang M, Fang L, Lv Q, He Q, Deng M et al (2012) Extracellular nucleotide inhibits cell proliferation and negatively regulates Toll-like receptor 4 signalling in human progenitor endothelial cells. Cell Biol Int 36(7):625\u2013633","journal-title":"Cell Biol Int"},{"issue":"4","key":"14_CR325","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3390\/ijms19041228","volume":"19","author":"Ren\u00e9 Rocha","year":"2018","unstructured":"Rocha R, Torres \u00c1, Ojeda K, Uribe D, Rocha D, Erices J et\u00a0al (2018) The adenosine A3 receptor regulates differentiation of glioblastoma stem-like cells to endothelial cells under hypoxia. Int J Mol Sci 19(4)","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"14_CR326","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059733","volume":"8","author":"N Siddaramappa Umapathy","year":"2013","unstructured":"Siddaramappa Umapathy N, Kaczmarek E, Fatteh N, Burns N, Lucas R, Stenmark KR et al (2013) Adenosine A1 receptors promote vasa vasorum endothelial cell barrier integrity via Gi and Akt-dependent actin cytoskeleton remodeling. Eltzschig HK, editor. PLoS One 8(4):e59733","journal-title":"PLoS One"},{"issue":"1 Pt 2","key":"14_CR327","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1161\/01.HYP.31.1.516","volume":"31","author":"RK Dubey","year":"1998","unstructured":"Dubey RK, Gillespie DG, Mi Z, Jackson EK (1998) Adenosine inhibits growth of human aortic smooth muscle cells via A2B receptors. Hypertension 31(1 Pt 2):516\u2013521","journal-title":"Hypertension"},{"issue":"6","key":"14_CR328","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1161\/HYPERTENSIONAHA.115.05912","volume":"66","author":"RK Dubey","year":"2015","unstructured":"Dubey RK, Fingerle J, Gillespie DG, Mi Z, Rosselli M, Imthurn B et al (2015) Adenosine attenuates human coronary artery smooth muscle cell proliferation by inhibiting multiple signaling pathways that converge on cyclin D. Hypertension 66(6):1207","journal-title":"Hypertension"},{"issue":"4","key":"14_CR329","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/sj.bjp.0701895","volume":"124","author":"S Harper","year":"1998","unstructured":"Harper S, Webb TE, Charlton SJ, Ng LL, Boarder MR (1998) Evidence that P2Y4 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP. Br J Pharmacol 124(4):703\u2013710","journal-title":"Br J Pharmacol"},{"issue":"1","key":"14_CR330","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0306-3623(97)00420-5","volume":"31","author":"D Erlinge","year":"1998","unstructured":"Erlinge D (1998) Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen Pharmacol 31(1):1\u20138","journal-title":"Gen Pharmacol"},{"issue":"2","key":"14_CR331","doi-asserted-by":"publisher","first-page":"H784","DOI":"10.1152\/ajpheart.00997.2000","volume":"282","author":"M Hou","year":"2002","unstructured":"Hou M, Harden TK, Kuhn CM, Baldetorp B, Lazarowski E, Pendergast W et al (2002) UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y 6 receptors. Am J Physiol Heart Circ Physiol 282(2):H784\u2013H792","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"14_CR332","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1124\/mol.108.046904","volume":"74","author":"I Bar","year":"2008","unstructured":"Bar I, Guns P-J, Metallo J, Cammarata D, Wilkin F, Boeynams J-M et al (2008) Knockout mice reveal a role for P2Y6 receptor in macrophages, endothelial cells, and vascular smooth muscle cells. Mol Pharmacol 74(3):777\u2013784","journal-title":"Mol Pharmacol"},{"issue":"10","key":"14_CR333","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/01.ATV.0000142376.30582.ed","volume":"24","author":"A-K Wihlborg","year":"2004","unstructured":"Wihlborg A-K, Wang L, Braun OO, Eyjolfsson A, Gustafsson R, Gudbjartsson T et al (2004) ADP receptor P2Y 12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arterioscler Thromb Vasc Biol 24(10):1810\u20131815","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"14_CR334","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1124\/jpet.112.198051","volume":"343","author":"C Mitchell","year":"2012","unstructured":"Mitchell C, Syed N -i-H, Tengah A, Gurney AM, Kennedy C (2012) Identification of contractile P2Y1, P2Y6, and P2Y12 receptors in rat intrapulmonary artery using selective ligands. J Pharmacol Exp Ther 343(3):755\u2013762","journal-title":"J Pharmacol Exp Ther"},{"issue":"17","key":"14_CR335","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1016\/j.febslet.2014.05.044","volume":"588","author":"KA Haanes","year":"2014","unstructured":"Haanes KA, Edvinsson L (2014) Characterization of the contractile P2Y14 receptor in mouse coronary and cerebral arteries. FEBS Lett 588(17):2936\u20132943","journal-title":"FEBS Lett"},{"key":"14_CR336","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S0008-6363(00)00032-8","volume":"46","author":"Y Sun","year":"2000","unstructured":"Sun Y, Weber KT (2000) Infarct scar: a dynamic tissue. Cardiovasc Res 46:250\u2013256","journal-title":"Cardiovasc Res"},{"issue":"7","key":"14_CR337","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nbt1117","volume":"23","author":"MA Laflamme","year":"2005","unstructured":"Laflamme MA, Murry CE (2005) Regenerating the heart. Nat Biotechnol 23(7):845\u2013856","journal-title":"Nat Biotechnol"},{"issue":"9","key":"14_CR338","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1634\/stemcells.2008-0428","volume":"26","author":"PJ Psaltis","year":"2008","unstructured":"Psaltis PJ, Zannettino ACW, Worthley SG, Gronthos S (2008) Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells 26(9):2201\u20132210","journal-title":"Stem Cells"},{"issue":"1","key":"14_CR339","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1161\/hc0102.101442","volume":"105","author":"C Toma","year":"2002","unstructured":"Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105(1):93\u201398","journal-title":"Circulation"},{"issue":"32","key":"14_CR340","doi-asserted-by":"publisher","first-page":"11474","DOI":"10.1073\/pnas.0504388102","volume":"102","author":"LC Amado","year":"2005","unstructured":"Amado LC, Saliaris AP, Schuleri KH, St. John M, Xie J-S, Cattaneo S et al (2005) Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci 102(32):11474\u201311479","journal-title":"Proc Natl Acad Sci"},{"issue":"21","key":"14_CR341","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1093\/eurheartj\/ehm426","volume":"28","author":"C Valina","year":"2007","unstructured":"Valina C, Pinkernell K, Song Y-H, Bai X, Sadat S, Campeau RJ et al (2007) Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J 28(21):2667\u20132677","journal-title":"Eur Heart J"},{"issue":"2","key":"14_CR342","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1161\/01.CIR.0000151812.86142.45","volume":"111","author":"GV Silva","year":"2005","unstructured":"Silva GV, Litovsky S, Assad JAR, Sousa ALS, Martin BJ, Vela D et al (2005) Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111(2):150\u2013156","journal-title":"Circulation"},{"issue":"4","key":"14_CR343","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1359\/jbmr.2003.18.4.696","volume":"18","author":"S Shi","year":"2003","unstructured":"Shi S, Gronthos S (2003) Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 18(4):696\u2013704","journal-title":"J Bone Miner Res"},{"issue":"2","key":"14_CR344","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/jcp.21210","volume":"214","author":"ACW Zannettino","year":"2008","unstructured":"Zannettino ACW, Paton S, Arthur A, Khor F, Itescu S, Gimble JM et al (2008) Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol 214(2):413\u2013421","journal-title":"J Cell Physiol"},{"issue":"2","key":"14_CR345","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2007.08.025","volume":"131","author":"B Sacchetti","year":"2007","unstructured":"Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I et al (2007) Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131(2):324\u2013336","journal-title":"Cell"},{"issue":"2","key":"14_CR346","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.bbrc.2004.09.087","volume":"324","author":"WSN Shim","year":"2004","unstructured":"Shim WSN, Jiang S, Wong P, Tan J, Chua YL, Seng Tan Y et al (2004) Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem Biophys Res Commun 324(2):481\u2013488","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"14_CR347","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2143\/AC.60.3.2005005","volume":"60","author":"J Yoon","year":"2005","unstructured":"Yoon J, Min BG, Kim Y-H, Shim WJ, Ro YM, Lim D-S (2005) Differentiation, engraftment and functional effects of pre-treated mesenchymal stem cells in a rat myocardial infarct model. Acta Cardiol 60(3):277\u2013284","journal-title":"Acta Cardiol"},{"issue":"1","key":"14_CR348","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0022-5223(03)00074-6","volume":"126","author":"S Rangappa","year":"2003","unstructured":"Rangappa S, Entwistle JWC, Wechsler AS, Kresh JY (2003) Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype. J Thorac Cardiovasc Surg 126(1):124\u2013132","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"Pt 3","key":"14_CR349","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1113\/jphysiol.2003.058719","volume":"555","author":"V Valiunas","year":"2004","unstructured":"Valiunas V, Doronin S, Valiuniene L, Potapova I, Zuckerman J, Walcott B et al (2004) Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J Physiol 555(Pt 3):617\u2013626","journal-title":"J Physiol"},{"issue":"S1","key":"14_CR350","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1038\/ncpcardio0404","volume":"3","author":"TP Martens","year":"2006","unstructured":"Martens TP, See F, Schuster MD, Sondermeijer HP, Hefti MM, Zannettino A et al (2006) Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium. Nat Clin Pract Cardiovasc Med 3(S1):S18\u2013S22","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"6","key":"14_CR351","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/S0003-4975(02)03517-8","volume":"73","author":"JG Shake","year":"2002","unstructured":"Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM et al (2002) Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73(6):1919\u20131926","journal-title":"Ann Thorac Surg"},{"issue":"90101","key":"14_CR352","doi-asserted-by":"publisher","first-page":"II253","DOI":"10.1161\/01.cir.0000089186.09692.fa","volume":"108","author":"S Davani","year":"2003","unstructured":"Davani S, Marandin A, Mersin N, Royer B, Kantelip B, Herv\u00e9 P et al (2003) Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108(90101):II253\u2013II258","journal-title":"Circulation"},{"issue":"2","key":"14_CR353","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ijcard.2006.03.028","volume":"115","author":"M Hou","year":"2007","unstructured":"Hou M, Yang K, Zhang H, Zhu W-Q, Duan F, Wang H et al (2007) Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats. Int J Cardiol 115(2):220\u2013228","journal-title":"Int J Cardiol"},{"issue":"6961","key":"14_CR354","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/nature02069","volume":"425","author":"M Alvarez-Dolado","year":"2003","unstructured":"Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fike JR, Lee HO, Pfeffer K et al (2003) Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425(6961):968\u2013973","journal-title":"Nature"},{"issue":"5","key":"14_CR355","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nm1040","volume":"10","author":"JM Nygren","year":"2004","unstructured":"Nygren JM, Jovinge S, Breitbach M, S\u00e4w\u00e9n P, R\u00f6ll W, Hescheler J et\u00a0al (2004) Bone marrow\u2013derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10(5):494\u2013501","journal-title":"Nat Med"},{"issue":"3","key":"14_CR356","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1172\/JCI115107","volume":"87","author":"F Bussolino","year":"1991","unstructured":"Bussolino F, Ziche M, Wang JM, Alessi D, Morbidelli L, Cremona O et al (1991) In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest 87(3):986\u2013995","journal-title":"J Clin Invest"},{"issue":"8","key":"14_CR357","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.11.033","volume":"24","author":"Z Fan","year":"2015","unstructured":"Fan Z, Cai H, Ge Z, Wang L, Zhang X, Li L et al (2015) The efficacy and safety of granulocyte colony-stimulating factor for patients with stroke. J Stroke Cerebrovasc Dis 24(8):1701\u20131708","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"14_CR358","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.yexcr.2005.06.005","volume":"309","author":"D Covas","year":"2005","unstructured":"Covas D, Piccinato C, Orellana M, Siufi J, Silvajr W, Protosiqueira R et al (2005) Mesenchymal stem cells can be obtained from the human saphena vein. Exp Cell Res 309(2):340\u2013344","journal-title":"Exp Cell Res"},{"issue":"6","key":"14_CR359","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1016\/j.thromres.2013.04.002","volume":"131","author":"S-M Fang","year":"2013","unstructured":"Fang S-M, Du D-Y, Li Y-T, Ge X-L, Qin P-T, Zhang Q-H et al (2013) Allogeneic bone marrow mesenchymal stem cells transplantation for stabilizing and repairing of atherosclerotic ruptured plaque. Thromb Res 131(6):e253\u2013e257","journal-title":"Thromb Res"},{"issue":"12","key":"14_CR360","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/01.CIR.0000124062.31102.57","volume":"109","author":"T Kinnaird","year":"2004","unstructured":"Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S et al (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109(12):1543\u20131549","journal-title":"Circulation"},{"issue":"5\u20136","key":"14_CR361","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000094140","volume":"17","author":"MH Moon","year":"2006","unstructured":"Moon MH, Kim SY, Kim YJ, Kim SJ, Lee JB, Bae YC et al (2006) Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of Hindlimb ischemia. Cell Physiol Biochem 17(5\u20136):279\u2013290","journal-title":"Cell Physiol Biochem"},{"issue":"8","key":"14_CR362","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1161\/ATVBAHA.113.301217","volume":"33","author":"R Katare","year":"2013","unstructured":"Katare R, Riu F, Rowlinson J, Lewis A, Holden R, Meloni M et al (2013) Perivascular delivery of encapsulated mesenchymal stem cells improves postischemic angiogenesis via paracrine activation of VEGF-A. Arterioscler Thromb Vasc Biol 33(8):1872\u20131880","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"14_CR363","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.diabres.2010.12.010","volume":"92","author":"D Lu","year":"2011","unstructured":"Lu D, Chen B, Liang Z, Deng W, Jiang Y, Li S et al (2011) Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract 92(1):26\u201336","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"14_CR364","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1096\/fj.05-5211com","volume":"20","author":"M Gnecchi","year":"2006","unstructured":"Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F et al (2006) Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20(6):661\u2013669","journal-title":"FASEB J"},{"issue":"4","key":"14_CR365","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1161\/01.STR.0000157661.69482.76","volume":"36","author":"K Hanabusa","year":"2005","unstructured":"Hanabusa K, Nagaya N, Iwase T, Itoh T, Murakami S, Shimizu Y et al (2005) Adrenomedullin enhances therapeutic potency of mesenchymal stem cells after experimental stroke in rats. Stroke 36(4):853\u2013858","journal-title":"Stroke"},{"issue":"3","key":"14_CR366","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10456-010-9169-x","volume":"13","author":"W Piao","year":"2010","unstructured":"Piao W, Wang H, Inoue M, Hasegawa M, Hamada H, Huang J (2010) Transplantation of Sendai viral angiopoietin-1-modified mesenchymal stem cells for ischemic limb disease. Angiogenesis 13(3):203\u2013210","journal-title":"Angiogenesis"},{"issue":"4","key":"14_CR367","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2174\/1574888X13666180313141416","volume":"13","author":"FSA Wahid","year":"2018","unstructured":"Wahid FSA, Ismail NA, Wan Jamaludin WF, Muhamad NA, Mohamad Idris MA, Lai NM (2018) Efficacy and safety of autologous cell-based therapy in patients with no-option critical limb ischaemia: a meta-analysis. Curr Stem Cell Res Ther 13(4):265\u2013283","journal-title":"Curr Stem Cell Res Ther"},{"issue":"3","key":"14_CR368","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057876","volume":"8","author":"W-H Lai","year":"2013","unstructured":"Lai W-H, Ho JCY, Chan Y-C, Ng JHL, Au K-W, Wong L-Y et al (2013) Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells. Ushio-Fukai M, editor. PLoS One 8(3):e57876","journal-title":"PLoS One"},{"issue":"11","key":"14_CR369","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/ATVBAHA.111.230938","volume":"31","author":"AJ Rufaihah","year":"2011","unstructured":"Rufaihah AJ, Huang NF, Jam\u00e9 S, Lee JC, Nguyen HN, Byers B et al (2011) Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol 31(11):e72\u2013e79","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"14_CR370","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijcard.2017.01.125","volume":"234","author":"ZE Clayton","year":"2017","unstructured":"Clayton ZE, Yuen GSC, Sadeghipour S, Hywood JD, Wong JWT, Huang NF et al (2017) A comparison of the pro-angiogenic potential of human induced pluripotent stem cell derived endothelial cells and induced endothelial cells in a murine model of peripheral arterial disease. Int J Cardiol 234:81\u201389","journal-title":"Int J Cardiol"},{"issue":"9","key":"14_CR371","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.109.898312","volume":"121","author":"Q Lian","year":"2010","unstructured":"Lian Q, Zhang Y, Zhang J, Zhang HK, Wu X, Zhang Y et al (2010) Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 121(9):1113\u20131123","journal-title":"Circulation"},{"issue":"2","key":"14_CR372","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.pharmthera.2005.04.013","volume":"112","author":"MJL Bours","year":"2006","unstructured":"Bours MJL, Swennen ELR, Di Virgilio F, Cronstein BN, Dagnelie PC (2006) Adenosine 5\u2032-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112(2):358\u2013404","journal-title":"Pharmacol Ther"},{"issue":"12A","key":"14_CR373","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0002-9149(97)00256-7","volume":"79","author":"JC Shryock","year":"1997","unstructured":"Shryock JC, Belardinelli L (1997) Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 79(12A):2\u201310","journal-title":"Am J Cardiol"},{"issue":"2\u20133","key":"14_CR374","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0163-7258(00)00053-X","volume":"87","author":"J Spychala","year":"2000","unstructured":"Spychala J (2000) Tumor-promoting functions of adenosine. Pharmacol Ther 87(2\u20133):161\u2013173","journal-title":"Pharmacol Ther"},{"issue":"3","key":"14_CR375","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nrd1983","volume":"5","author":"KA Jacobson","year":"2006","unstructured":"Jacobson KA, Gao Z-G (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5(3):247\u2013264","journal-title":"Nat Rev Drug Discov"},{"key":"14_CR376","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1359\/JBMR.051021","volume":"21","author":"BA Evans","year":"2006","unstructured":"Evans BA, Elford C, Pexa A, Francis K, Hughes AC, Deussen A et al (2006) Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin. J Bone Miner Res 21:228\u2013236","journal-title":"J Bone Miner Res"},{"key":"14_CR377","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1006\/jsre.1999.5716","volume":"87","author":"LL Sun","year":"1999","unstructured":"Sun LL, Xu LL, Nielsen TB, Rhee P, Burris D (1999) Cyclopentyladenosine improves cell proliferation, wound healing, and hair growth. J Surg Res 87:14","journal-title":"J Surg Res"},{"key":"14_CR378","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF02529732","volume":"58","author":"S Shimegi","year":"1996","unstructured":"Shimegi S (1996) ATP and adenosine act as a mitogen for osteoblast-like cells (MC3T3-E1). Calcif Tissue Int 58:109","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"14_CR379","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.4049\/jimmunol.158.6.2926","volume":"158","author":"BA Walker","year":"1997","unstructured":"Walker BA, Rocchini C, Boone RH, Ip S, Jacobson MA (1997) Adenosine A2a receptor activation delays apoptosis in human neutrophils. J Immunol 158(6):2926\u20132931","journal-title":"J Immunol"},{"key":"14_CR380","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1006\/jmcc.2000.1275","volume":"33","author":"ZQ Zhao","year":"2001","unstructured":"Zhao ZQ, Budde JM, Morris C, Wang NP, Velez DA, Muraki S et al (2001) Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins. J Mol Cell Cardiol 33:57","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"14_CR381","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1515\/BC.2003.054","volume":"384","author":"R Napieralski","year":"2003","unstructured":"Napieralski R, Kempkes B, Gutensohn W (2003) Evidence for coordinated induction and repression of Ecto-5\u2019-Nucleotidase (CD73) and the A2a adenosine receptor in a human B cell line. Biol Chem 384(3):483\u2013487","journal-title":"Biol Chem"},{"key":"14_CR382","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4252\/wjsc.v6.i2.153","volume":"6","author":"S Scarf\u00ec","year":"2014","unstructured":"Scarf\u00ec S (2014) Purinergic receptors and nucleotide processing ectoenzymes: their roles in regulating mesenchymal stem cell functions. World J Stem Cells 6:153","journal-title":"World J Stem Cells"},{"issue":"4","key":"14_CR383","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ceca.2005.11.008","volume":"39","author":"S Kawano","year":"2006","unstructured":"Kawano S, Otsu K, Kuruma A, Shoji S, Yanagida E, Muto Y et al (2006) ATP autocrine\/paracrine signaling induces calcium oscillations and NFAT activation in human mesenchymal stem cells. Cell Calcium 39(4):313\u2013324","journal-title":"Cell Calcium"},{"key":"14_CR384","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/jcp.21680","volume":"219","author":"J Ichikawa","year":"2009","unstructured":"Ichikawa J, Gemba H (2009) Cell density-dependent changes in intracellular Ca 2+ mobilization via the P2Y 2 receptor in rat bone marrow stromal cells. J Cell Physiol 219:372","journal-title":"J Cell Physiol"},{"issue":"3","key":"14_CR385","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/j.1476-5381.2012.01831.x","volume":"166","author":"J-B Chen","year":"2012","unstructured":"Chen J-B, Liu W-J, Che H, Liu J, Sun H-Y, Li G-R (2012) Adenosine-5\u2032-triphosphate up-regulates proliferation of human cardiac fibroblasts. Br J Pharmacol 166(3):1140\u20131150","journal-title":"Br J Pharmacol"},{"key":"14_CR386","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s11302-013-9380-5","volume":"9","author":"AV Hinze","year":"2013","unstructured":"Hinze AV, Mayer P, Harst A, von K\u00fcgelgen I (2013) P2X1 receptor-mediated inhibition of the proliferation of human coronary smooth muscle cells involving the transcription factor NR4A1. Purinergic Signal 9:677","journal-title":"Purinergic Signal"},{"issue":"2","key":"14_CR387","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/01.HYP.37.2.716","volume":"37","author":"RK Dubey","year":"2001","unstructured":"Dubey RK, Gillespie DG, Zacharia LC, Mi Z, Jackson EK (2001) A 2B receptors mediate the antimitogenic effects of adenosine in cardiac fibroblasts. Hypertension 37(2):716\u2013721","journal-title":"Hypertension"},{"key":"14_CR388","doi-asserted-by":"publisher","first-page":"H2478","DOI":"10.1152\/ajpheart.00217.2004","volume":"287","author":"Y Chen","year":"2004","unstructured":"Chen Y, Epperson S, Makhsudova L, Ito B, Suarez J, Dillmann W et al (2004) Functional effects of enhancing or silencing adenosine A 2b receptors in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 287:H2478","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"14_CR389","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1023\/A:1025551229566","volume":"252","author":"I Goldenberg","year":"2003","unstructured":"Goldenberg I, Shainberg A, Jacobson KA, Shneyvays V, Grossman E (2003) Adenosine protects against angiotensin II-induced apoptosis in rat cardiocyte cultures. Mol Cell Biochem 252:133","journal-title":"Mol Cell Biochem"},{"key":"14_CR390","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.csbj.2014.11.003","volume":"13","author":"C Kaebisch","year":"2015","unstructured":"Kaebisch C, Schipper D, Babczyk P, Tobiasch E (2015) The role of purinergic receptors in stem cell differentiation. Comput Struct Biotechnol J 13:75\u201384","journal-title":"Comput Struct Biotechnol J"},{"key":"14_CR391","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.ncl.2016.06.016","volume":"34","author":"J Howard","year":"2016","unstructured":"Howard J, Trevick S, Younger DS (2016) Epidemiology of multiple sclerosis. Neurol Clin 34:919","journal-title":"Neurol Clin"},{"key":"14_CR392","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neurol.2015.10.006","volume":"172","author":"E Leray","year":"2016","unstructured":"Leray E, Moreau T, Fromont A, Edan G (2016) Epidemiology of musisltiple sclero. Rev Neurol (Paris) 172:3","journal-title":"Rev Neurol (Paris)"},{"issue":"7359","key":"14_CR393","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"S Sawcer","year":"2011","unstructured":"Sawcer S, Hellenthal G, Pirinen M, Spencer CCA, Patsopoulos NA, Moutsianas L et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476(7359):214\u2013219","journal-title":"Nature"},{"key":"14_CR394","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1474-4422(14)70267-4","volume":"14","author":"L Belbasis","year":"2015","unstructured":"Belbasis L, Bellou V, Evangelou E, Ioannidis JPA, Tzoulaki I (2015) Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol 14:263","journal-title":"Lancet Neurol"},{"issue":"20","key":"14_CR395","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1056\/NEJM200011163432001","volume":"343","author":"Christian Confavreux","year":"2000","unstructured":"Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med. 2000 Nov 16;343(20):1430-8","journal-title":"New England Journal of Medicine"},{"key":"14_CR396","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1001\/jamaneurol.2013.599","volume":"70","author":"A Scalfari","year":"2013","unstructured":"Scalfari A, Neuhaus A, Daumer M, DeLuca GC, Muraro PA, Ebers GC (2013) Early relapses, onset of progression, and late outcome in multiple sclerosis. JAMA Neurol 70:214","journal-title":"JAMA Neurol"},{"key":"14_CR397","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/ane.13010","volume":"139","author":"AC Rahn","year":"2019","unstructured":"Rahn AC, K\u00f6pke S, Stellmann JP, Schiffmann I, Lukas C, Chard D et al (2019) Magnetic resonance imaging as a prognostic disability marker in clinically isolated syndrome: a systematic review. Acta Neurol Scand 139:18","journal-title":"Acta Neurol Scand"},{"issue":"0","key":"14_CR398","doi-asserted-by":"publisher","first-page":"S861","DOI":"10.1007\/s100720070027","volume":"21","author":"I.L. Simone","year":"2000","unstructured":"Simone IL, Carrara D, Tortorella C, Ceccarelli A, Livrea P. Early onset multiple sclerosis. Neurol Sci. 2000;21(4 Suppl 2):S861-3. Essa refer\u00eancia est\u00e1 errada no cap\u00edtulo. Esta \u00e9 a correta, provavelmente o Mendeley importou errado, porque ao fazer o search agora, ele buscou o certo","journal-title":"Neurological Sciences"},{"issue":"2_suppl","key":"14_CR399","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/1352458517708097","volume":"23","author":"G Kobelt","year":"2017","unstructured":"Kobelt G, Eriksson J, Phillips G, Berg J (2017) The burden of multiple sclerosis 2015: methods of data collection, assessment and analysis of costs, quality of life and symptoms. Mult Scler 23(2_suppl):4\u201316","journal-title":"Mult Scler"},{"key":"14_CR400","first-page":"263","volume-title":"Neuromethods","author":"Tarek Nafee","year":"2018","unstructured":"Nafee T., Watanabe R., Fregni F. (2018) Multiple Sclerosis. In: Fregni F. (eds) Clinical Trials in Neurology. Neuromethods, vol 138. Humana Press, New York, NY"},{"key":"14_CR401","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/glia.20424","volume":"54","author":"AM Butt","year":"2006","unstructured":"Butt AM (2006) Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology. Glia 54:666","journal-title":"Glia"},{"key":"14_CR402","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2377-6-12","volume":"6","author":"Y Yiangou","year":"2006","unstructured":"Yiangou Y, Facer P, Durrenberger P, Chessell IP, Naylor A, Bountra C et al (2006) COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol 6:12","journal-title":"BMC Neurol"},{"issue":"2","key":"14_CR403","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/glia.20110","volume":"49","author":"L Narcisse","year":"2005","unstructured":"Narcisse L, Scemes E, Zhao Y, Lee SC, Brosnan CF (2005) The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes. Glia [Internet]. 49(2):245\u2013258. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15472991","journal-title":"Glia [Internet]."},{"key":"14_CR404","doi-asserted-by":"publisher","first-page":"9525","DOI":"10.1523\/JNEUROSCI.0579-07.2007","volume":"27","author":"C Matute","year":"2007","unstructured":"Matute C, Torre I, Perez-Cerda F, Perez-Samartin A, Alberdi E, Etxebarria E et al (2007) P2X7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J Neurosci 27:9525","journal-title":"J Neurosci"},{"key":"14_CR405","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jneuroim.2012.02.002","volume":"245","author":"M Caragnano","year":"2012","unstructured":"Caragnano M, Tortorella P, Bergami A, Ruggieri M, Livrea P, Specchio LM et al (2012) Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis. J Neuroimmunol 245:93","journal-title":"J Neuroimmunol"},{"key":"14_CR406","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ceca.2011.08.002","volume":"50","author":"O Oyanguren-Desez","year":"2011","unstructured":"Oyanguren-Desez O, Rodr\u00edguez-Antig\u00fcedad A, Villoslada P, Domercq M, Alberdi E, Matute C (2011) Gain-of-function of P2X7 receptor gene variants in multiple sclerosis. Cell Calcium 50:468","journal-title":"Cell Calcium"},{"key":"14_CR407","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1093\/hmg\/ddv278","volume":"24","author":"BJ Gu","year":"2015","unstructured":"Gu BJ, Field J, Dutertre S, Ou A, Kilpatrick TJ, Lechner-Scott J et\u00a0al (2015) A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis. Hum Mol Genet 24:5644","journal-title":"Hum Mol Genet"},{"issue":"5","key":"14_CR408","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.4049\/jimmunol.176.5.3115","volume":"176","author":"Lanfen Chen","year":"2006","unstructured":"Chen L, Brosnan CF. Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-\/- mice: evidence for loss of apoptotic activity in lymphocytes. J Immunol. 2006 Mar 1;176(5):3115\u201326. O ano dessa refer\u00eancia est\u00e1 errado no cap\u00edtulo","journal-title":"The Journal of Immunology"},{"key":"14_CR409","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1073\/pnas.0510418103","volume":"103","author":"A Witting","year":"2006","unstructured":"Witting A, Chen L, Cudaback E, Straiker A, Walter L, Rickman B et al (2006) Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. Proc Natl Acad Sci 103:6362","journal-title":"Proc Natl Acad Sci"},{"key":"14_CR410","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fphar.2018.00325","volume":"9","author":"O-G \u00e1gatha","year":"2018","unstructured":"\u00e1gatha O-G, Naaldijk Y, Sard\u00e1-Arroyo L, Gon\u00e7alves MCB, Corr\u00eaa-Velloso J, Pillat MM et al (2018) Purinergic receptors in neurological diseases with motor symptoms: targets for therapy. Front Pharmacol 9:325","journal-title":"Front Pharmacol"},{"key":"14_CR411","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11302-015-9471-6","volume":"11","author":"D F\u00f6rster","year":"2015","unstructured":"F\u00f6rster D, Reiser G (2015) Supportive or detrimental roles of P2Y receptors in brain pathology?\u2014the two faces of P2Y receptors in stroke and neurodegeneration detected in neural cell and in animal model studies. Purinergic Signal 11:441","journal-title":"Purinergic Signal"},{"key":"14_CR412","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/cercor\/bhp193","volume":"20","author":"S Amadio","year":"2010","unstructured":"Amadio S, Montilli C, Magliozzi R, Bernardi G, Reynolds R, Volont\u00e9 C (2010) P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis. Cereb Cortex 20:1263","journal-title":"Cereb Cortex"},{"key":"14_CR413","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbi.2016.12.001","volume":"62","author":"J Zhang","year":"2017","unstructured":"Zhang J, Li Z, Hu X, Su Q, He C, Liu J et\u00a0al (2017) Knockout of P2Y12 aggravates experimental autoimmune encephalomyelitis in mice via increasing of IL-23 production and Th17 cell differentiation by dendritic cells. Brain Behav Immun 62:245","journal-title":"Brain Behav Immun"},{"issue":"24","key":"14_CR414","doi-asserted-by":"publisher","first-page":"11294","DOI":"10.1073\/pnas.92.24.11294","volume":"92","author":"L. Probert","year":"1995","unstructured":"Probert L1, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11294\u20138. O ano dessa refer\u00eancia est\u00e1 errado no cap\u00edtulo","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"14_CR415","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ana.1007","volume":"49","author":"JB Johnston","year":"2001","unstructured":"Johnston JB, Silva C, Gonzalez G, Holden J, Warren KG, Metz LM et al (2001) Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosis. Ann Neurol 49:650","journal-title":"Ann Neurol"},{"key":"14_CR416","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1523\/JNEUROSCI.4271-03.2004","volume":"24","author":"S Tsutsui","year":"2004","unstructured":"Tsutsui S (2004) A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J Neurosci 24:1521","journal-title":"J Neurosci"},{"key":"14_CR417","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/jnnp-2015-312176","volume":"87","author":"AK Hedstr\u00f6m","year":"2016","unstructured":"Hedstr\u00f6m AK, Mowry EM, Gianfrancesco MA, Shao X, Schaefer CA, Shen L et al (2016) High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies. J Neurol Neurosurg Psychiatry 87:454","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"14_CR418","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","volume":"13","author":"T Olsson","year":"2017","unstructured":"Olsson T, Barcellos LF, Alfredsson L (2017) Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol 13(1):25\u201336","journal-title":"Nat Rev Neurol"},{"key":"14_CR419","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1212\/01.WNL.0000032256.35561.D6","volume":"59","author":"M Clanet","year":"2002","unstructured":"Clanet M, Radue EW, Kappos L, Hartung HP, Hohlfeld R, Sandberg-Wollheim M et al (2002) A randomized, double-blind, dose-comparison study of weekly interferon \u03b2-1a in relapsing MS. Neurology 59:1507","journal-title":"Neurology"},{"key":"14_CR420","doi-asserted-by":"publisher","first-page":"e00362","DOI":"10.1002\/brb3.362","volume":"5","author":"N Garg","year":"2015","unstructured":"Garg N, Smith TW (2015) An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain Behav 5:e00362","journal-title":"Brain Behav"},{"key":"14_CR421","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1191\/1352458505ms1190oa","volume":"11","author":"JS Sloka","year":"2005","unstructured":"Sloka JS, Stefanelli M (2005) The mechanism of action of methylprednisolone in the treatment of multiple sclerosis. Mult Scler 11:425","journal-title":"Mult Scler"},{"key":"14_CR422","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s40263-017-0429-9","volume":"31","author":"P Sarkar","year":"2017","unstructured":"Sarkar P, Rice CM, Scolding NJ (2017) Cell therapy for multiple sclerosis. CNS Drugs 31:453","journal-title":"CNS Drugs"},{"key":"14_CR423","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrd.2017.115","volume":"16","author":"JR Plemel","year":"2017","unstructured":"Plemel JR, Liu WQ, Yong VW (2017) Remyelination therapies: a new direction and challenge in multiple sclerosis. Nat Rev Drug Discov 16:617","journal-title":"Nat Rev Drug Discov"},{"key":"14_CR424","doi-asserted-by":"publisher","first-page":"17002","DOI":"10.1038\/cddiscovery.2017.2","volume":"3","author":"AP Ng","year":"2017","unstructured":"Ng AP, Alexander WS (2017) Haematopoietic stem cells: past, present and future. Cell Death Discov 3:17002","journal-title":"Cell Death Discov"},{"key":"14_CR425","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nrrheum.2017.7","volume":"13","author":"JF Swart","year":"2017","unstructured":"Swart JF, Delemarre EM, Van Wijk F, Boelens JJ, Kuball J, Van Laar JM et al (2017) Haematopoietic stem cell transplantation for autoimmune diseases. Nat Rev Rheumatol 13:244","journal-title":"Nat Rev Rheumatol"},{"key":"14_CR426","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jns.2004.04.021","volume":"223","author":"D Karussis","year":"2004","unstructured":"Karussis D, Slavin S (2004) Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures. J Neurol Sci 223:59","journal-title":"J Neurol Sci"},{"issue":"5","key":"14_CR427","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","volume":"106","author":"E Zappia","year":"2005","unstructured":"Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E et al (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106(5):1755\u20131761","journal-title":"Blood"},{"issue":"3","key":"14_CR428","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/ana.21076","volume":"61","author":"E Gerdoni","year":"2007","unstructured":"Gerdoni E, Gallo B, Casazza S, Musio S, Bonanni I, Pedemonte E et al (2007) Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 61(3):219\u2013227","journal-title":"Ann Neurol"},{"issue":"11","key":"14_CR429","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/glia.20841","volume":"57","author":"L Bai","year":"2009","unstructured":"Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD et al (2009) Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 57(11):1192\u20131203","journal-title":"Glia"},{"issue":"10","key":"14_CR430","doi-asserted-by":"publisher","first-page":"797","DOI":"10.5966\/sctm.2013-0026","volume":"2","author":"BA Scruggs","year":"2013","unstructured":"Scruggs BA, Semon JA, Zhang X, Zhang S, Bowles AC, Pandey AC et al (2013) Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model. Stem Cells Transl Med 2(10):797\u2013807","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"14_CR431","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/stem.2272","volume":"34","author":"AL Strong","year":"2016","unstructured":"Strong AL, Bowles AC, Wise RM, Morand JP, Dutreil MF, Gimble JM et al (2016) Human adipose stromal\/stem cells from obese donors show reduced efficacy in halting disease progression in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Stem Cells 34(3):614\u2013626","journal-title":"Stem Cells"},{"issue":"1","key":"14_CR432","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/scrt391","volume":"5","author":"JA Semon","year":"2014","unstructured":"Semon JA, Maness C, Zhang X, Sharkey SA, Beuttler MM, Shah FS et al (2014) Comparison of human adult stem cells from adipose tissue and bone marrow in the treatment of experimental autoimmune encephalomyelitis. Stem Cell Res Ther 5(1):2","journal-title":"Stem Cell Res Ther"},{"key":"14_CR433","doi-asserted-by":"crossref","unstructured":"Shu J, He X, Li H, Liu X, Qiu X, Zhou T et al (2018) The beneficial effect of human amnion Mesenchymal cells in inhibition of inflammation and induction of neuronal repair in EAE mice. J Immunol Res","DOI":"10.1155\/2018\/5083797"},{"key":"14_CR434","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.stemcr.2014.01.013","volume":"2","author":"D Doi","year":"2014","unstructured":"Doi D, Samata B, Katsukawa M, Kikuchi T, Morizane A, Ono Y et al (2014) Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Rep 2:337\u2013350","journal-title":"Stem Cell Rep"},{"issue":"2","key":"14_CR435","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.etap.2013.05.005","volume":"36","author":"N Xiong","year":"2013","unstructured":"Xiong N, Yang H, Liu L, Xiong J, Zhang Z, Zhang X et al (2013) BFGF promotes the differentiation and effectiveness of human bone marrow mesenchymal stem cells in a rotenone model for Parkinson\u2019s disease. Environ Toxicol Pharmacol 36(2):411\u2013422","journal-title":"Environ Toxicol Pharmacol"},{"issue":"11","key":"14_CR436","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.bbmt.2010.06.004","volume":"16","author":"N Xiong","year":"2010","unstructured":"Xiong N, Cao X, Zhang Z, Huang J, Chen C, Zhang Z et al (2010) Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats. Biol Blood Marrow Transplant 16(11):1519\u20131529","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"14_CR437","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/gt.2010.152","volume":"18","author":"N Xiong","year":"2011","unstructured":"Xiong N, Zhang Z, Huang J, Chen C, Zhang Z, Jia M et al (2011) VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinsons disease. Gene Ther 18(4):394\u2013402","journal-title":"Gene Ther"},{"issue":"3","key":"14_CR438","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.stem.2015.01.018","volume":"16","author":"PJ Hallett","year":"2015","unstructured":"Hallett PJ, Deleidi M, Astradsson A, Smith GA, Osborn T, Sundberg M et al (2015) Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson\u2019s disease. Cell Stem Cell 16(3):269\u2013274","journal-title":"Cell Stem Cell"},{"issue":"15","key":"14_CR439","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1073\/pnas.0801677105","volume":"105","author":"M Wernig","year":"2008","unstructured":"Wernig M, Zhao J-P, Pruszak J, Hedlund E, Fu D, Soldner F et al (2008) Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson\u2019s disease. Proc Natl Acad Sci 105(15):5856\u20135861","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"14_CR440","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/stem.662","volume":"29","author":"M Deleidi","year":"2011","unstructured":"Deleidi M, Hargus G, Hallett P, Osborn T, Isacson O (2011) Development of histocompatible primate-induced pluripotent stem cells for neural transplantation. Stem Cells 29(7):1052\u20131063","journal-title":"Stem Cells"},{"issue":"3","key":"14_CR441","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.celrep.2013.02.016","volume":"3","author":"ME Emborg","year":"2013","unstructured":"Emborg ME, Liu Y, Xi J, Zhang X, Yin Y, Lu J et\u00a0al (2013) Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain. Cell Rep 3(3):646\u2013650","journal-title":"Cell Rep"},{"issue":"12","key":"14_CR442","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1038\/mt.2008.197","volume":"16","author":"M Suzuki","year":"2008","unstructured":"Suzuki M, McHugh J, Tork C, Shelley B, Hayes A, Bellantuono I et al (2008) Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther 16(12):2002\u20132010","journal-title":"Mol Ther"},{"issue":"3","key":"14_CR443","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.nbd.2008.05.016","volume":"31","author":"A Vercelli","year":"2008","unstructured":"Vercelli A, Mereuta OM, Garbossa D, Muraca G, Mareschi K, Rustichelli D et al (2008) Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 31(3):395\u2013405","journal-title":"Neurobiol Dis"},{"issue":"1\u20132","key":"14_CR444","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jns.2007.05.016","volume":"265","author":"L Mazzini","year":"2008","unstructured":"Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Nasuelli N et al (2008) Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci 265(1\u20132):78\u201383","journal-title":"J Neurol Sci"},{"issue":"5","key":"14_CR445","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2119\/molmed.2011.00498","volume":"18","author":"A Uccelli","year":"2012","unstructured":"Uccelli A, Milanese M, Principato MC, Morando S, Bonifacino T, Vergani L et al (2012) Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis. Mol Med 18(5):1","journal-title":"Mol Med"},{"issue":"3","key":"14_CR446","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neulet.2009.10.074","volume":"468","author":"H Kim","year":"2010","unstructured":"Kim H, Kim HY, Choi MR, Hwang S, Nam KH, Kim HC et al (2010) Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci Lett 468(3):190\u2013194","journal-title":"Neurosci Lett"},{"key":"14_CR447","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.stemcr.2017.03.003","volume":"8","author":"K Qian","year":"2017","unstructured":"Qian K, Huang H, Peterson A, Hu B, Maragakis NJ, Ming G et al (2017) Sporadic ALS astrocytes induce neuronal degeneration in vivo. Stem Cell Rep 8:843\u2013855","journal-title":"Stem Cell Rep"},{"key":"14_CR448","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.stemcr.2014.05.017","volume":"3","author":"T Kondo","year":"2014","unstructured":"Kondo T, Funayama M, Tsukita K, Hotta A, Yasuda A, Nori S et al (2014) Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice. Stem Cell Reports 3:242\u2013249","journal-title":"Stem Cell Reports"},{"issue":"1","key":"14_CR449","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1742-2094-6-39","volume":"6","author":"JK Ryu","year":"2009","unstructured":"Ryu JK, Cho T, Wang YT, McLarnon JG (2009) Neural progenitor cells attenuate inflammatory reactivity and neuronal loss in an animal model of inflamed AD brain. J Neuroinflammation 6(1):39","journal-title":"J Neuroinflammation"},{"issue":"32","key":"14_CR450","doi-asserted-by":"publisher","first-page":"13594","DOI":"10.1073\/pnas.0901402106","volume":"106","author":"M Blurton-Jones","year":"2009","unstructured":"Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, M\u00fcller F-J, Loring JF et al (2009) Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci 106(32):13594\u201313599","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"14_CR451","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2217\/rme-2016-0032","volume":"11","author":"S Misra","year":"2016","unstructured":"Misra S, Chopra K, Saikia UN, Sinha VR, Sehgal R, Modi M et al (2016) Effect of mesenchymal stem cells and galantamine nanoparticles in rat model of Alzheimer\u2019s disease. Regen Med 11(7):629\u2013646","journal-title":"Regen Med"},{"key":"14_CR452","doi-asserted-by":"publisher","first-page":"369417","DOI":"10.1155\/2012\/369417","volume":"2012","author":"P Babaei","year":"2012","unstructured":"Babaei P, Soltani Tehrani B, Alizadeh A (2012) Transplanted bone marrow mesenchymal stem cells improve memory in rat models of Alzheimer\u2019s disease. Stem Cells Int 2012:369417","journal-title":"Stem Cells Int"},{"issue":"7","key":"14_CR453","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/stem.1125","volume":"30","author":"JK Lee","year":"2012","unstructured":"Lee JK, Schuchman EH, Jin HK, Bae J-S (2012) Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid \u03b2 ameliorates Alzheimer\u2019s disease in mice by recruiting bone marrow-induced microglia immune responses. Stem Cells 30(7):1544\u20131555","journal-title":"Stem Cells"},{"key":"14_CR454","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fnagi.2014.00030","volume":"6","author":"KO Garcia","year":"2014","unstructured":"Garcia KO, Ornellas FLM, Martin PKM, Patti CL, Mello LE, Frussa-Filho R et al (2014) Therapeutic effects of the transplantation of VEGF overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of Alzheimer\u2019s disease. Front Aging Neurosci 6:30","journal-title":"Front Aging Neurosci"},{"key":"14_CR455","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bbr.2016.12.021","volume":"320","author":"Y Cui","year":"2017","unstructured":"Cui Y, Ma S, Zhang C, Cao W, Liu M, Li D et al (2017) Human umbilical cord mesenchymal stem cells transplantation improves cognitive function in Alzheimer\u2019s disease mice by decreasing oxidative stress and promoting hippocampal neurogenesis. Behav Brain Res 320:291\u2013301","journal-title":"Behav Brain Res"},{"key":"14_CR456","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1471-4159.2012.07700.x","volume":"121","author":"HJ Kim","year":"2012","unstructured":"Kim HJ, Ajit D, Peterson TS, Wang Y, Camden JM, Gibson Wood W et al (2012) Nucleotides released from A\u03b21-42-treated microglial cells increase cell migration and A\u03b21-42 uptake through P2Y2 receptor activation. J Neurochem 121:228","journal-title":"J Neurochem"},{"issue":"4","key":"14_CR457","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/scrt227","volume":"4","author":"H Yang","year":"2013","unstructured":"Yang H, Xie Z, Wei L, Yang H, Yang S, Zhu Z et al (2013) Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an A\u03b2PP\/PS1 transgenic mouse model. Stem Cell Res Ther 4(4):76","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"14_CR458","first-page":"95","volume":"1","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Seo SW, Chang JW, Lee JI, Kim CH, Chin J et\u00a0al (2015) Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: a phase 1 clinical trial. Alzheimer\u2019s Dement (New York, N Y) 1(2):95\u2013102","journal-title":"Alzheimer\u2019s Dement (New York, N Y)"},{"issue":"8","key":"14_CR459","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s12272-016-0799-4","volume":"39","author":"SE Park","year":"2016","unstructured":"Park SE, Lee J, Chang EH, Kim JH, Sung J-H, Na DL et al (2016) Activin A secreted by human mesenchymal stem cells induces neuronal development and neurite outgrowth in an in vitro model of Alzheimer\u2019s disease: neurogenesis induced by MSCs via activin A. Arch Pharm Res 39(8):1171\u20131179","journal-title":"Arch Pharm Res"},{"issue":"1","key":"14_CR460","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.expneurol.2007.07.016","volume":"208","author":"G Ren","year":"2007","unstructured":"Ren G, Li T, Lan JQ, Wilz A, Simon RP, Boison D (2007) Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control. Exp Neurol 208(1):26\u201337","journal-title":"Exp Neurol"},{"issue":"2","key":"14_CR461","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.seizure.2009.12.003","volume":"19","author":"ZSM Costa-Ferro","year":"2010","unstructured":"Costa-Ferro ZSM, Vitola AS, Pedroso MF, Cunha FB, Xavier LL, Machado DC et al (2010) Prevention of seizures and reorganization of hippocampal functions by transplantation of bone marrow cells in the acute phase of experimental epilepsy. Seizure 19(2):84\u201392","journal-title":"Seizure"},{"issue":"2","key":"14_CR462","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.nbd.2011.12.001","volume":"46","author":"ZSM Costa-Ferro","year":"2012","unstructured":"Costa-Ferro ZSM, Souza BSF, Leal MMT, Kaneto CM, Azevedo CM, da Silva IC et al (2012) Transplantation of bone marrow mononuclear cells decreases seizure incidence, mitigates neuronal loss and modulates pro-inflammatory cytokine production in epileptic rats. Neurobiol Dis 46(2):302\u2013313","journal-title":"Neurobiol Dis"},{"issue":"7\u20138","key":"14_CR463","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.lfs.2011.06.006","volume":"89","author":"GT Venturin","year":"2011","unstructured":"Venturin GT, Greggio S, Marinowic DR, Zanirati G, Cammarota M, Machado DC et al (2011) Bone marrow mononuclear cells reduce seizure frequency and improve cognitive outcome in chronic epileptic rats. Life Sci 89(7\u20138):229\u2013234","journal-title":"Life Sci"},{"issue":"2","key":"14_CR464","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.expneurol.2008.04.040","volume":"212","author":"B Hattiangady","year":"2008","unstructured":"Hattiangady B, Rao MS, Shetty AK (2008) Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy. Exp Neurol 212(2):468\u2013481","journal-title":"Exp Neurol"},{"issue":"7","key":"14_CR465","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/stem.446","volume":"28","author":"B Waldau","year":"2010","unstructured":"Waldau B, Hattiangady B, Kuruba R, Shetty AK (2010) Medial ganglionic eminence-derived neural stem cell grafts ease spontaneous seizures and restore GDNF expression in a rat model of chronic temporal lobe epilepsy. Stem Cells 28(7):1153\u20131164","journal-title":"Stem Cells"},{"key":"14_CR466","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.brainres.2009.07.079","volume":"1295","author":"M Jing","year":"2009","unstructured":"Jing M, Shingo T, Yasuhara T, Kondo A, Morimoto T, Wang F et al (2009) The combined therapy of intrahippocampal transplantation of adult neural stem cells and intraventricular erythropoietin-infusion ameliorates spontaneous recurrent seizures by suppression of abnormal mossy fiber sprouting. Brain Res 1295:203\u2013217","journal-title":"Brain Res"},{"key":"14_CR467","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fncel.2015.00127","volume":"9","author":"MK Jaiswal","year":"2015","unstructured":"Jaiswal MK, Keros S, Zhao M, Inan M, Schwartz TH, Anderson SA et al (2015) Reduction in focal ictal activity following transplantation of MGE interneurons requires expression of the GABAA receptor \u03b14 subunit. Front Cell Neurosci 9:127","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"14_CR468","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s12035-013-8480-0","volume":"48","author":"K Huicong","year":"2013","unstructured":"Huicong K, Zheng X, Furong W, Zhouping T, Feng X, Qi H et al (2013) The imbalanced expression of adenosine receptors in an epilepsy model corrected using targeted mesenchymal stem cell transplantation. Mol Neurobiol 48(3):921\u2013930","journal-title":"Mol Neurobiol"},{"issue":"1","key":"14_CR469","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1523\/JNEUROSCI.2683-11.2012","volume":"32","author":"X Maisano","year":"2012","unstructured":"Maisano X, Litvina E, Tagliatela S, Aaron GB, Grabel LB, Naegele JR (2012) Differentiation and functional incorporation of embryonic stem cell-derived GABAergic interneurons in the dentate gyrus of mice with temporal lobe epilepsy. J Neurosci 32(1):46\u201361","journal-title":"J Neurosci"},{"issue":"2","key":"14_CR470","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.brainres.2004.07.045","volume":"1023","author":"K Chu","year":"2004","unstructured":"Chu K, Kim M, Jung K-H, Jeon D, Lee S-T, Kim J et\u00a0al (2004) Human neural stem cell transplantation reduces spontaneous recurrent seizures following pilocarpine-induced status epilepticus in adult rats. Brain Res 1023(2):213\u2013221","journal-title":"Brain Res"},{"issue":"6","key":"14_CR471","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1179\/1743132810Y.0000000018","volume":"33","author":"A Abdanipour","year":"2011","unstructured":"Abdanipour A, Tiraihi T, Mirnajafi-Zadeh J (2011) Improvement of the pilocarpine epilepsy model in rat using bone marrow stromal cell therapy. Neurol Res 33(6):625\u2013632","journal-title":"Neurol Res"},{"key":"14_CR472","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/sj.bmt.1700944","volume":"20","author":"A Fassas","year":"1997","unstructured":"Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V et al (1997) Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant 20:631","journal-title":"Bone Marrow Transplant"},{"key":"14_CR473","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1136\/jnnp-2013-307207","volume":"85","author":"J Burman","year":"2014","unstructured":"Burman J, Iacobaeus E, Svenningsson A, Lycke J, Gunnarsson M, Nilsson P et al (2014) Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience. J Neurol Neurosurg Psychiatry 85:1116","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"14_CR474","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jama.2014.17986","volume":"313","author":"RK Burt","year":"2015","unstructured":"Burt RK, Balabanov R, Han X, Sharrack B, Morgan A, Quigley K et al (2015) Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis. JAMA - J Am Med Assoc 313:275","journal-title":"JAMA - J Am Med Assoc"},{"key":"14_CR475","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1212\/WNL.0000000000003660","volume":"88","author":"RA Nash","year":"2017","unstructured":"Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Steinmiller KC et al (2017) High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS. Neurology 88:842","journal-title":"Neurology"},{"key":"14_CR476","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1084\/jem.20041679","volume":"201","author":"PA Muraro","year":"2005","unstructured":"Muraro PA, Douek DC, Packer A, Chung K, Guenaga FJ, Cassiani-Ingoni R et al (2005) Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 201:805","journal-title":"J Exp Med"},{"key":"14_CR477","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s10072-017-2933-6","volume":"38","author":"B Casanova","year":"2017","unstructured":"Casanova B, Jarque I, Gasc\u00f3n F, Hern\u00e1ndez-Boluda JC, P\u00e9rez-Miralles F, de la Rubia J et\u00a0al (2017) Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis. Neurol Sci 38:1213","journal-title":"Neurol Sci"},{"key":"14_CR478","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.arcmed.2013.03.007","volume":"44","author":"M Mohyeddin Bonab","year":"2013","unstructured":"Mohyeddin Bonab M, Mohajeri M, Sahraian MA, Yazdanifar M, Aghsaie A, Farazmand A et al (2013) Evaluation of cytokines in multiple sclerosis patients treated withmesenchymal stem cells. Arch Med Res 44:266","journal-title":"Arch Med Res"},{"key":"14_CR479","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1177\/1352458509104590","volume":"15","author":"J Liang","year":"2009","unstructured":"Liang J, Zhang H, Hua B, Wang H, Wang J, Han Z et al (2009) Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Mult Scler 15:644","journal-title":"Mult Scler"},{"key":"14_CR480","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2174\/157488812804484648","volume":"7","author":"M Mohyeddin Bonab","year":"2012","unstructured":"Mohyeddin Bonab M, Ali Sahraian M, Aghsaie A, Ahmadi Karvigh S, Massoud Hosseinian S, Nikbin B et al (2012) Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study. Curr Stem Cell Res Ther 7:407","journal-title":"Curr Stem Cell Res Ther"},{"key":"14_CR481","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.3727\/096368914X685005","volume":"23 Suppl 1","author":"J-F Li","year":"2014","unstructured":"Li J-F, Zhang D-J, Geng T, Chen L, Huang H, Yin H-L et al (2014) The potential of human umbilical cord-derived mesenchymal stem cells as a novel cellular therapy for multiple sclerosis. Cell Transplant 23 Suppl 1:S113\u2013S122","journal-title":"Cell Transplant"},{"key":"14_CR482","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/cdd.2010.107","volume":"18","author":"A Casati","year":"2011","unstructured":"Casati A, Frascoli M, Traggiai E, Proietti M, Schenk U, Grassi F (2011) Cell-autonomous regulation of hematopoietic stem cell cycling activity by ATP. Cell Death Differ 18:396","journal-title":"Cell Death Differ"},{"key":"14_CR483","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1182\/blood-2004-03-0834","volume":"104","author":"RM Lemoli","year":"2004","unstructured":"Lemoli RM, Ferrari D, Fogli M, Rossi L, Pizzirani C, Forchap S et al (2004) Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo. Blood 104:1662","journal-title":"Blood"},{"key":"14_CR484","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1182\/blood-2006-01-035634","volume":"109","author":"L Rossi","year":"2007","unstructured":"Rossi L, Manfredini R, Bertolini F, Ferrari D, Fogli M, Zini R et al (2007) The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration. Blood 109:533","journal-title":"Blood"},{"issue":"3","key":"14_CR485","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neulet.2010.09.013","volume":"485","author":"V Kermer","year":"2010","unstructured":"Kermer V, Ritter M, Albuquerque B, Leib C, Stanke M, Zimmermann H (2010) Knockdown of tissue nonspecific alkaline phosphatase impairs neural stem cell proliferation and differentiation. Neurosci Lett 485(3):208\u2013211","journal-title":"Neurosci Lett"},{"key":"14_CR486","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1189\/jlb.1102561","volume":"73","author":"K Sak","year":"2003","unstructured":"Sak K, Boeynaems J-M, Everaus H (2003) Involvement of P2Y receptors in the differentiation of haematopoietic cells. J Leukoc Biol 73:442","journal-title":"J Leukoc Biol"},{"key":"14_CR487","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1634\/stemcells.2006-0669","volume":"25","author":"E Coppi","year":"2007","unstructured":"Coppi E, Pugliese AM, Urbani S, Melani A, Cerbai E, Mazzanti B et al (2007) ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells. Stem Cells 25:1840","journal-title":"Stem Cells"},{"key":"14_CR488","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/j.1471-4159.2009.06008.x","volume":"109","author":"C Delarasse","year":"2009","unstructured":"Delarasse C, Gonnord P, Galante M, Auger R, Daniel H, Motta I et al (2009) Neural progenitor cell death is induced by extracellular ATP via ligation of P2X7 receptor. J Neurochem 109:846","journal-title":"J Neurochem"},{"key":"14_CR662","unstructured":"Braak H, Braak E, Yilmazer D, Schultz C, de Vos RA, Jansen EN (1995) Nigral and extranigral pathology in Parkinson\u2019s disease. J Neural Transm 46:15\u201331"},{"issue":"8","key":"14_CR663","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","volume":"122","author":"P. Damier","year":"1999","unstructured":"Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease. Brain. 122(Pt8):1437\u20131448","journal-title":"Brain"},{"key":"14_CR489","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912","journal-title":"Lancet"},{"issue":"9680","key":"14_CR490","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"A Lees","year":"2009","unstructured":"Lees A, Hardy J, Revesz T (2009) Parkinson \u2019 s disease. Lancet 373(9680):2055\u20132066","journal-title":"Lancet"},{"issue":"6","key":"14_CR491","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrneurol.2010.52","volume":"6","author":"AHV Schapira","year":"2010","unstructured":"Schapira AHV, Tolosa E (2010) Molecular and clinical prodrome of Parkinson disease: implications for treatment. Nat Rev Neurol 6(6):309\u2013317","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"14_CR492","doi-asserted-by":"publisher","first-page":"180138","DOI":"10.1098\/rsob.180138","volume":"8","author":"E Taoufik","year":"2018","unstructured":"Taoufik E, Kouroupi G, Zygogianni O, Matsas R (2018) Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models. Open Biol 8(9):180138","journal-title":"Open Biol"},{"issue":"April","key":"14_CR493","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson \u2019 s disease: a target for neuroprotection ? Lancet 8(April):382\u2013397","journal-title":"Lancet"},{"issue":"1","key":"14_CR494","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mds.25249","volume":"28","author":"AB Singleton","year":"2013","unstructured":"Singleton AB, Farrer MJ, Bonifati V (2013) The genetics of Parkinson\u2019s disease: progress and therapeutic implications. Mov Disord 28(1):14\u201323","journal-title":"Mov Disord"},{"key":"14_CR495","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0304-3940(96)12706-3","volume":"211","author":"M Mogi","year":"1996","unstructured":"Mogi M, Harada M, Narabayashi H, Inagaki H, Minami M, Nagatsu T (1996) Interleukin (IL)-1beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson\u2019s disease. Neurosci Lett 211:13\u201316","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"14_CR496","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","volume":"165","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T (1994) Tumor necrosis factor-\u03b1 (TNF-\u03b1) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165(1\u20132):208\u2013210","journal-title":"Neurosci Lett"},{"issue":"2","key":"14_CR497","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0304-3940(95)11686-Q","volume":"193","author":"M Mogi","year":"1995","unstructured":"Mogi M, Harada M, Kondo T, Narabayashi H, Riederer P, Nagatsu T (1995) Transforming growth factor-\u03b21 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson\u2019s disease. Neurosci Lett 193(2):129\u2013132","journal-title":"Neurosci Lett"},{"key":"14_CR498","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jns.2016.09.030","volume":"370","author":"J Pereira","year":"2016","unstructured":"Pereira J, Santos L, Santos R, Campos A, Pimenta A, de Oliveira M et al (2016) IL-6 serum levels are elevated in Parkinson\u2019s disease patients with fatigue compared to patients without fatigue. J Neurol Sci 370:153\u2013156","journal-title":"J Neurol Sci"},{"issue":"1","key":"14_CR499","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadi\u00e8re B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V et al (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119(1):182\u2013192","journal-title":"J Clin Invest"},{"issue":"2","key":"14_CR500","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cyto.2011.03.027","volume":"55","author":"A Nicoletti","year":"2011","unstructured":"Nicoletti A, Fagone P, Donzuso G, Mangano K, Dibilio V, Caponnetto S et al (2011) Parkinson\u2019s disease is associated with increased serum levels of macrophage migration inhibitory factor. Cytokine 55(2):165\u2013167","journal-title":"Cytokine"},{"issue":"2","key":"14_CR501","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","volume":"441","author":"B Brodacki","year":"2008","unstructured":"Brodacki B, Staszewski J, Toczy\u0142owska B, Koz\u0142owska E, Drela N, Chalimoniuk M et al (2008) Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNF\u03b1, and INF\u03b3 concentrations are elevated in patients with atypical and idiopathic parkinsonism. Neurosci Lett 441(2):158\u2013162","journal-title":"Neurosci Lett"},{"issue":"4","key":"14_CR502","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s11481-012-9402-z","volume":"7","author":"JAH Saunders","year":"2012","unstructured":"Saunders JAH, Estes KA, Kosloski LM, Allen HE, Dempsey KM, Torres-Russotto DR et al (2012) CD4+ regulatory and effector\/memory T cell subsets profile motor dysfunction in Parkinson\u2019s disease. J Neuroimmune Pharmacol 7(4):927\u2013938","journal-title":"J Neuroimmune Pharmacol"},{"issue":"6","key":"14_CR503","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0301-0082(99)00017-9","volume":"59","author":"MP Rathbone","year":"1999","unstructured":"Rathbone MP, Middlemiss PJ, Gysbers JW, Andrew C, Herman MAR, Reed JK et al (1999) Trophic effects of purines in neurons and glial cells. Prog Neurobiol 59(6):663\u2013690","journal-title":"Prog Neurobiol"},{"issue":"6","key":"14_CR504","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2174\/187152712803581137","volume":"11","author":"C Volont\u00e9","year":"2012","unstructured":"Volont\u00e9 C, Apolloni S, Skaper SD, Burnstock G (2012) P2X7 receptors: channels, pores and more. CNS Neurol Disord Drug Targets [Internet] 11(6):705\u2013721. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22963440","journal-title":"CNS Neurol Disord Drug Targets [Internet]"},{"issue":"6","key":"14_CR505","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00702-010-0400-0","volume":"117","author":"D Marcellino","year":"2010","unstructured":"Marcellino D, Su\u00e1rez-Boomgaard D, S\u00e1nchez-Reina MD, Aguirre JA, Yoshitake T, Yoshitake S et al (2010) On the role of P2X7 receptors in dopamine nerve cell degeneration in a rat model of Parkinson\u2019s disease: studies with the P2X 7 receptor antagonist A-438079. J Neural Transm 117(6):681\u2013687","journal-title":"J Neural Transm"},{"key":"14_CR506","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3727\/096368917X695227","volume":"26","author":"EG Ferrazoli","year":"2017","unstructured":"Ferrazoli EG, de Souza HDN, Nascimento IC, Oliveira-Giacomelli \u00c1, Schwindt TT, Britto LR et al (2017) Brilliant blue-G but not fenofibrate treatment reverts hemiparkinsonian behavior and restores dopamine levels in an animal model of Parkinson\u2019s disease. Cell Transplant 26:669\u2013677","journal-title":"Cell Transplant"},{"issue":"2","key":"14_CR507","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3892\/mmr.2016.6070","volume":"15","author":"XH Wang","year":"2017","unstructured":"Wang XH, Xie X, Luo XG, Shang H, He ZY (2017) Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson\u2019s disease. Mol Med Rep 15(2):768\u2013776","journal-title":"Mol Med Rep"},{"key":"14_CR508","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.neuropharm.2014.01.045","volume":"81","author":"M Carmo","year":"2014","unstructured":"Carmo M, Menezes A, Nunes A, Pliassova A, Rolo A, Palmeira C et al (2014) The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis. Neuropharmacology 81:145\u2013152","journal-title":"Neuropharmacology"},{"key":"14_CR509","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-6-28","volume":"6","author":"Z Hracsk\u00f3","year":"2011","unstructured":"Hracsk\u00f3 Z, Baranyi M, Cs\u00f6lle C, G\u00f6l\u00f6ncser F, Madar\u00e1sz E, Kittel A et al (2011) Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson\u2019s disease. Mol Neurodegener 6:1\u201318","journal-title":"Mol Neurodegener"},{"issue":"1","key":"14_CR510","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0779-0","volume":"14","author":"X Yang","year":"2017","unstructured":"Yang X, Lou Y, Liu G, Wang X, Qian Y, Ding J et\u00a0al (2017) Microglia P2Y6 receptor is related to Parkinson\u2019s disease through neuroinflammatory process. J Neuroinflammation 14(1):1\u201312","journal-title":"J Neuroinflammation"},{"issue":"3","key":"14_CR511","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1046\/j.1471-4159.2001.00607.x","volume":"79","author":"S Latini","year":"2001","unstructured":"Latini S, Pedata F (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 79(3):463\u2013484","journal-title":"J Neurochem"},{"key":"14_CR512","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0306-4522(02)00080-5","volume":"112","author":"LV Lopes","year":"2002","unstructured":"Lopes LV, Cunha R, Kull B, Fredholm BB, Ribeiro J (2002) Adenosine A2A receptor facilitation of hippocampal synaptic transmission is dependent on tonic A1 receptor inhibition. Neuroscience 112:319","journal-title":"Neuroscience"},{"issue":"16","key":"14_CR513","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1073\/pnas.88.16.7238","volume":"88","author":"S Ferre","year":"1991","unstructured":"Ferre S, von Euler G, Johansson B, Fredholm BB, Fuxe K (1991) Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci 88(16):7238\u20137241","journal-title":"Proc Natl Acad Sci"},{"key":"14_CR514","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.nbd.2014.05.030","volume":"69","author":"I Villar-Men\u00e9ndez","year":"2014","unstructured":"Villar-Men\u00e9ndez I, Porta S, Buira SP, Pereira-Veiga T, D\u00edaz-S\u00e1nchez S, Albasanz JL et al (2014) Increased striatal adenosine A2A receptor levels is an early event in Parkinson\u2019s disease-related pathology and it is potentially regulated by miR-34b. Neurobiol Dis 69:206","journal-title":"Neurobiol Dis"},{"issue":"2","key":"14_CR515","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ana.22630","volume":"71","author":"A Kachroo","year":"2012","unstructured":"Kachroo A, Schwarzschild MA (2012) Adenosine A2A receptor gene disruption protects in an \u03b1-synuclein model of Parkinson\u2019s disease. Ann Neurol 71(2):278\u2013282","journal-title":"Ann Neurol"},{"key":"14_CR516","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.nbd.2014.03.004","volume":"67","author":"S Gyoneva","year":"2014","unstructured":"Gyoneva S, Shapiro L, Lazo C, Garnier-Amblard E, Smith Y, Miller GW et al (2014) Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson\u2019s disease. Neurobiol Dis 67:191\u2013202","journal-title":"Neurobiol Dis"},{"issue":"3","key":"14_CR517","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S1474-4422(11)70012-6","volume":"10","author":"RA Hauser","year":"2011","unstructured":"Hauser RA, Cantillon M, Pourcher E, Micheli F, Mok V, Onofrj M et al (2011) Preladenant in patients with Parkinson\u2019s disease and motor fluctuations: a phase 2, double-blind, randomised trial. Lancet Neurol 10(3):221\u2013229","journal-title":"Lancet Neurol"},{"issue":"23","key":"14_CR518","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1212\/WNL.0000000000004003","volume":"88","author":"F Stocchi","year":"2017","unstructured":"Stocchi F, Rascol O, Hauser R, Huyck S, Tzontcheva A, Capece R et al (2017) Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease. Neurology 88(23):2198\u20132206","journal-title":"Neurology"},{"issue":"12","key":"14_CR519","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1001\/jamaneurol.2015.2268","volume":"72","author":"RA Hauser","year":"2015","unstructured":"Hauser RA, Stocchi F, Rascol O, Huyck SB, Capece R, Ho TW et al (2015) Preladenant as an adjunctive therapy with levodopa in Parkinson disease. JAMA Neurol 72(12):1491","journal-title":"JAMA Neurol"},{"issue":"1","key":"14_CR520","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12013-014-0162-7","volume":"71","author":"Y Tao","year":"2014","unstructured":"Tao Y, Liang G (2014) Efficacy of adenosine A2A receptor antagonist istradefylline as augmentation for Parkinson\u2019s disease: a meta-analysis of randomized controlled trials. Cell Biochem Biophys 71(1):57\u201362","journal-title":"Cell Biochem Biophys"},{"issue":"12","key":"14_CR521","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1586\/14737175.2015.1113131","volume":"15","author":"RJ Vorovenci","year":"2015","unstructured":"Vorovenci RJ, Antonini A (2015) The efficacy of oral adenosine A2Aantagonist istradefylline for the treatment of moderate to severe Parkinson\u2019s disease. Expert Rev Neurother 15(12):1383\u20131390","journal-title":"Expert Rev Neurother"},{"issue":"23","key":"14_CR522","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1212\/01.wnl.0000313834.22171.17","volume":"70","author":"M Stacy","year":"2008","unstructured":"Stacy M, Silver D, Mendis T, Sutton J, Mori A, Chaikin P et al (2008) A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease. Neurology 70(23):2233\u20132240","journal-title":"Neurology"},{"issue":"11","key":"14_CR523","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1179\/1743132814Y.0000000375","volume":"36","author":"C Zhu","year":"2014","unstructured":"Zhu C, Wang G, Li J, Chen L, Wang C, Wang Y et al (2014) Adenosine A2A receptor antagonist istradefylline 20 versus 40 mg\/day as augmentation for Parkinson\u2019s disease: a meta-analysis. Neurol Res 36(11):1028\u20131034","journal-title":"Neurol Res"},{"key":"14_CR524","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S1474-4422(14)70153-X","volume":"13","author":"A Antonini","year":"2014","unstructured":"Antonini A, Poewe W (2014) Adenosine A2A receptor antagonists in Parkinson\u2019 s disease: still in the running. Lancet Neurol 13:748\u2013749","journal-title":"Lancet Neurol"},{"issue":"5","key":"14_CR525","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s40263-014-0161-7","volume":"28","author":"A Pinna","year":"2014","unstructured":"Pinna A (2014) Adenosine A2Areceptor antagonists in Parkinson\u2019s disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued. CNS Drugs 28(5):455\u2013474","journal-title":"CNS Drugs"},{"issue":"1","key":"14_CR526","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.neuroscience.2007.07.015","volume":"149","author":"C Heine","year":"2007","unstructured":"Heine C, Wegner A, Grosche J, Allgaier C, Illes P, Franke H (2007) P2 receptor expression in the dopaminergic system of the rat brain during development. Neuroscience 149(1):165\u2013181","journal-title":"Neuroscience"},{"issue":"2","key":"14_CR527","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.neurobiolaging.2014.10.037","volume":"36","author":"M Gan","year":"2015","unstructured":"Gan M, Moussaud S, Jiang P, McLean PJ (2015) Extracellular ATP induces intracellular alpha-synuclein accumulation via P2X1 receptor-mediated lysosomal dysfunction. Neurobiol Aging 36(2):1209\u20131220","journal-title":"Neurobiol Aging"},{"key":"14_CR528","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2019.00175","volume":"13","author":"E Zucchi","year":"2019","unstructured":"Zucchi E, Ticozzi N, Mandrioli J (2019) Psychiatric symptoms in amyotrophic lateral sclerosis: beyond a motor neuron disorder. Front Neurosci 13:1\u201311","journal-title":"Front Neurosci"},{"key":"14_CR529","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fneur.2019.00191","volume":"10","author":"SE Kirk","year":"2019","unstructured":"Kirk SE, Tracey TJ, Steyn FJ, Ngo ST (2019) Biomarkers of metabolism in amyotrophic lateral sclerosis. Front Neurol 10:191","journal-title":"Front Neurol"},{"key":"14_CR530","first-page":"63","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:63\u2013117","journal-title":"Nat Rev Dis Primers"},{"key":"14_CR531","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/S0140-6736(07)60944-1","volume":"369","author":"JD Mitchell","year":"2007","unstructured":"Mitchell JD, Borasio GD (2007) Amyotrophic lateral sclerosis. Lancet 369:2031\u20132041","journal-title":"Lancet"},{"issue":"3","key":"14_CR532","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1468-1331.2006.01575.x","volume":"14","author":"S Zoccolella","year":"2007","unstructured":"Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V et al (2007) Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy. Eur J Neurol 14(3):262\u2013268","journal-title":"Eur J Neurol"},{"issue":"1","key":"14_CR533","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2188\/jea.JE20120119","volume":"23","author":"CT-C Lee","year":"2013","unstructured":"Lee CT-C, Chiu Y-W, Wang K-C, Hwang C-S, Lin K-H, Lee I-T et al (2013) Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: a population-based study of 1149 cases in Taiwan. J Epidemiol 23(1):35\u201340","journal-title":"J Epidemiol"},{"issue":"3","key":"14_CR534","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/cdd.2015.153","volume":"23","author":"C Parisi","year":"2016","unstructured":"Parisi C, Napoli G, Amadio S, Spalloni A, Apolloni S, Longone P et al (2016) MicroRNA-125b regulates microglia activation and motor neuron death in ALS. Cell Death Differ 23(3):531\u2013541","journal-title":"Cell Death Differ"},{"issue":"1","key":"14_CR535","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nn.3584","volume":"17","author":"AE Renton","year":"2014","unstructured":"Renton AE, Chi\u00f2 A, Traynor BJ (2014) State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17(1):17\u201323","journal-title":"Nat Neurosci"},{"issue":"3","key":"14_CR536","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1089\/ars.2007.1760","volume":"10","author":"M Cozzolino","year":"2008","unstructured":"Cozzolino M, Ferri A, Carr\u00ec MT (2008) Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications. Antioxid Redox Signal 10(3):405\u2013443","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"14_CR537","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11481-009-9171-5","volume":"4","author":"JS Henkel","year":"2009","unstructured":"Henkel JS, Beers DR, Zhao W, Appel SH (2009) Microglia in ALS: the good, the bad, and the resting. J Neuroimmune Pharmacol 4(4):389\u2013398","journal-title":"J Neuroimmune Pharmacol"},{"key":"14_CR538","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","volume":"10","author":"T Philips","year":"2011","unstructured":"Philips T, Robberecht W (2011) Neuroinfl ammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol 10:253\u2013263","journal-title":"Lancet Neurol"},{"issue":"4","key":"14_CR539","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mus.10191","volume":"26","author":"PL McGeer","year":"2002","unstructured":"McGeer PL, McGeer EG (2002) Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26(4):459\u2013470","journal-title":"Muscle Nerve"},{"issue":"12","key":"14_CR540","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1371\/journal.pone.0052941","volume":"7","author":"P Corcia","year":"2012","unstructured":"Corcia P, Tauber C, Vercoullie J, Arlicot N, Prunier C, Praline J et\u00a0al (2012) Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLoS One 7(12):6\u201312","journal-title":"PLoS One"},{"issue":"4","key":"14_CR541","doi-asserted-by":"publisher","first-page":"e36000","DOI":"10.1371\/journal.pone.0036000","volume":"7","author":"YN Gerber","year":"2012","unstructured":"Gerber YN, Sabourin JC, Rabano M, Vivanco M, Perrin FE (2012) Early functional deficit and microglial disturbances in a mouse model of amyotrophic lateral sclerosis. PLoS One 7(4):e36000","journal-title":"PLoS One"},{"key":"14_CR542","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2014.00117","volume":"8","author":"D Brites","year":"2014","unstructured":"Brites D, Vaz AR (2014) Microglia centered pathogenesis in ALS: insights in cell interconnectivity. Front Cell Neurosci 8:1\u201324","journal-title":"Front Cell Neurosci"},{"issue":"11\u201312","key":"14_CR543","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1089\/ars.2006.8.2075","volume":"8","author":"K Hensley","year":"2006","unstructured":"Hensley K, Mhatre M, Mou S, Pye QN, Stewart C, West M et al (2006) On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid Redox Signal 8(11\u201312):2075\u20132087","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"14_CR544","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/glia.20210","volume":"51","author":"SA Sargsyan","year":"2005","unstructured":"Sargsyan SA, Monk PN, Shaw PJ (2005) Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 51(4):241\u2013253","journal-title":"Glia"},{"key":"14_CR545","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.nbd.2013.11.009","volume":"69","author":"M Nikodemova","year":"2014","unstructured":"Nikodemova M, Small AL, Smith SMC, Mitchell GS, Watters JJ (2014) Spinal but not cortical microglia acquire an atypical phenotype with high VEGF, galectin-3 and osteopontin, and blunted inflammatory responses in ALS rats. Neurobiol Dis 69:43\u201353","journal-title":"Neurobiol Dis"},{"key":"14_CR546","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neuroscience.2018.12.021","volume":"405","author":"S Calovi","year":"2019","unstructured":"Calovi S, Mut-Arbona P, Sperl\u00e1gh B (2019) Microglia and the purinergic signaling system. Neuroscience 405:137\u2013147","journal-title":"Neuroscience"},{"issue":"7","key":"14_CR547","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.4049\/jimmunol.0901212","volume":"183","author":"N D\u2019Ambrosi","year":"2009","unstructured":"D\u2019Ambrosi N, Finocchi P, Apolloni S, Cozzolino M, Ferri A, Padovano V et al (2009) The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis. J Immunol 183(7):4648\u20134656","journal-title":"J Immunol"},{"issue":"10","key":"14_CR548","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.4049\/jimmunol.1203262","volume":"190","author":"S Apolloni","year":"2013","unstructured":"Apolloni S, Parisi C, Pesaresi MG, Rossi S, Carri MT, Cozzolino M et al (2013) The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis. J Immunol 190(10):5187\u20135195","journal-title":"J Immunol"},{"key":"14_CR549","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-7-33","volume":"7","author":"M Gandelman","year":"2010","unstructured":"Gandelman M, Peluffo H, Beckman J, Cassina P, Barbeito L (2010) Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis. J Neuroinflammation 7:1\u20139","journal-title":"J Neuroinflammation"},{"issue":"1","key":"14_CR550","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.nbd.2006.08.018","volume":"25","author":"M Andries","year":"2007","unstructured":"Andries M, Van Damme P, Robberecht W, Van Den Bosch L (2007) Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 25(1):8\u201316","journal-title":"Neurobiol Dis"},{"issue":"1","key":"14_CR551","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/cne.21527","volume":"506","author":"A Casanovas","year":"2008","unstructured":"Casanovas A, Hern\u00e1ndez S, Tarabal O, Rossell\u00f3 J, Esquerda JE (2008) Strong P2X4 purinergic receptor-like immunoreactivity is selectively associated with degenerating neurons in transgenic rodent models of amyotrophic lateral sclerosis. J Comp Neurol 506(1):75\u201392","journal-title":"J Comp Neurol"},{"issue":"2","key":"14_CR552","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/NEN.0b013e3181cd3e33","volume":"69","author":"S Hern\u00e1ndez","year":"2010","unstructured":"Hern\u00e1ndez S, Casanovas A, Piedrafita L, Tarabal O, Esquerda JE (2010) Neurotoxic species of misfolded SOD1G93A recognized by antibodies against the P2X4 subunit of the ATP receptor accumulate in damaged neurons of transgenic animal models of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 69(2):176\u2013187","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"14_CR553","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2169\/internalmedicine.38.133","volume":"38","author":"Y Yoshida","year":"2008","unstructured":"Yoshida Y, Une F, Utatsu Y, Nomoto M, Furukawa Y, Maruyama Y et al (2008) Adenosine and neopterin levels in cerebrospinal fluid of patients with neurological disorders. Intern Med 38(2):133\u2013139","journal-title":"Intern Med"},{"issue":"5\u20136","key":"14_CR554","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3109\/21678421.2013.793358","volume":"14","author":"F Vincenzi","year":"2013","unstructured":"Vincenzi F, Corciulo C, Targa M, Casetta I, Gentile M, Granieri E et al (2013) A2A adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener 14(5\u20136):406\u2013413","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"36","key":"14_CR555","doi-asserted-by":"publisher","first-page":"9250","DOI":"10.1523\/JNEUROSCI.1856-06.2006","volume":"26","author":"J Mojsilovic-Petrovic","year":"2006","unstructured":"Mojsilovic-Petrovic J, Jeong G-B, Crocker A, Arneja A, David S, Russell D et al (2006) Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors. J Neurosci 26(36):9250\u20139263","journal-title":"J Neurosci"},{"issue":"2","key":"14_CR556","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/exnr.2002.8011","volume":"177","author":"BM K\u00fcst","year":"2002","unstructured":"K\u00fcst BM, Copray JCVM, Brouwer N, Troost D, Boddeke HWGM (2002) Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis. Exp Neurol 177(2):419\u2013427","journal-title":"Exp Neurol"},{"key":"14_CR557","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.expneurol.2015.03.004","volume":"267","author":"S k Ng","year":"2015","unstructured":"Ng S k, Higashimori H, Tolman M, Yang Y (2015) Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis. Exp Neurol 267:115\u2013122","journal-title":"Exp Neurol"},{"issue":"8","key":"14_CR558","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0104081","volume":"9","author":"F Nascimento","year":"2014","unstructured":"Nascimento F, Pousinha PA, Correia AM, Gomes R, Sebasti\u00e3o AM, Ribeiro JA (2014) Adenosine A2A receptors activation facilitates neuromuscular transmission in the pre-symptomatic phase of the SOD1(G93A) ALS mice, but not in the symptomatic phase. PLoS One 9(8):1\u201310","journal-title":"PLoS One"},{"issue":"4","key":"14_CR559","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/jnr.23185","volume":"91","author":"RL Potenza","year":"2013","unstructured":"Potenza RL, Armida M, Ferrante A, P\u00e8zzola A, Matteucci A, Puopolo M et al (2013) Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis. J Neurosci Res 91(4):585\u2013592","journal-title":"J Neurosci Res"},{"issue":"4","key":"14_CR560","first-page":"592","volume":"20","author":"S Nabavi","year":"2019","unstructured":"Nabavi S, Arab L, Jarooghi N, Bolurieh T, Abbasi F, Mardpour S et al (2019) Safety, feasibility of intravenous and intrathecal injection of autologous bone marrow derived mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: an open label phase I clinical trial. Cell J 20(4):592\u2013598","journal-title":"Cell J"},{"issue":"4","key":"14_CR561","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3727\/096368916X693716","volume":"26","author":"E Sykov\u00e1","year":"2017","unstructured":"Sykov\u00e1 E, Rychmach P, Drahor\u00e1dov\u00e1 I, \u0160i K, R\u016f\u017ei\u010dkov\u00e1 K, Vo\u0159\u00ed\u0161ek I et al (2017) Transplantation of mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: results of phase I\/IIa clinical trial. Cell Transplant 26(4):647\u2013658","journal-title":"Cell Transplant"},{"issue":"3","key":"14_CR562","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/jamaneurol.2015.4321","volume":"73","author":"P Petrou","year":"2016","unstructured":"Petrou P, Gothelf Y, Argov Z, Gotkine M, Levy YS, Kassis I et al (2016) Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis. JAMA Neurol 73(3):337\u2013344","journal-title":"JAMA Neurol"},{"issue":"5","key":"14_CR563","doi-asserted-by":"publisher","first-page":"e96281","DOI":"10.1371\/journal.pone.0096281","volume":"9","author":"T Glaser","year":"2014","unstructured":"Glaser T, De Oliveira SLB, Cheffer A, Beco R, Martins P, Fornazari M et al (2014) Modulation of mouse embryonic stem cell proliferation and neural differentiation by the P2X7 receptor. PLoS One 9(5):e96281","journal-title":"PLoS One"},{"issue":"23","key":"14_CR564","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.4103\/1673-5374.147925","volume":"9","author":"H Ulrich","year":"2014","unstructured":"Ulrich H, Illes P (2014) P2X receptors in maintenance and differentiation of neural progenitor cells. Neural Regen Res 9(23):2040\u20132041","journal-title":"Neural Regen Res"},{"key":"14_CR565","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.neuropharm.2013.05.035","volume":"73","author":"E Coppi","year":"2013","unstructured":"Coppi E, Cellai L, Maraula G, Pugliese AM, Pedata F (2013) Neuropharmacology Adenosine A2A receptors inhibit delayed rectifier potassium currents and cell differentiation in primary purified oligodendrocyte cultures. Neuropharmacology 73:301\u2013310","journal-title":"Neuropharmacology"},{"issue":"3","key":"14_CR566","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1189\/jlb.0908520","volume":"85","author":"M Katebi","year":"2009","unstructured":"Katebi M, Soleimani M, Cronstein BN (2009) Adenosine A2A receptors play an active role in mouse bone marrow-derived mesenchymal stem cell development. J Leukoc Biol 85(3):438\u2013444","journal-title":"J Leukoc Biol"},{"key":"14_CR567","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3389\/fphar.2018.00506","volume":"9","author":"N Irrera","year":"2018","unstructured":"Irrera N, Arcoraci V, Mannino F, Vermiglio G, Pallio G, Minutoli L et al (2018) Activation of A2A receptor by PDRN reduces neuronal damage and stimulates WNT\/\u03b2-CATENIN driven neurogenesis in spinal cord injury. Front Pharmacol 9:506","journal-title":"Front Pharmacol"},{"key":"14_CR568","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuropharm.2017.08.027","volume":"126","author":"M Moscoso-Castro","year":"2017","unstructured":"Moscoso-Castro M, L\u00f3pez-Cano M, Gracia-Rubio I, Ciruela F, Valverde O (2017) Cognitive impairments associated with alterations in synaptic proteins induced by the genetic loss of adenosine A2A receptors in mice. Neuropharmacology 126:48\u201357","journal-title":"Neuropharmacology"},{"issue":"4","key":"14_CR569","doi-asserted-by":"publisher","first-page":"e1095","DOI":"10.1038\/tp.2017.64","volume":"7","author":"A Oliveros","year":"2017","unstructured":"Oliveros A, Cho CH, Cui A, Choi S, Lindberg D, Hinton D et al (2017) Adenosine A2A receptor and ERK-driven impulsivity potentiates hippocampal neuroblast proliferation. Transl Psychiatry 7(4):e1095","journal-title":"Transl Psychiatry"},{"issue":"9503","key":"14_CR654","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","volume":"366","author":"Cleusa P Ferri","year":"2005","unstructured":"Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al (2005) Global prevalence of dementia: a Delphi consensus study. Lancet (London, England). 366(9503):2112\u20132117","journal-title":"The Lancet"},{"issue":"15","key":"14_CR570","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1007\/s00018-008-8053-y","volume":"65","author":"B Waldau","year":"2008","unstructured":"Waldau B, Shetty AK (2008) Behavior of neural stem cells in the Alzheimer brain. Cell Mol Life Sci 65(15):2372\u20132384","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"14_CR656","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/0957154X9100200505","volume":"2","author":"A. Alzheimer","year":"1991","unstructured":"Alzheimer A, Forstl H, Levy R (1991) On certain peculiar diseases of old age. Hist Psychiatry [Internet]. 2(5 Pt 1):71\u2013101. Available from: 544","journal-title":"History of Psychiatry"},{"issue":"3","key":"14_CR657","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"George G. Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 120(3):885\u2013890","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"6","key":"14_CR658","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"Dennis J Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med [Internet]. 8(6):595\u2013608","journal-title":"EMBO Molecular Medicine"},{"issue":"18","key":"14_CR659","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1021\/bi00069a001","volume":"32","author":"Joseph T. Jarrett","year":"1993","unstructured":"Jarrett JT, Berger EP, Lansbury PT (1993) The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer\u2019s disease. Biochemistry. American Chemical Society; 32(18):4693\u20134697","journal-title":"Biochemistry"},{"issue":"5094","key":"14_CR660","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1126\/science.8424174","volume":"259","author":"X. Cai","year":"1993","unstructured":"Cai XD, Golde TE, Younkin SG (1993) Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science (80- ). 259(5094):514 LP-516","journal-title":"Science"},{"key":"14_CR661","doi-asserted-by":"crossref","unstructured":"Kim J, Onstead L, Randle S, Price R, Smithson L, Zwizinski C, et al (2007) Abeta40 inhibits amyloid deposition in vivo. J Neurosci [Internet]. 27(3):627\u2013633","DOI":"10.1523\/JNEUROSCI.4849-06.2007"},{"issue":"1\u20132","key":"14_CR571","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0006-8993(93)90211-5","volume":"616","author":"M Ikeda","year":"1993","unstructured":"Ikeda M, Mackay KB, Dewar D, McCulloch J (1993) Differential alterations in adenosine A1 and \u03ba1 opioid receptors in the striatum in Alzheimer\u2019s disease. Brain Res 616(1\u20132):211\u2013217","journal-title":"Brain Res"},{"issue":"4","key":"14_CR572","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0306-4522(93)90533-L","volume":"52","author":"J U\u0142as","year":"1993","unstructured":"U\u0142as J, Brunner LC, Nguyen L, Cotman CW (1993) Reduced density of adenosine A1 receptors and preserved coupling of adenosine A1 receptors to G proteins in alzheimer hippocampus: a quantitative autoradiographic study. Neuroscience 52(4):843\u2013854","journal-title":"Neuroscience"},{"issue":"2","key":"14_CR573","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0304-3940(90)90641-L","volume":"118","author":"RN Kalaria","year":"1990","unstructured":"Kalaria RN, Sromek S, Wilcox BJ, Unnerstall JR (1990) Hippocampal adenosine A1 receptors are decreased in Alzheimer\u2019s disease. Neurosci Lett 118(2):257\u2013260","journal-title":"Neurosci Lett"},{"issue":"2","key":"14_CR574","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1750-3639.2007.00112.x","volume":"18","author":"JL Albasanz","year":"2008","unstructured":"Albasanz JL, Perez S, Barrachina M, Ferrer I, Mart\u00edn M (2008) Up-regulation of adenosine receptors in the frontal cortex in Alzheimer\u2019s disease. Brain Pathol 18(2):211\u2013219","journal-title":"Brain Pathol"},{"issue":"2","key":"14_CR575","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0006-8993(87)90213-7","volume":"415","author":"H Onodera","year":"1987","unstructured":"Onodera H, Sato G, Kogure K (1987) Quantitative autoradiographic analysis of muscarinic cholinergic and adenosine A1 binding sites after transient forebrain ischemia in the gerbil. Brain Res 415(2):309\u2013322","journal-title":"Brain Res"},{"issue":"3","key":"14_CR576","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0304-3940(89)90112-2","volume":"103","author":"KA Rudolphi","year":"1989","unstructured":"Rudolphi KA, Keil M, Fastbom J, Fredholm BB (1989) Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment. Neurosci Lett 103(3):275\u2013280","journal-title":"Neurosci Lett"},{"issue":"4","key":"14_CR577","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1750-3639.2003.tb00475.x","volume":"13","author":"E Angulo","year":"2003","unstructured":"Angulo E, Casad\u00f3 V, Mallol J, Canela EI, Vi\u00f1als F, Ferrer I et al (2003) A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer\u2019s disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathol 13(4):440\u2013451","journal-title":"Brain Pathol"},{"issue":"4","key":"14_CR578","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.neuroscience.2006.07.021","volume":"142","author":"GW Arendash","year":"2006","unstructured":"Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR et al (2006) Caffeine protects Alzheimer\u2019s mice against cognitive impairment and reduces brain \u03b2-amyloid production. Neuroscience 142(4):941\u2013952","journal-title":"Neuroscience"},{"issue":"2","key":"14_CR579","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3233\/JAD-160324","volume":"54","author":"B Arosio","year":"2016","unstructured":"Arosio B, Casati M, Gussago C, Ferri E, Abbate C, Scortichini V et al (2016) Adenosine type A2A receptor in peripheral cell from patients with Alzheimer\u2019s disease, vascular dementia, and idiopathic Normal pressure hydrocephalus: a new\/old potential target. J Alzheimers Dis 54(2):417\u2013425","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"14_CR580","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.expneurol.2006.08.008","volume":"203","author":"OP Dall\u2019Igna","year":"2007","unstructured":"Dall\u2019Igna OP, Fett P, Gomes MW, Souza DO, Cunha RA, Lara DR (2007) Caffeine and adenosine A2a receptor antagonists prevent \u03b2-amyloid (25-35)-induced cognitive deficits in mice. Exp Neurol 203(1):241\u2013245","journal-title":"Exp Neurol"},{"issue":"11","key":"14_CR581","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1097\/01.jnen.0000240470.97295.d3","volume":"65","author":"JG McLarnon","year":"2006","unstructured":"McLarnon JG, Ryu JK, Walker DG, Choi HB (2006) Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus. J Neuropathol Exp Neurol [Internet] 65(11):1090\u20131097. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17086106","journal-title":"J Neuropathol Exp Neurol [Internet]"},{"issue":"7","key":"14_CR582","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.4049\/jimmunol.0803612","volume":"182","author":"JM Sanz","year":"2009","unstructured":"Sanz JM, Chiozzi P, Ferrari D, Colaianna M, Idzko M, Falzoni S et al (2009) Activation of microglia by amyloid {beta} requires P2X7 receptor expression. J Immunol [Internet] 182(7):4378\u20134385. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19299738","journal-title":"J Immunol [Internet]"},{"key":"14_CR583","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuroscience.2014.08.036","volume":"279","author":"X Chen","year":"2014","unstructured":"Chen X, Hu J, Jiang L, Xu S, Zheng B, Wang C et al (2014) Brilliant Blue G improves cognition in an animal model of Alzheimer\u2019s disease and inhibits amyloid-beta-induced loss of filopodia and dendrite spines in hippocampal neurons. Neuroscience [Internet] 279:94\u2013101. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25193238","journal-title":"Neuroscience [Internet]"},{"issue":"8","key":"14_CR584","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1016\/j.neurobiolaging.2011.09.040","volume":"33","author":"JI Diaz-Hernandez","year":"2012","unstructured":"Diaz-Hernandez JI, Gomez-Villafuertes R, Leon-Otegui M, Hontecillas-Prieto L, Del Puerto A, Trejo JL et al (2012) In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer\u2019s disease through GSK3beta and secretases. Neurobiol Aging [Internet] 33(8):1816\u20131828. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22048123","journal-title":"Neurobiol Aging [Internet]"},{"issue":"14","key":"14_CR585","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.febslet.2011.05.048","volume":"585","author":"M Le\u00f3n-Otegui","year":"2011","unstructured":"Le\u00f3n-Otegui M, G\u00f3mez-Villafuertes R, D\u00edaz-Hern\u00e1ndez JI, D\u00edaz-Hern\u00e1ndez M, Miras-Portugal MT, Gualix J (2011) Opposite effects of P2X7 and P2Y2 nucleotide receptors on \u03b1-secretase-dependent APP processing in Neuro-2a cells. FEBS Lett 585(14):2255\u20132262","journal-title":"FEBS Lett"},{"key":"14_CR586","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.csbj.2015.02.005","volume":"13","author":"MT Miras-Portugal","year":"2015","unstructured":"Miras-Portugal MT, Diaz-Hernandez JI, Gomez-Villafuertes R, Diaz-Hernandez M, Artalejo AR, Gualix J (2015) Role of P2X7 and P2Y2receptors on \u03b1-secretase-dependent APP processing: control of amyloid plaques formation \u201cin vivo\u201d by P2X7 receptor. Comput Struct Biotechnol J 13:176\u2013181","journal-title":"Comput Struct Biotechnol J"},{"issue":"3","key":"14_CR587","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1124\/pr.58.3.3","volume":"58","author":"MP Abbracchio","year":"2006","unstructured":"Abbracchio MP, Burnstock G, Boeynaems J-M, Barnard EA, Boyer JL, Kennedy C et al (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58(3):281\u2013341","journal-title":"Pharmacol Rev"},{"issue":"3","key":"14_CR588","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1083\/jcb.153.3.491","volume":"153","author":"L Erb","year":"2001","unstructured":"Erb L, Liu J, Ockerhausen J, Kong Q, Garrad RC, Griffin K et al (2001) An RGD sequence in the P2Y2 receptor interacts with \u03b1v\u03b23 integrins and is required for Go-mediated signal transduction. J Cell Biol 153(3):491\u2013502","journal-title":"J Cell Biol"},{"issue":"9","key":"14_CR589","doi-asserted-by":"publisher","first-page":"8212","DOI":"10.1074\/jbc.M312230200","volume":"279","author":"J Liu","year":"2004","unstructured":"Liu J, Liao Z, Camden J, Griffin KD, Garrad RC, Santiago-P\u00e9rez LI et al (2004) Src homology 3 binding sites in the P2Y 2 nucleotide receptor interact with Src and regulate activities of Src, Proline-rich tyrosine kinase 2, and growth factor receptors. J Biol Chem 279(9):8212\u20138218","journal-title":"J Biol Chem"},{"issue":"3","key":"14_CR590","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1471-4159.2005.03408.x","volume":"95","author":"Min Wang","year":"2005","unstructured":"Wang M1, Kong Q, Gonzalez FA, Sun G, Erb L, Seye C, Weisman GA. P2Y nucleotide receptor interaction with alpha integrin mediates astrocyte migration. J Neurochem. 2005 Nov;95(3):630-40. Epub 2005 Aug 31","journal-title":"Journal of Neurochemistry"},{"issue":"2\u20133","key":"14_CR591","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s12035-010-8115-7","volume":"41","author":"TS Peterson","year":"2010","unstructured":"Peterson TS, Camden JM, Wang Y, Seye CI, Wood WG, Sun GY et al (2010) P2Y2 nucleotide receptor-mediated responses in brain cells. Mol Neurobiol 41(2\u20133):356\u2013366","journal-title":"Mol Neurobiol"},{"issue":"10","key":"14_CR592","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.1074\/jbc.M109.078170","volume":"285","author":"AM Ratchford","year":"2010","unstructured":"Ratchford AM, Baker OJ, Camden JM, Rikka S, Petris MJ, Seye CI et al (2010) P2Y2 nucleotide receptors mediate metalloprotease-dependent phosphorylation of epidermal growth factor receptor and ErbB3 in human salivary gland cells. J Biol Chem 285(10):7545\u20137555","journal-title":"J Biol Chem"},{"issue":"19","key":"14_CR593","doi-asserted-by":"publisher","first-page":"18696","DOI":"10.1074\/jbc.M500219200","volume":"280","author":"JM Camden","year":"2005","unstructured":"Camden JM, Schrader AM, Camden RE, Gonz\u00e1lez F a, Erb L, Seye CI et al (2005) P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing. J Biol Chem 280(19):18696\u201318702","journal-title":"J Biol Chem"},{"issue":"5","key":"14_CR594","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/j.1471-4159.2009.06048.x","volume":"109","author":"Q Kong","year":"2009","unstructured":"Kong Q, Peterson TS, Baker O, Stanley E, Camden J, Seye CI et al (2009) Interleukin-1\u03b2 enhances nucleotide-induced and \u03b1-secretase- dependent amyloid precursor protein processing in rat primary cortical neurons via up-regulation of the P2Y2 receptor. J Neurochem 109(5):1300\u20131310","journal-title":"J Neurochem"},{"issue":"6","key":"14_CR595","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/jnc.12252","volume":"125","author":"TS Peterson","year":"2013","unstructured":"Peterson TS, Thebeau CN, Ajit D, Camden JM, Woods LT, Wood WG et al (2013) Up-regulation and activation of the P2Y 2 nucleotide receptor mediate neurite extension in IL-1\u03b2-treated mouse primary cortical neurons. J Neurochem 125(6):885\u2013896","journal-title":"J Neurochem"},{"issue":"2","key":"14_CR596","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s12035-013-8577-5","volume":"49","author":"D Ajit","year":"2014","unstructured":"Ajit D, Woods LT, Camden JM, Thebeau CN, El-Sayed FG, Greeson GW et al (2014) Loss of P2Y2nucleotide receptors enhances early pathology in the TgCRND8 mouse model of Alzheimer\u2019s disease. Mol Neurobiol 49(2):1031\u20131042","journal-title":"Mol Neurobiol"},{"issue":"8","key":"14_CR597","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00702-008-0067-y","volume":"115","author":"MKP Lai","year":"2008","unstructured":"Lai MKP, Tan MGK, Kirvell S, Hobbs C, Lee J, Esiri MM et al (2008) Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer\u2019s disease neuropathology. J Neural Transm 115(8):1165\u20131172","journal-title":"J Neural Transm"},{"key":"14_CR598","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fnins.2016.00178","volume":"10","author":"C Hollands","year":"2016","unstructured":"Hollands C, Bartolotti N, Lazarov O (2016) Alzheimer\u2019s disease and hippocampal adult neurogenesis; exploring shared mechanisms. Front Neurosci 10:178","journal-title":"Front Neurosci"},{"issue":"1","key":"14_CR599","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1750-1326-6-85","volume":"6","author":"Y Mu","year":"2011","unstructured":"Mu Y, Gage FH (2011) Adult hippocampal neurogenesis and its role in Alzheimer\u2019s disease. Mol Neurodegener 6(1):85","journal-title":"Mol Neurodegener"},{"key":"14_CR600","doi-asserted-by":"publisher","first-page":"260925","DOI":"10.1155\/2013\/260925","volume":"2013","author":"A Fuster-Matanzo","year":"2013","unstructured":"Fuster-Matanzo A, Llorens-Mart\u00edn M, Hern\u00e1ndez F, Avila J (2013) Role of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approaches. Mediat Inflamm 2013:260925","journal-title":"Mediat Inflamm"},{"key":"14_CR601","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fnagi.2013.00043","volume":"5","author":"O Lazarov","year":"2013","unstructured":"Lazarov O, Marr RA (2013) Of mice and men: neurogenesis, cognition and Alzheimer\u2019s disease. Front Aging Neurosci 5:43","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"14_CR602","doi-asserted-by":"publisher","first-page":"314","DOI":"10.2174\/157436211797483949","volume":"6","author":"RE Gonzalez-Castaneda","year":"2011","unstructured":"Gonzalez-Castaneda RE, Galvez-Contreras AY, Luquin S, Gonzalez-Perez O (2011) Neurogenesis in Alzheimers disease: a realistic alternative to neuronal degeneration? Curr Signal Transduct Ther 6(3):314\u2013319","journal-title":"Curr Signal Transduct Ther"},{"issue":"10","key":"14_CR603","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.bbadis.2009.12.008","volume":"1802","author":"TT Chuang","year":"2010","unstructured":"Chuang TT (2010) Neurogenesis in mouse models of Alzheimer\u2019s disease. Biochim Biophys Acta 1802(10):872\u2013880","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"14_CR604","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.neuron.2013.10.037","volume":"80","author":"FH Gage","year":"2013","unstructured":"Gage FH, Temple S (2013) Neural stem cells: generating and regenerating the brain. Neuron 80(3):588\u2013601","journal-title":"Neuron"},{"issue":"2","key":"14_CR605","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.expneurol.2009.08.009","volume":"223","author":"O Lazarov","year":"2010","unstructured":"Lazarov O, Marr RA (2010) Neurogenesis and Alzheimer\u2019s disease: at the crossroads. Exp Neurol 223(2):267\u2013281","journal-title":"Exp Neurol"},{"issue":"5","key":"14_CR606","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00406-007-0732-4","volume":"257","author":"HG Kuhn","year":"2007","unstructured":"Kuhn HG, Cooper-Kuhn CM, Boekhoorn K, Lucassen PJ (2007) Changes in neurogenesis in dementia and Alzheimer mouse models: are they functionally relevant? Eur Arch Psychiatry Clin Neurosci 257(5):281\u2013289","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"14_CR607","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuroscience.2004.05.040","volume":"127","author":"H Dong","year":"2004","unstructured":"Dong H, Goico B, Martin M, Csernansky CA, Bertchume A, Csernansky JG (2004) Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience 127(3):601\u2013609","journal-title":"Neuroscience"},{"issue":"8","key":"14_CR608","doi-asserted-by":"publisher","first-page":"5796","DOI":"10.1007\/s12035-016-0018-9","volume":"53","author":"MS Unger","year":"2016","unstructured":"Unger MS, Marschallinger J, Kaindl J, H\u00f6fling C, Rossner S, Heneka MT et al (2016) Early changes in hippocampal neurogenesis in transgenic mouse models for Alzheimer\u2019s disease. Mol Neurobiol 53(8):5796\u20135806","journal-title":"Mol Neurobiol"},{"issue":"4","key":"14_CR609","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/cdd.2011.140","volume":"19","author":"J-Y Kim","year":"2011","unstructured":"Kim J-Y, Kim DH, Kim JH, Lee D, Jeon HB, Kwon S-J et al (2011) Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-\u03b2 plaques. Cell Death Differ 19(4):680\u2013691","journal-title":"Cell Death Differ"},{"issue":"1","key":"14_CR610","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4161\/auto.26508","volume":"10","author":"JY Shin","year":"2014","unstructured":"Shin JY, Park HJ, Kim HN, Oh SH, Bae J-S, Ha H-J et al (2014) Mesenchymal stem cells enhance autophagy and increase \u03b2-amyloid clearance in Alzheimer disease models. Autophagy 10(1):32\u201344","journal-title":"Autophagy"},{"issue":"12","key":"14_CR611","doi-asserted-by":"publisher","first-page":"e958","DOI":"10.1038\/cddis.2013.490","volume":"4","author":"H-M Yun","year":"2013","unstructured":"Yun H-M, Kim HS, Park K-R, Shin JM, Kang AR, Il Lee K et al (2013) Placenta-derived mesenchymal stem cells improve memory dysfunction in an A\u03b21-42-infused mouse model of Alzheimer\u2019s disease. Cell Death Dis 4(12):e958","journal-title":"Cell Death Dis"},{"issue":"3","key":"14_CR612","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1053\/seiz.2001.0617","volume":"11","author":"P Timary de","year":"2002","unstructured":"de Timary P, Fouchet P, Sylin M, Indriets JP, de Barsy T, Lef\u00e8bvre A et al (2002) Non-epileptic seizures: delayed diagnosis in patients presenting with electroencephalographic (EEG) or clinical signs of epileptic seizures. Seizure 11(3):193\u2013197","journal-title":"Seizure"},{"issue":"1","key":"14_CR613","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.pharep.2016.09.018","volume":"69","author":"M Cie\u015blak","year":"2017","unstructured":"Cie\u015blak M, Wojtczak A, Komoszy\u0144ski M (2017) Role of the purinergic signaling in epilepsy. Pharmacol Rep 69(1):130\u2013138","journal-title":"Pharmacol Rep"},{"issue":"3","key":"14_CR614","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/epi.12895","volume":"56","author":"N Jette","year":"2015","unstructured":"Jette N, Beghi E, Hesdorffer D, Mosh\u00e9 SL, Zuberi SM, Medina MT et al (2015) ICD coding for epilepsy: past, present, and future\u2014a report by the International League Against Epilepsy Task Force on ICD codes in epilepsy. Epilepsia 56(3):348\u2013355","journal-title":"Epilepsia"},{"issue":"8","key":"14_CR615","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1523\/JNEUROSCI.1574-14.2015","volume":"35","author":"S Robel","year":"2015","unstructured":"Robel S, Buckingham SC, Boni JL, Campbell SL, Danbolt NC, Riedemann T et al (2015) Reactive astrogliosis causes the development of spontaneous seizures. J Neurosci 35(8):3330\u20133345","journal-title":"J Neurosci"},{"issue":"4","key":"14_CR616","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s11910-007-0053-z","volume":"7","author":"HE Scharfman","year":"2007","unstructured":"Scharfman HE (2007) The neurobiology of epilepsy. Curr Neurol Neurosci Rep 7(4):348\u2013354","journal-title":"Curr Neurol Neurosci Rep"},{"key":"14_CR617","volume-title":"Electrophysiology of the neuron: an interactive tutorial","author":"J Huguenard","year":"1994","unstructured":"Huguenard J, McCormick DA (1994) Electrophysiology of the neuron: an interactive tutorial. Oxford University Press, New York"},{"issue":"6","key":"14_CR618","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1152\/jn.00244.2002","volume":"88","author":"C Vaillend","year":"2002","unstructured":"Vaillend C, Mason SE, Cuttle MF, Alger BE (2002) Mechanisms of neuronal hyperexcitability caused by partial inhibition of Na+-K+-ATPases in the rat CA1 hippocampal region. J Neurophysiol 88(6):2963\u20132978","journal-title":"J Neurophysiol"},{"issue":"12","key":"14_CR619","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.molmed.2005.10.007","volume":"11","author":"T Fellin","year":"2005","unstructured":"Fellin T, Haydon PG (2005) Do astrocytes contribute to excitation underlying seizures? Trends Mol Med 11(12):530\u2013533","journal-title":"Trends Mol Med"},{"key":"14_CR620","unstructured":"Duffy S, MacVicar BA (1999) Modulation of neuronal excitability by astrocytes. Adv Neurol 79:573\u2013581. 3 rd ed Philadelphia: Lippincott Williams & Wilkins."},{"issue":"1","key":"14_CR621","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/neu.2016.47","volume":"29","author":"F Alyu","year":"2017","unstructured":"Alyu F, Dikmen M (2017) Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms. Acta Neuropsychiatr 29(1):1\u201316","journal-title":"Acta Neuropsychiatr"},{"issue":"1","key":"14_CR622","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12974-018-1192-7","volume":"15","author":"A Rana","year":"2018","unstructured":"Rana A, Musto AE (2018) The role of inflammation in the development of epilepsy. J Neuroinflammation 15(1):144","journal-title":"J Neuroinflammation"},{"issue":"12","key":"14_CR623","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/nm.1878","volume":"14","author":"PF Fabene","year":"2008","unstructured":"Fabene PF, Mora GN, Martinello M, Rossi B, Merigo F, Ottoboni L et al (2008) A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 14(12):1377","journal-title":"Nat Med"},{"issue":"4","key":"14_CR624","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00415-008-0752-7","volume":"255","author":"M Calabrese","year":"2008","unstructured":"Calabrese M, De Stefano N, Atzori M, Bernardi V, Mattisi I, Barachino L et al (2008) Extensive cortical inflammation is associated with epilepsy in multiple sclerosis. J Neurol 255(4):581\u2013586","journal-title":"J Neurol"},{"issue":"3","key":"14_CR625","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0304-3940(89)90178-X","volume":"106","author":"A Wieraszko","year":"1989","unstructured":"Wieraszko A, Seyfried TN (1989) Increased amount of extracellular ATP in stimulated hippocampal slices of seizure prone mice. Neurosci Lett 106(3):287\u2013293","journal-title":"Neurosci Lett"},{"key":"14_CR626","series-title":"Purinergic approaches Exp Ther","first-page":"423","volume-title":"Adenosine and ATP in epilepsy","author":"LJS Knutsen","year":"1997","unstructured":"Knutsen LJS (1997) Adenosine and ATP in epilepsy, Purinergic approaches Exp Ther. Wiley-Liss, New York, pp 423\u2013447"},{"key":"14_CR627","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1046\/j.1528-1157.43.s.5.26.x","volume":"43","author":"EPM Vianna","year":"2002","unstructured":"Vianna EPM, Ferreira AT, Naffah-Mazzacoratti M d G, Sanabria ERG, Funke M, Cavalheiro EA et al (2002) Evidence that ATP participates in the pathophysiology of pilocarpine-induced temporal lobe epilepsy: a fluorimetric, immunohistochemical, and Western blot studies. Epilepsia 43:227\u2013229","journal-title":"Epilepsia"},{"issue":"4","key":"14_CR628","first-page":"174","volume":"4","author":"T Engel","year":"2012","unstructured":"Engel T, Jimenez-Pacheco A, Miras-Portugal MT, Diaz-Hernandez M, Henshall DC (2012) P2X7 receptor in epilepsy; role in pathophysiology and potential targeting for seizure control. Int J Physiol Pathophysiol Pharmacol 4(4):174\u2013187","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"issue":"10","key":"14_CR629","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1023\/A:1025618324593","volume":"28","author":"JO Malva","year":"2003","unstructured":"Malva JO, Silva AP, Cunha RA (2003) Presynaptic modulation controlling neuronal excitability and epileptogenesis: role of kainate, adenosine and neuropeptide Y receptors. Neurochem Res 28(10):1501\u20131515","journal-title":"Neurochem Res"},{"issue":"1","key":"14_CR630","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0304-3940(93)90217-9","volume":"163","author":"F Angelatou","year":"1993","unstructured":"Angelatou F, Pagonopoulou O, Maraziotis T, Olivier A, Villemeure JG, Avoli M et al (1993) Upregulation of A1 adenosine receptors in human temporal lobe epilepsy: a quantitative autoradiographic study. Neurosci Lett 163(1):11\u201314","journal-title":"Neurosci Lett"},{"key":"14_CR631","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/0006-8993(95)01313-X","volume":"710","author":"M Glass","year":"1996","unstructured":"Glass M, Faull RLM, Jansen K, Walker EB, Synek BJL, Dragunow M (1996) Loss of A1 adenosine receptors in human temporal lobe epilepsy. Brain Res 710:56\u201368","journal-title":"Brain Res"},{"issue":"9","key":"14_CR632","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1097\/00001756-199806220-00042","volume":"9","author":"A Ekonomou","year":"1998","unstructured":"Ekonomou A, Angelatou F, Vergnes M, Kostopoulos G (1998) Lower density of A1 adenosine receptors in nucleus reticularis thalami in rats with genetic absence epilepsy. Neuroreport 9(9):2135\u20132140","journal-title":"Neuroreport"},{"issue":"7","key":"14_CR633","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1046\/j.1528-1157.2003.03603.x","volume":"44","author":"N Gouder","year":"2003","unstructured":"Gouder N, Fritschy J, Boison D (2003) Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 44(7):877\u2013885","journal-title":"Epilepsia"},{"issue":"1","key":"14_CR634","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/epi.12000","volume":"54","author":"AT S\u00f8rensen","year":"2013","unstructured":"S\u00f8rensen AT, Kokaia M (2013) Novel approaches to epilepsy treatment. Epilepsia 54(1):1\u201310","journal-title":"Epilepsia"},{"issue":"8","key":"14_CR635","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/glia.22285","volume":"60","author":"D Boison","year":"2011","unstructured":"Boison D (2011) Adenosine dysfunction in epilepsy. Glia 60(8):1234\u20131243","journal-title":"Glia"},{"issue":"5","key":"14_CR636","doi-asserted-by":"publisher","first-page":"4","DOI":"10.29252\/qums.22.5.4","volume":"22","author":"Z Esmaili","year":"2018","unstructured":"Esmaili Z, Heydari A (2018) Involvement of nitric oxide in the effect of caffeine on the pentylenetetrazole-induced seizure threshold in mice. J Qazvin Univ Med Sci 22(5):4\u201313","journal-title":"J Qazvin Univ Med Sci"},{"key":"14_CR637","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3389\/fncel.2014.00312","volume":"8","author":"MF Miranda","year":"2014","unstructured":"Miranda MF, Hamani C, de Almeida A-CG, Amorim BO, Macedo CE, Fernandes MJS et al (2014) Role of adenosine in the antiepileptic effects of deep brain stimulation. Front Cell Neurosci 8:312","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"14_CR638","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.yebeh.2010.06.038","volume":"19","author":"RS Fisher","year":"2010","unstructured":"Fisher RS, Engel JJ Jr (2010) Definition of the postictal state: when does it start and end? Epilepsy Behav 19(2):100\u2013104","journal-title":"Epilepsy Behav"},{"key":"14_CR639","unstructured":"Abood W, Bandyopadhyay S (2018) Seizure, postictal state. In: StatPearls [Internet]. StatPearls Publishing"},{"issue":"5","key":"14_CR640","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/ana.410320504","volume":"32","author":"MJ During","year":"1992","unstructured":"During MJ, Spencer DD (1992) Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann Neurol 32(5):618\u2013624","journal-title":"Ann Neurol"},{"key":"14_CR641","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/B978-0-12-418693-4.00008-X","volume":"114","author":"F Zubler","year":"2014","unstructured":"Zubler F, Steimer A, Gast H, Schindler KA (2014) Seizure termination. Int Rev Neurobiol. Elsevier; 114:187\u2013207","journal-title":"Int Rev Neurobiol"},{"issue":"6","key":"14_CR642","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2217\/rme.10.72","volume":"5","author":"N Joyce","year":"2010","unstructured":"Joyce N, Annett G, Wirthlin L, Olson S, Bauer G, Nolta JA (2010) Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 5(6):933\u2013946","journal-title":"Regen Med"},{"key":"14_CR643","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fncel.2015.00211","volume":"9","author":"F Cavaliere","year":"2015","unstructured":"Cavaliere F, Donno C, D\u2019Ambrosi N (2015) Purinergic signaling: a common pathway for neural and mesenchymal stem cell maintenance and differentiation. Front Cell Neurosci 9:211","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"14_CR644","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11302-011-9282-3","volume":"8","author":"T Glaser","year":"2012","unstructured":"Glaser T, Cappellari AR, Pillat MM, Iser IC, Wink MR, Battastini AMO et al (2012) Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration. Purinergic Signal 8(3):523\u2013537","journal-title":"Purinergic Signal"},{"issue":"4","key":"14_CR645","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrd3955","volume":"12","author":"J-F Chen","year":"2013","unstructured":"Chen J-F, Eltzschig HK, Fredholm BB (2013) Adenosine receptors as drug targets\u00a0\u2013 what are the challenges? Nat Rev Drug Discov 12(4):265\u2013286","journal-title":"Nat Rev Drug Discov"},{"issue":"13","key":"14_CR646","doi-asserted-by":"publisher","first-page":"7611","DOI":"10.1073\/pnas.131102898","volume":"98","author":"A Huber","year":"2001","unstructured":"Huber A, Padrun V, D\u00e9glon N, Aebischer P, M\u00f6hler H, Boison D (2001) Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc Natl Acad Sci U S A 98(13):7611\u20137616","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"14_CR647","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/brain\/awm057","volume":"130","author":"T Li","year":"2007","unstructured":"Li T, Steinbeck JA, Lusardi T, Koch P, Lan JQ, Wilz A et al (2007) Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. Brain 130(5):1276\u20131288","journal-title":"Brain"},{"issue":"3","key":"14_CR648","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1528-1167.2010.02947.x","volume":"52","author":"P Theofilas","year":"2011","unstructured":"Theofilas P, Brar S, Stewart K-A, Shen H-Y, Sandau US, Poulsen D et al (2011) Adenosine kinase as a target for therapeutic antisense strategies in epilepsy. Epilepsia 52(3):589\u2013601","journal-title":"Epilepsia"},{"issue":"2\u20133","key":"14_CR649","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neulet.2004.08.031","volume":"370","author":"DE Fedele","year":"2004","unstructured":"Fedele DE, Koch P, Scheurer L, Simpson EM, M\u00f6hler H, Br\u00fcstle O et al (2004) Engineering embryonic stem cell derived glia for adenosine delivery. Neurosci Lett 370(2\u20133):160\u2013165","journal-title":"Neurosci Lett"},{"issue":"0 6","key":"14_CR650","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/epi.12268","volume":"54 Suppl 6","author":"D Boison","year":"2013","unstructured":"Boison D (2013) Role of adenosine in status epilepticus: a potential new target? Epilepsia 54 Suppl 6(0 6):20\u201322","journal-title":"Epilepsia"},{"issue":"2\u20133","key":"14_CR651","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.eplepsyres.2009.01.002","volume":"84","author":"T Li","year":"2009","unstructured":"Li T, Ren G, Kaplan DL, Boison D (2009) Human mesenchymal stem cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis. Epilepsy Res 84(2\u20133):238\u2013241","journal-title":"Epilepsy Res"},{"issue":"1 Suppl","key":"14_CR652","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3727\/096368912X612512","volume":"21","author":"MAG Friedrich","year":"2012","unstructured":"Friedrich MAG, Martins MP, Ara\u00fajo MD, Klamt C, Vedolin L, Garicochea B et al (2012) Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke. Cell Transplant 21(1 Suppl):13\u201321","journal-title":"Cell Transplant"},{"issue":"2","key":"14_CR653","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.advms.2016.12.004","volume":"62","author":"F Hlebokazov","year":"2017","unstructured":"Hlebokazov F, Dakukina T, Ihnatsenko S, Kosmacheva S, Potapnev M, Shakhbazau A et al (2017) Treatment of refractory epilepsy patients with autologous mesenchymal stem cells reduces seizure frequency: an open label study. Adv Med Sci 62(2):273\u2013279","journal-title":"Adv Med Sci"}],"container-title":["Advances in Experimental Medicine and Biology","Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-31206-0_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T15:00:48Z","timestamp":1722265248000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-31206-0_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030312053","9783030312060"],"references-count":662,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-31206-0_14","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"3 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}